ผลงานวิจัย

Division of Infectious Diseases (สาขาวิชาโรคติดเชื้อ)

2023 (42)

1. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial.

   Avihingsanon A, Lu H, Leong CL, Hung CC, Koenig E, Kiertiburanakul S, Lee MP, Supparatpinyo K, Zhang F, Rahman S, D'Antoni ML, Wang H, Hindman JT, Martin H, Baeten JM, Li T; ALLIANCE Study Team. Lancet HIV. 2023 Oct;10(10):e640-e652.

• Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.

  MalariaGEN; Abdel Hamid MM, Abdelraheem MH, Acheampong DO, Ahouidi A, Ali M, Almagro-Garcia J, Amambua-Ngwa A, Amaratunga C, Amenga-Etego L, Andagalu B, Anderson T, Andrianaranjaka V, Aniebo I, Aninagyei E, Ansah F, Ansah PO, Apinjoh T, Arnaldo P, Ashley E, Auburn S, Awandare GA, Ba H, Baraka V, Barry A, Bejon P, Bertin GI, Boni MF, Borrmann S, Bousema T, Bouyou-Akotet M, Branch O, Bull PC, Cheah H, Chindavongsa K, Chookajorn T, Chotivanich K, Claessens A, Conway DJ, Corredor V, Courtier E, Craig A, D'Alessandro U, Dama S, Day N, Denis B, Dhorda M, Diakite M, Djimde A, Dolecek C, Dondorp A, Doumbia S, Drakeley C, Drury E, Duffy P, Echeverry DF, Egwang TG, Enosse SMM, Erko B, Fairhurst RM, Faiz A, Fanello CA, Fleharty M, Forbes M, Fukuda M, Gamboa D, Ghansah A, Golassa L, Goncalves S, Harrison GLA, Healy SA, Hendry JA, Hernandez-Koutoucheva A, Hien TT, Hill CA, Hombhanje F, Hott A, Htut Y, Hussein M, Imwong M, Ishengoma D, Jackson SA, Jacob CG, Jeans J, Johnson KJ, Kamaliddin C, Kamau E, Keatley J, Kochakarn T, Konate DS, Konaté A, Kone A, Kwiatkowski DP, Kyaw MP, Kyle D, Lawniczak M, Lee SK, Lemnge M, Lim P, Lon C, Loua KM, Mandara CI, Marfurt J, Marsh K, Maude RJ, Mayxay M… See abstract for full author list ➔ Wellcome Open Res. 2023 Jan 16;8:22.

• Projecting spatiotemporal dynamics of severe fever with thrombocytopenia syndrome in the mainland of China.

  Ding FY, Ge HH, Ma T, Wang Q, Hao MM, Li H, Zhang XA, Maude RJ, Wang LP, Jiang D, Fang LQ, Liu W. Glob Chang Biol. 2023 Dec;29(23):6647-6660.

• Label free electrochemical DNA biosensor for COVID-19 diagnosis.

  Lomae A, Preechakasedkit P, Hanpanich O, Ozer T, Henry CS, Maruyama A, Pasomsub E, Phuphuakrat A, Rengpipat S, Vilaivan T, Chailapakul O, Ruecha N, Ngamrojanavanich N. Talanta. 2023 Feb 1;253:123992.

• Clinical and immunological characteristics for BK polyomavirus-associated nephropathy after kidney transplantation.

  Siripoon T, Apiwattanakul N, Mongkolrattanakul P, Tongsook C, Unwanatham N, Hongeng S, Kantachuvesiri S, Bruminhent J. Immun Inflamm Dis. 2023 Aug;11(8):e956.

• Lung abscess and empyema in a heart transplant recipient from Thailand.

  Bruminhent J, López-Medrano F, Pogatchnik BP, Nascimento E, Namsiripongpun W, Yingchoncharoen T, Ngodngamthaweesuk M, Sukprapruet A, Naratreekoon B, Rodriguez-Goncer I, Hernández A, Polanco N, Andrés A, Aguado JM, Pouch SM, Clemente WT. Transpl Infect Dis. 2023 Feb;25(1):e13984.

• Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study.

  Srichatrapimuk S, Wongsa A, Sungkanuparph S, Kiertiburanakul S, Tassaneetrithep B, Phuphuakrat A. AIDS Res Ther. 2023 Feb 27;20(1):13.

• Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.

  Tripura R, von Seidlein L, Sovannaroth S, Peto TJ, Callery JJ, Sokha M, Ean M, Heng C, Conradis-Jansen F, Madmanee W, Peerawaranun P, Waithira N, Khonputsa P, Jongdeepaisal M, Pongsoipetch K, Chotthanawathit P, Soviet U, Pell C, Duanguppama J, Rekol H, Tarning J, Imwong M, Mukaka M, White NJ, Dondorp AM, Maude RJ. Lancet Infect Dis. 2023 Jan;23(1):81-90.

• ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance.

  Mo Y, Ding Y, Cao Y, Hopkins J, Ashley EA, Waithira N, Wannapinij P, Lee SJ, Ling CL, Hamers RL, Roberts T, Lubell Y, Karkey A, Akech S, Lissauer S, Opintan J, Okeke I, Eremin S, Tornimbene B, Hsu LY, Thwaites L, Lam MY, Pham NT, Pham TK, Teo J, Kwa AL, Marimuthu K, Ng OT, Vasoo S, Kitsaran S, Anunnatsiri S, Kosalaraksa P, Chotiprasitsakul D, Santanirand P, Plongla R, Chua HH, Tiong XT, Wong KJ, Ponnampalavanar SSS, Sulaiman HB, Mazlan MZ, Salmuna ZN, Rajahram GS, Zaili MZBM, Francis JR, Sarmento N, Guterres H, Oakley T, Yan J, Tilman A, Khalid MOR, Hashmi M, Mahmood SF, Dhiloo AK, Fatima A, Lubis IND, Wijaya H, Abad CL, Roman AD, Lazarte CCM, Mamun GMS, Asli R, Momin MHFBHA, Nyamdavaa K, Gurjav U, Bory S, Varghese GM, Gupta L, Tantia P, Sinto R, Doi Y, Khanal B, Malijan G, Lazaro J, Gunasekara S, Withanage S, Liu PY, Xiao Y, Wang M, Paterson DL, van Doorn HR, Turner P. Wellcome Open Res. 2023 Aug 16;8:179.

• A systematic review of the data, methods and environmental covariates used to map Aedes-borne arbovirus transmission risk.

  Lim AY, Jafari Y, Caldwell JM, Clapham HE, Gaythorpe KAM, Hussain-Alkhateeb L, Johansson MA, Kraemer MUG, Maude RJ, McCormack CP, Messina JP, Mordecai EA, Rabe IB, Reiner RC Jr, Ryan SJ, Salje H, Semenza JC, Rojas DP, Brady OJ. BMC Infect Dis. 2023 Oct 20;23(1):708.

• Risks and challenges in COVID-19 infection prevention and control in a hospital setting: Perspectives of healthcare workers in Thailand.

  Jongdeepaisal M, Chunekamrai P, Maude RR, Maude RJ. PLoS One. 2023 Dec 19;18(12):e0267996.

• A Prospective Immunogenicity Study of a Quadrivalent Inactivated Influenza Vaccine Among Persons With HIV With Different Levels of CD4 Cell Count.

  Satanon S, Kiertiburanakul S, Boonnak K, Bruminhent J. J Acquir Immune Defic Syndr. 2023 Jul 1;93(3):251-259.

• Longitudinal study of disease severity and external factors in cognitive failure after COVID-19 among Indonesian population.

  Herman B, Wong MCS, Chantharit P, Hannanu FF, Viwattanakulvanid P. Sci Rep. 2023 Nov 8;13(1):19405.

• Epidemiology of malaria in Rohingya refugee camps in Bangladesh within 2017-2020.

  Khan MAA, Maude RJ, Musa S, Khanum H. Malar J. 2023 Sep 28;22(1):288.

• Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials.

  Avihingsanon A, Chetchotisakd P, Kiertiburanakul S, Ratanasuwan W, Siripassorn K, Supparatpinyo K, Martin H, Wang H, Wong T, Wang HY. HIV Med. 2023 Mar;24(3):290-300.

• Diagnostic stewardship to limit repeat plasma cytomegalovirus viral load testing.

  Trirattanapikul A, Pasomsub E, Siriyotha S, Pattanaprateep O, Phuphuakrat A. BMC Infect Dis. 2023 Jun 9;23(1):387.

• Health related quality of life in anti interferon γ autoantibody associated immunodeficiency syndrome measured with EQ5D5L and SF36.

  Temsangsukmanee J, Laisuan W, Thadanipon K, Pisitkun P, Ngamjanyaporn P, Suangtamai T, Oncham S, Chantharit P, Rotjanapan P. Sci Rep. 2023 Sep 1;13(1):14346.

• Epidemiological characteristics and risk factors for cystic and alveolar echinococcosis in China: an analysis of a national population-based field survey.

  Ma T, Wang Q, Hao M, Xue C, Wang X, Han S, Wang Q, Zhao J, Ma X, Wu X, Jiang X, Cao L, Yang Y, Feng Y, Gongsang Q, Scheffran J, Fang L, Maude RJ, Zheng C, Ding F, Wu W, Jiang D. Parasit Vectors. 2023 Jun 3;16(1):181.

• Spatiotemporal reproduction number with Bayesian model selection for evaluation of emerging infectious disease transmissibility: an application to COVID-19 national surveillance data.

  Rotejanaprasert C, Lawson AB, Maude RJ. BMC Med Res Methodol. 2023 Mar 14;23(1):62.

• Saliva and wastewater surveillance for SARS-CoV-2 during school reopening amid COVID-19 pandemic in Thailand.

  Nakgul L, Pasomsub E, Thongpradit S, Chanprasertyothin S, Prasongtanakij S, Thadanipon K, Jadmuang C, Kunanan D, Ongphiphadhanakul B, Phuphuakrat A. Public Health Pract (Oxf). 2023 Jun;5:100378.

• School and community driven dengue vector control and monitoring in Myanmar: Study protocol for a cluster randomized controlled trial.

  Overgaard HJ, Linn NYY, Kyaw AMM, Braack L, Win Tin M, Bastien S, Vande Velde F, Echaubard P, Zaw W, Mukaka M, Maude R. Wellcome Open Res. 2023 Dec 28;7:206.

• Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic.

  Solante R, Alvarez-Moreno C, Burhan E, Chariyalertsak S, Chiu NC, Chuenkitmongkol S, Dung DV, Hwang KP, Ortiz Ibarra J, Kiertiburanakul S, Kulkarni PS, Lee C, Lee PI, Lobo RC, Macias A, Nghia CH, Ong-Lim AL, Rodriguez-Morales AJ, Richtmann R, Safadi MAP, Satari HI, Thwaites G. Expert Rev Vaccines. 2023 Jan-Dec;22(1):1-16.

• Successful treatment of Rhodococcus lung abscess and empyema thoracis in a heart transplant recipient.

  Namsiripongpun W, Yingchoncharoen T, Ngodngamthaweesuk M, Sukprapruet A, Naratreekoon B, Bruminhent J. Transpl Infect Dis. 2023 Dec;25(6):e14140.

• Epidemiology of extended-spectrum β-lactamase-producing Enterobacterales infection in kidney transplant recipients.

  Promsuwan O, Malathum K, Ingsathit A. Antimicrob Resist Infect Control. 2023 Nov 10;12(1):123.

• Patient-level performance evaluation of a smartphone-based malaria diagnostic application.

  Yu H, Mohammed FO, Abdel Hamid M, Yang F, Kassim YM, Mohamed AO, Maude RJ, Ding XC, Owusu EDA, Yerlikaya S, Dittrich S, Jaeger S. Malar J. 2023 Jan 27;22(1):33.

• Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais.

  Boonyawat K, Phojanasenee T, Noikongdee P, Police P, Chantrathammachart P, Niparuck P, Puavilai T, Phuphuakrat A, Angchaisuksiri P. Thromb J. 2023 Sep 6;21(1):92.

• Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications.

  Conradis-Jansen F, Tripura R, Peto TJ, Callery JJ, Adhikari B, Ean M, Jongdeepaisal M, Pell C, Khonputsa P, Murgia R, Sovannaroth S, Müller O, Cheah PY, Dondorp AM, von Seidlein L, Maude RJ. Malar J. 2023 Jun 8;22(1):178.

• Dengue in Myanmar: Spatiotemporal epidemiology, association with climate and short-term prediction.

  Zaw W, Lin Z, Ko Ko J, Rotejanaprasert C, Pantanilla N, Ebener S, Maude RJ. PLoS Negl Trop Dis. 2023 Jun 5;17(6):e0011331.

• Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.

  Ross J, Rupasinghe D, Avihingsanon A, Lee MP, Pujari S, Sharp G, Kumarasamy N, Khusuwan S, Khol V, Agus Somia IK, Pham TN, Kiertiburanakul S, Choi JY, Duy Do C, Sohn AH, Jiamsakul A; TAHOD-LITE study group of IeDEA Asia‐Pacific. PLoS One. 2023 Jun 28;18(6):e0287909.

• Gaps in research and capacity development for malaria surveillance and response in the Asia-Pacific: meeting report.

  Sirimatayanant M, Hein PS, Anderson LF, Montoya LF, Potter R, Nghipumbwa M, Ranaweera P, Ngor P, Phetsouvanh R, Maude RJ. Malar J. 2023 Mar 10;22(1):91.

• Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand.

  Kategeaw W, Nakkam N, Kiertiburanakul S, Sukasem C, Tassaneeyakul W, Chaiyakunapruk N. J Med Econ. 2023 Jan-Dec;26(1):1330-1341.

• From Epidemiology of Community-Onset Bloodstream Infections to the Development of Empirical Antimicrobial Treatment-Decision Algorithm in a Region with High Burden of Antimicrobial Resistance.

  Chotiprasitsakul D, Trirattanapikul A, Namsiripongpun W, Chaihongsa N, Santanirand P. Antibiotics (Basel). 2023 Dec 5;12(12):1699. d

• BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia-Pacific region.

  Khuon D, Rupasinghe D, Saphonn V, Kwong TS, Widhani A, Chaiwarith R, Ly PS, Do CD, Avihingsanon A, Khusuwan S, Merati TP, Van Nguyen K, Kumarasamy N, Chan YJ, Azwa I, Ng OT, Kiertiburanakul S, Tanuma J, Pujari S, Ditangco R, Zhang F, Choi JY, Gani Y, Sangle S, Ross J, Gorbach PM, Jiamsakul A; IeDEA Asia-Pacific. HIV Med. 2023 Feb;24(2):139-152.

• Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis.

  Wasakul V, Disratthakit A, Mayxay M, Chindavongsa K, Sengsavath V, Thuy-Nhien N, Pearson RD, Phalivong S, Xayvanghang S, Maude RJ, Gonçalves S, Day NP, Newton PN, Ashley EA, Kwiatkowski DP, Dondorp AM, Miotto O. Lancet Infect Dis. 2023 May;23(5):568-577.

• Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines - A prospective multi-center study.

  Phuensan P, Sirimongkolkasem J, Tantawichien T, Phannajit J, Kerr SJ, Hansasuta P, Chantharit P, Wongsa A, Fuengfoo P, Chittinandana A, Vareesangthip K, Chayakulkeeree M, Jangsirikul S, Schmidt A, Wanvimonsuk K, Winichakoon P, Kajeekul R, Prayoonwiwat W, Rerknimitr R. Heliyon. 2023 Dec 3;10(1):e23246.

• The feasibility of novel point-of-care diagnostics for febrile illnesses at health centres in Southeast Asia: a mixed-methods study.

  Adella FJ, Vanna M, Adhikari B, Ol S, Tripura R, Davoeung C, Callery JJ, Sovann Y, Chandna A, Bunreth V, Asnong C, von Seidlein L, Dondorp AM, Maude RJ, Lubell Y, Wills B, Lek D, Peto TJ. Trans R Soc Trop Med Hyg. 2023 Nov 3;117(11):788-796.

• Expanding the role of village malaria workers in Cambodia: Implementation and evaluation of four health education packages.

  Betrian M, Umans D, Vanna M, Ol S, Adhikari B, Davoeung C, Callery JJ, Sovann Y, Peto TJ, Maude RJ, van der Pluijm RW, Bunreth V, Grobusch MP, van Vugt M, Lubell Y, von Seidlein L, Dondorp AM, Sovannaroth S, Lek D, Tripura R. PLoS One. 2023 Sep 8;18(9):e0283405.

• Utility of the Interferon-Gamma Enzyme-Linked Immunosorbent Spot Assay to Predict Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

  Namsiripongpun W, Kantachuvesiri S, Bruminhent J. Transpl Int. 2024 Jan 5;36:11527.

• Spatial and temporal distribution of reported dengue cases and hot spot identification in Quezon City, Philippines, 2010-2017.

  Medina JRC, Takeuchi R, Mercado CEG, de Los Reyes CS, Cruz RV, Abrigo MDR, Hernandez PMR, Garcia FB Jr, Salanguit M, Gregorio ER Jr, Kawamura S, Hung KE, Kaneko M, Nonaka D, Maude RJ, Kobayashi J. Trop Med Health. 2023 May 25;51(1):31.

• CD4/CD8 Ratio Recovery Among People Living With HIV Starting With First-Line Integrase Strand Transfer Inhibitors: A Prospective Regional Cohort Analysis.

  Han WM, Avihingsanon A, Rajasuriar R, Tanuma J, Mundhe S, Lee MP, Choi JY, Pujari S, Chan YJ, Somia A, Zhang F, Kumarasamy N, Tek Ng O, Gani Y, Chaiwarith R, Pham TN, Do CD, Ditangco R, Kiertiburanakul S, Khol V, Ross J, Jiamsakul A; IeDEA Asia‐Pacific. J Acquir Immune Defic Syndr. 2023 Feb 1;92(2):180-188.

• Treatment Outcomes After Switching to Second-Line Anti-Retroviral Therapy: Results From the Thai National Treatment Program.

  Sudsila P, Teeraananchai S, Kiertiburanakul S, Lertpiriyasuwat C, Triamwichanon R, Gatechompol S, Putcharoen O, Chetchotisakd P, Avihingsanon A, Kerr SJ, Ruxrungtham K. J Int Assoc Provid AIDS Care. 2023 Jan-Dec;22:23259582231220513.

• Author Correction: Longitudinal study of disease severity and external factors in cognitive failure after COVID-19 among Indonesian population.

  Herman B, Wong MCS, Chantharit P, Hannanu FF, Viwattanakulvanid P. Sci Rep. 2023 Dec 18;13(1):22514.

 

2022 (62)

1. Defining post-COVID condition.

   Villar JC, Gumisiriza N, Abreu LG, Maude RJ, Colebunders R. Lancet Infect Dis. 2022 Mar;22(3):316-317.

• Current state of antimicrobial stewardship and organ transplantation in Thailand.

  Chotiprasitsakul D, Bruminhent J, Watcharananan SP. Transpl Infect Dis. 2022 Oct;24(5):e13877.

• New Zealand maternity and midwifery services and the COVID-19 response: A systematic scoping review.

  Crowther S, Maude R, Zhao IY, Bradford B, Gilkison A. Women Birth. 2022 May;35(3):213-222.

• Expert review on global real-world vaccine effectiveness against SARS-CoV-2.

  Chuenkitmongkol S, Solante R, Burhan E, Chariyalertsak S, Chiu NC, Do-Van D, Husin M, Hwang KP, Kiertiburanakul S, Kulkarni PS, Lee PI, Lobo RC, Nghia CH, Ong-Lim A, Sivasampu S, Suah JL, Tok PSK, Thwaites G; SEA Vaccine Effectiveness Expert Working Group. Expert Rev Vaccines. 2022 Sep;21(9):1255-1268.

• Use of Favipiravir for the Treatment of Coronavirus Disease 2019 in the Setting of Hospitel.

  Surapat B, Kobpetchyok W, Kiertiburanakul S, Arnuntasupakul V. Int J Clin Pract. 2022 Mar 29;2022:3098527.

• Prevalence of Diabetes Mellitus in Patients with Tuberculosis: A Prospective Cohort Study.

  Buasroung P, Petnak T, Liwtanakitpipat P, Kiertiburanakul S. Int J Infect Dis. 2022 Mar;116:374-379.

• Patterns and prognosis of holding regimens for people living with HIV in Asian countries.

  Kim JH, Jiamsakul A, Kiertiburanakul S, Huy BV, Khusuwan S, Kumarasamy N, Ng OT, Ly PS, Lee MP, Chan YJ, Gani YM, Azwa I, Avihingsanon A, Merati TP, Pujari S, Chaiwarith R, Zhang F, Tanuma J, Do CD, Ditangco R, Yunihastuti E, Ross J, Choi JY; IeDEA Asia-Pacific. PLoS One. 2022 Mar 30;17(3):e0264157.

• Association between gut microbiota and prediabetes in people living with HIV.

  Jayanama K, Phuphuakrat A, Pongchaikul P, Prombutara P, Nimitphong H, Reutrakul S, Sungkanuparph S. Curr Res Microb Sci. 2022 May 31;3:100143.

• Label free electrochemical DNA biosensor for COVID-19 diagnosis.

  Lomae A, Preechakasedkit P, Hanpanich O, Ozer T, Henry CS, Maruyama A, Pasomsub E, Phuphuakrat A, Rengpipat S, Vilaivan T, Chailapakul O, Ruecha N, Ngamrojanavanich N. Talanta. 2023 Feb 1;253:123992.

• A Prospective Study of Plasma and Bronchoalveolar Lavage Fluid CMV DNA Load Quantification for the Diagnosis and Outcome of CMV Pneumonitis in Immunocompromised Hosts.

  Saksirisampant G, Kawamatawong T, Promsombat K, Sukkasem W, Liamsombut S, Pasomsub E, Bruminhent J. J Clin Virol. 2022 Oct;155:105243.

• The Association of HLA-B*35 and GSTT1 Genotypes and Hepatotoxicity in Thai People Living with HIV.

  Chanhom N, Jittikoon J, Wattanapokayakit S, Mahasirimongkol S, Charoenyingwattana A, Udomsinprasert W, Chaikledkaew U, Suvichapanich S, Mushiroda T, Kiertiburanakul S, Rojanawiwat A, Wangsomboonsiri W, Manosuthi W, Kantipong P, Apisarnthanarak A, Sangsirinakakul W, Wongprasit P, Chaiwarith R, Tantisiriwat W, Sungkanuparph S, Chantratita W. J Pers Med. 2022 Jun 8;12(6):940.

• Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria.

  Tarning J, von Seidlein L, Dondorp AM, White NJ, Maude RJ. BMC Res Notes. 2022 Oct 2;15(1):313.

• Clinical Course and Outcomes among COVID-19 Patients at the Hospitel in Bangkok: A Retrospective Study.

  Bruminhent J, Kaewsanga Y, Jiraaumpornpat W, Arnuntasupakul V, Suwatanapongched T, Kiertiburanakul S. Trop Med Infect Dis. 2022 Sep 10;7(9):238.

• Lung abscess and empyema in a heart transplant recipient from Thailand.

  Bruminhent J, López-Medrano F, Pogatchnik BP, Nascimento E, Namsiripongpun W, Yingchoncharoen T, Ngodngamthaweesuk M, Sukprapruet A, Naratreekoon B, Rodriguez-Goncer I, Hernández A, Polanco N, Andrés A, Aguado JM, Pouch SM, Clemente WT. Transpl Infect Dis. 2023 Feb;25(1):e13984.

• Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study.

  Kagoro FM, Allen E, Mabuza A, Workman L, Magagula R, Kok G, Davies C, Malatje G, Guérin PJ, Dhorda M, Maude RJ, Raman J, Barnes KI. Malar J. 2022 Jun 29;21(1):207.

• The Impact of Timing of Antiretroviral Therapy Initiation on Retention in Care, Viral Load Suppression and Mortality in People Living with HIV: A Study in a University Hospital in Thailand.

  Eamsakulrat P, Kiertiburanakul S. J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221082607.

• Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update.

  Sripongpun P, Pinpathomrat N, Bruminhent J, Kaewdech A. Front Med (Lausanne). 2022 Jun 22;9:924454.

• Diagnostic Yield and Impact on Antimicrobial Management of 16S rRNA Testing of Clinical Specimens.

  Eamsakulrat P, Santanirand P, Phuphuakrat A. Microbiol Spectr. 2022 Dec 21;10(6):e0209422.

• Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.

  Tripura R, von Seidlein L, Sovannaroth S, Peto TJ, Callery JJ, Sokha M, Ean M, Heng C, Conradis-Jansen F, Madmanee W, Peerawaranun P, Waithira N, Khonputsa P, Jongdeepaisal M, Pongsoipetch K, Chotthanawathit P, Soviet U, Pell C, Duanguppama J, Rekol H, Tarning J, Imwong M, Mukaka M, White NJ, Dondorp AM, Maude RJ. Lancet Infect Dis. 2023 Jan;23(1):81-90.

• Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.

  Peto TJ, Tripura R, Callery JJ, Lek D, Nghia HDT, Nguon C, Thuong NTH, van der Pluijm RW, Dung NTP, Sokha M, Van Luong V, Long LT, Sovann Y, Duanguppama J, Waithira N, Hoglund RM, Chotsiri P, Chau NH, Ruecker A, Amaratunga C, Dhorda M, Miotto O, Maude RJ, Rekol H, Chotivanich K, Tarning J, von Seidlein L, Imwong M, Mukaka M, Day NPJ, Hien TT, White NJ, Dondorp AM. Lancet Infect Dis. 2022 Jun;22(6):867-878.

• Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific.

  Rupasinghe D, Choi JY, Yunihastuti E, Kiertiburanakul S, Ross J, Ly PS, Chaiwarith R, Do CD, Chan YJ, Kumarasamy N, Avihingsanon A, Kamarulzaman A, Khusuwan S, Zhang F, Lee MP, Van Nguyen K, Merati TP, Sangle S, Oon Tek N, Tanuma J, Ditangco R, Sim BLH, Pujari S, Jiamsakul A; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. J Med Virol. 2022 Nov;94(11):5451-5464.

• Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate.

  Phuphuakrat A, Pasomsub E, Chantratita W, Mahasirimongkol S, Disthabanchong S, Sungkanuparph S, Kiertiburanakul S. J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221134751.

• Impact of Carbapenem Peri-Transplant Prophylaxis and Risk of Extended-Spectrum Cephalosporin-Resistant Enterobacterales Early Urinary Tract Infection in Kidney Transplant Recipients: A Propensity Score-Matched Analysis.

  Aramwittayanukul S, Malathum K, Kantachuvesiri S, Arpornsujaritkun N, Chootip P, Bruminhent J. Front Med (Lausanne). 2022 Jun 6;9:841293.

• Climate drives the spatiotemporal dynamics of scrub typhus in China.

  Ding F, Wang Q, Hao M, Maude RJ, John Day NP, Lai S, Chen S, Fang L, Ma T, Zheng C, Jiang D. Glob Chang Biol. 2022 Nov;28(22):6618-6628.

• Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis.

  Kagoro FM, Barnes KI, Marsh K, Ekapirat N, Mercado CEG, Sinha I, Humphreys G, Dhorda M, Guerin PJ, Maude RJ. Lancet Microbe. 2022 Mar;3(3):e184-e192.

• Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in Asia.

  Teeraananchai S, Law M, Boettiger D, Mata N, Gupte N, Chan YL, Pham TN, Chaiwarith R, Ly PS, Chan YJ, Kiertiburanakul S, Khusuwan S, Zhang F, Yunihastuti E, Kumarasamy N, Pujari S, Azwa I, Somia IKA, Tanuma J, Ditangco R, Choi JY, Ng OT, Do CD, Gani Y, Ross J, Jiamsakul A; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. J Int AIDS Soc. 2022 Aug;25(8):e25989.

• Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.

  Phuphuakrat A, Pasomsub E, Srichatrapimuk S, Kirdlarp S, Suksatu A, Srisaowakarn C, Manopwisedjaroen S, Ludowyke N, Purwono PB, Priengprom T, Wongsa A, Thakkinstian A, Hongeng S, Malathum K, Thitithanyanont A, Tassaneetrithep B. Microbiol Spectr. 2022 Jun 29;10(3):e0050322.

• Surveillance to achieve malaria elimination in eastern Myanmar: a 7-year observational study.

  Rae JD, Nosten S, Kajeechiwa L, Wiladphaingern J, Parker DM, Landier J, Thu AM, Dah H, Be A, Cho WC, Paw K', Paw ES, Shee PB, Poe C, Nu C, Nyaw B, Simpson JA, Devine A, Maude RJ, Moo KL, Min MC, Thwin MM, Tun SW, Nosten FH. Malar J. 2022 Jun 7;21(1):175.

• Spatiotemporal Epidemiology of Tuberculosis in Thailand from 2011 to 2020.

  Chinpong K, Thavornwattana K, Armatrmontree P, Chienwichai P, Lawpoolsri S, Silachamroon U, Maude RJ, Rotejanaprasert C. Biology (Basel). 2022 May 16;11(5):755.

• Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials.

  Avihingsanon A, Chetchotisakd P, Kiertiburanakul S, Ratanasuwan W, Siripassorn K, Supparatpinyo K, Martin H, Wang H, Wong T, Wang HY. HIV Med. 2023 Mar;24(3):290-300.

• Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV.

  Han WM, Law MG, Choi JY, Ditangco R, Kumarasamy N, Chaiwarith R, Ly PS, Khusuwan S, Merati TP, Do CD, Yunihastuti E, Azwa I, Lee MP, Pham TN, Chan YJ, Kiertiburanakul S, Ng OT, Tanuma J, Pujari S, Zhang F, Gani Y, Mave V, Ross J, Avihingsanon A; TREAT Asia HIV Observational Database of IeDEA Asia-Pacific. HIV Med. 2022 Mar;23(3):274-286.

• Lung Ultrasound Estimates the Overhydration and Benefits Blood Pressure Control in Normal or Mild Symptomatic Hemodialysis Patients.

  Trirattanapikul A, Kongpetch S, Lukkanalikitkul E, Ahooja A, Seesuk P, Sharma A, Anutrakulchai S. Int J Nephrol Renovasc Dis. 2022 Dec 19;15:383-395.

• Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Thailand.

  Jongdeepaisal M, Khonputsa P, Prasert O, Maneenet S, Pongsoipetch K, Jatapai A, Rotejanaprasert C, Sudathip P, Maude RJ, Pell C. Malar J. 2022 Feb 14;21(1):47.

• Forest malaria and prospects for anti-malarial chemoprophylaxis among forest goers: findings from a qualitative study in Lao PDR.

  Jongdeepaisal M, Inthasone S, Khonputsa P, Malaphone V, Pongsoipetch K, Pongvongsa T, Mayxay M, Chindavongsa K, Pell C, Maude RJ. Malar J. 2022 Jan 5;21(1):8.

• Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients.

  Singkham N, Avihingsanon A, Brundage RC, Birnbaum AK, Thammajaruk N, Ruxrungtham K, Bunupuradah T, Kiertiburanakul S, Chetchotisakd P, Punyawudho B; LASA study team. Expert Rev Clin Pharmacol. 2022 Jan;15(1):99-108.

• Clinical outcome of rapid diagnosis and antibiotic stewardship in patients with bloodstream infection in Lampang Hospital.

  Sakulkonkij P, Bruminhent J. Antimicrob Steward Healthc Epidemiol. 2022 Oct 28;2(1):e174.

• Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers.

  Watcharananan SP, Jaru-Ampornpan P, Sahawongcharoen S, Naitook N, Himananto O, Jongkaewwattana A, Setthaudom C, Rattanasiri S, Phuphuakrat A, Thakkinstian A, Mavichak V; Praram 9-BIOTEC-Ramathibodi COVID-19 Vaccine Study Group. Am J Transplant. 2022 May;22(5):1459-1466.

• Practice, skills and experience with the Pinard stethoscope for intrapartum Foetal monitoring: Focus group interviews with Norwegian midwives.

  Engelhart CH, Nilsen ABV, Pay ASD, Maude R, Kaasen A, Blix E. Midwifery. 2022 May;108:103288.

• Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic.

  Solante R, Alvarez-Moreno C, Burhan E, Chariyalertsak S, Chiu NC, Chuenkitmongkol S, Dung DV, Hwang KP, Ortiz Ibarra J, Kiertiburanakul S, Kulkarni PS, Lee C, Lee PI, Lobo RC, Macias A, Nghia CH, Ong-Lim AL, Rodriguez-Morales AJ, Richtmann R, Safadi MAP, Satari HI, Thwaites G. Expert Rev Vaccines. 2023 Jan-Dec;22(1):1-16.

• Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients.

  Hayuk P, Boongird S, Pornsuriyasak P, Bruminhent J. Front Cell Infect Microbiol. 2022 Nov 14;12:1046373.

• School and community driven dengue vector control and monitoring in Myanmar: Study protocol for a cluster randomized controlled trial.

  Overgaard HJ, Linn NYY, Kyaw AMM, Braack L, Win Tin M, Bastien S, Vande Velde F, Echaubard P, Zaw W, Mukaka M, Maude R. Wellcome Open Res. 2023 Dec 28;7:206.

• Virtual reality is beneficial in decreasing pain in labouring women: A preliminary study.

  Massov L, Robinson B, Rodriguez-Ramirez E, Maude R. Aust N Z J Obstet Gynaecol. 2022 Jul 25.

• Climate change and health in Southeast Asia - defining research priorities and the role of the Wellcome Trust Africa Asia Programmes.

  Choisy M, McBride A, Chambers M, Ho Quang C, Nguyen Quang H, Xuan Chau NT, Thi GN, Bonell A, Evans M, Ming D, Ngo-Duc T, Quang Thai P, Dang Giang DH, Dan Thanh HN, Ngoc Nhung H, Lowe R, Maude R, Elyazar I, Surendra H, Ashley EA, Thwaites L, van Doorn HR, Kestelyn E, Dondorp AM, Thwaites G, Vinh Chau NV, Yacoub S. Wellcome Open Res. 2022 Sep 5;6:278.

• The overuse of intrapartum cardiotocography (CTG) for low-risk women: An actor-network theory analysis of data from focus groups.

  Jepsen I, Blix E, Cooke H, Adrian SW, Maude R. Women Birth. 2022 Nov;35(6):593-601.

• Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific.

  Rupasinghe D, Choi JY, Kumarasamy N, Pujari S, Sun LP, Merati TP, Lee MP, Kinh NV, Kiertiburanakul S, Do CD, Avihingsanon A, Ross J, Jiamsakul A; IeDEA Asia-Pacific. HIV Med. 2022 Oct;23(9):959-968.

• Design of an Integrated Clinical Research Informatics System for a Multi-Centre and Multi-Visit Prospective Birth Cohort Study.

  Sinitkul R, Maude RJ, Nithirochananont U. Stud Health Technol Inform. 2022 Jun 6;290:125-129.

• Good recovery of immunization stress-related responses presenting as a cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations.

  Apiwattanakul M, Suanprasert N, Rojana-Udomsart A, Termglinchan T, Sinthuwong C, Tantirittisak T, Hanchaiphiboolkul S, Angchaisuksiri P, Srimahachota S, Wongsawat J, Stiudomkajorn S, Kiertiburanakul S, Techasaensiri C, Laisuan W, Manosuthi W, Doungngern P, Jaroenkunathum W, Jivapaisarnpong T, Panjangampatthana A, Chimmanee J, Chokephaibulkit K. PLoS One. 2022 Aug 25;17(8):e0266118.

• Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project.

  Chandna A, Chew R, Shwe Nwe Htun N, Peto TJ, Zhang M, Liverani M, Brummaier T, Phommasone K, Perrone C, Pyae Phyo A, Sattabongkot J, Roobsoong W, Nguitragool W, Sen A, Ibna Zaman S, Sandar Zaw A, Batty E, Waithira N, Abdad MY, Blacksell SD, Bodhidatta L, Callery JJ, Fagnark W, Huangsuranun W, Islam S, Lertcharoenchoke S, Lohavittayavikant S, Mukaka M, Moul V, Kumer Neogi A, Nedsuwan S, Pongvongsa T, Ponsap P, Richard-Greenblatt M, Schilling WHK, Thaipadungpanit J, Tripura R, Dondorp AM, Mayxay M, White NJ, Nosten F, Smithuis F, Ashley EA, Maude RJ, Day NPJ, Lubell Y. Wellcome Open Res. 2022 Mar 10;6:64.

• Anti-HIV serological test algorithms to reduce false-positive and inconclusive results for low HIV prevalence and resource-limited areas.

  Srichatrapimuk S, Setthaudom C, Apiwattanakul N, Sungkanuparph S, Phuphuakrat A. Int J STD AIDS. 2022 Jan;33(1):63-72.

• Use of Machine Learning Consensus Clustering to Identify Distinct Subtypes of Black Kidney Transplant Recipients and Associated Outcomes.

  Thongprayoon C, Vaitla P, Jadlowiec CC, Leeaphorn N, Mao SA, Mao MA, Pattharanitima P, Bruminhent J, Khoury NJ, Garovic VD, Cooper M, Cheungpasitporn W. JAMA Surg. 2022 Jul 1;157(7):e221286.

• Brief Report: Mortality After Loss to Follow-Up-A Linkage Study of People Living With HIV in Thailand and Malaysia.

  Jiamsakul A, Gani Y, Avihingsanon A, Azwa I, Chaiwarith R, Khusuwan S, Ross J, Law M, Kiertiburanakul S; IeDEA Asia-Pacific. J Acquir Immune Defic Syndr. 2022 Nov 1;91(3):290-295.

• Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine.

  Boongird S, Chuengsaman P, Setthaudom C, Nongnuch A, Assanatham M, Phanprasert S, Kitpermkiat R, Kiertiburanakul S, Malathum K, Phuphuakrat A, Davenport A, Bruminhent J. Infect Dis Ther. 2022 Feb;11(1):351-365.

• Rates, types, and associated factors of acute adverse effects after the first dose of ChAdOx1 nCoV-19 vaccine administration in Thailand.

  Watcharananan SA, Nadee C, Kongsuwattanaleart P, Sangthong N, Ngorsakun P, Vimonvattaravetee P, Phuphuakrat A, Udomsubpayakul U. IJID Reg. 2022 Mar;2:35-39.

• BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia-Pacific region.

  Khuon D, Rupasinghe D, Saphonn V, Kwong TS, Widhani A, Chaiwarith R, Ly PS, Do CD, Avihingsanon A, Khusuwan S, Merati TP, Van Nguyen K, Kumarasamy N, Chan YJ, Azwa I, Ng OT, Kiertiburanakul S, Tanuma J, Pujari S, Ditangco R, Zhang F, Choi JY, Gani Y, Sangle S, Ross J, Gorbach PM, Jiamsakul A; IeDEA Asia-Pacific. HIV Med. 2023 Feb;24(2):139-152.

• Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis.

  Wasakul V, Disratthakit A, Mayxay M, Chindavongsa K, Sengsavath V, Thuy-Nhien N, Pearson RD, Phalivong S, Xayvanghang S, Maude RJ, Gonçalves S, Day NP, Newton PN, Ashley EA, Kwiatkowski DP, Dondorp AM, Miotto O. Lancet Infect Dis. 2023 May;23(5):568-577.

• Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.

  Bruminhent J, Setthaudom C, Kitpermkiat R, Kiertiburanakul S, Malathum K, Assanatham M, Nongnuch A, Phuphuakrat A, Chaumdee P, Janphram C, Thotsiri S, Chuengsaman P, Boongird S. Sci Rep. 2022 Mar 4;12(1):3587.

• Further implications on the global real-world vaccine effectiveness against SARS-CoV-2.

  Solante R, Alvarez-Moreno C, Burhan E, Chariyalertsak S, Chiu NC, Chuenkitmongkol S, Do-Van D, Hwang KP, Kiertiburanakul S, Lee PI, Lobo RC, Macias A, Nghia CH, Ong-Lim A, Ortiz Ibarra J, Richtmann R, Rodriguez-Morales AJ, Safadi MAP, Satari HI. Expert Rev Vaccines. 2022 Sep;21(9):1355-1357.

• SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period.

  Srichatrapimuk S, Chookajorn T, Kochakarn T, Kirdlarp S, Pasomsub E, Chantratita W, Iamsirithaworn S, Kunakorn M, Thitithanyanont A, Sungkanuparph S, Phuphuakrat A. Travel Med Infect Dis. 2022 Mar-Apr;46:102271.

• An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study).

  Bruminhent J, Setthaudom C, Phornkittikorn P, Chaumdee P, Prasongtanakij S, Srisala S, Malathum K, Boongird S, Nongnuch A, Assanatham M, Nakgul L, Sanmeema N, Phuphuakrat A, Kiertiburanakul S; Ramathibodi Transplant Infectious Diseases (RTID) Study Group. Am J Transplant. 2022 Nov;22(11):2651-2660.

• Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis.

  Dejprapasorn S, Kantachuvesiri S, Pornsuriyasak P, Sakulchairungrueng B, Gesprasert G, Bruminhent J. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):684-687.

• SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study).

  Bruminhent J, Setthaudom C, Chaumdee P, Boongird S, Kiertiburanakul S, Malathum K, Nongnuch A, Phuphuakrat A, Jirasiritham S, Janphram C, Thotsiri S, Upama S, Assanatham M; Ramathibodi Transplant Infectious Diseases (RTID) Study Group. Am J Transplant. 2022 Mar;22(3):813-822.

• Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3).

  Boongird S, Setthaudom C, Kitpermkiat R, Prasongtanakij S, Srisala S, Chuengsaman P, Nongnuch A, Assanatham M, Kiertiburanakul S, Malathum K, Phuphuakrat A, Bruminhent J. Vaccines (Basel). 2022 Jul 1;10(7):1064.

2021

1. Saliva sample pooling for the detection of SARS-CoV-2. Pasomsub E, Watcharananan SP, Watthanachockchai T, Rakmanee K, Tassaneetrithep B, Kiertiburanakul S, Phuphuakrat A. J Med Virol. 2021 Mar;93(3):1506-1511. doi: 10.1002/jmv.26460. Epub 2020 Sep 29. PMID: 32841429 Free PMC article.

2. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Pasomsub E, Watcharananan SP, Boonyawat K, Janchompoo P, Wongtabtim G, Suksuwan W, Sungkanuparph S, Phuphuakrat A. Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4. doi: 10.1016/j.cmi.2020.05.001. Epub 2020 May 15. PMID: 32422408 Free PMC article.

3. Thailand's national strategic plan on antimicrobial resistance: progress and challenges. Sumpradit N, Wongkongkathep S, Malathum K, Janejai N, Paveenkittiporn W, Yingyong T, Chuxnum T, Vijitleela A, Boonyarit P, Akaleephan C, Manosuthi W, Thienthong V, Srinha J, Wongsrichai S, Laoprasert T, Athipunyakom P, Kriengchaiyaprug N, Intarukdach K, Numsawad S, Somjetanakul N, Punnin S, Kiatying-Angsulee N. Bull World Health Organ. 2021 Sep 1;99(9):661-673. doi: 10.2471/BLT.20.280644. Epub 2021 Jul 1. PMID: 34475603 Free PMC article.

4. A Comparison of Bone Mineral Density and Its Predictors in HIV-Infected and HIV-Uninfected Older Men. Nimitphong H, Sungkanuparph S, Saetung S, Chailurkit LO, Sritara C, Musikarat S, Ongphiphadhanakul B. Endocr Pract. 2021 Jul 31:S1530-891X(21)01153-8. doi: 10.1016/j.eprac.2021.07.015. Online ahead of print. PMID: 34343711

5. Clinical Characteristics of Late-Onset Cytomegalovirus Infection After Kidney Transplantation. Nuansri S, Kantachuvesiri S, Watcharananan SP, Thongprayoon C, Cheungpasitporn W, Bruminhent J. Transplant Proc. 2021 Aug 14:S0041-1345(21)00506-6. doi: 10.1016/j.transproceed.2021.07.033. Online ahead of print. PMID: 34404538

6. Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV. Han WM, Jiamsakul A, Jantarapakde J, Yunihastuti E, Choi JY, Ditangco R, Chaiwarith R, Sun LP, Khusuwan S, Merati TP, Do CD, Azwa I, Lee MP, Van Nguyen K, Chan YJ, Kiertiburanakul S, Ng OT, Tanuma J, Pujari S, Zhang F, Gani YM, Sangle S, Ross J, Kumarasamy N; the TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. HIV Med. 2021 Apr;22(4):294-306. doi: 10.1111/hiv.13017. Epub 2020 Nov 17. PMID: 33200864 Free PMC article.

7. Infectious causes of acute meningitis among Thai adults in a university hospital. Aimbudlop K, Bruminhent J, Kiertiburanakul S. J Infect Chemother. 2021 Feb;27(2):198-204. doi: 10.1016/j.jiac.2020.09.002. Epub 2020 Sep 12. PMID: 32933857

8. Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a. Joonlasak K, Batty EM, Kochakarn T, Panthan B, Kümpornsin K, Jiaranai P, Wangwiwatsin A, Huang A, Kotanan N, Jaru-Ampornpan P, Manasatienkij W, Watthanachockchai T, Rakmanee K, Jones AR, Fernandez S, Sensorn I, Sungkanuparph S, Pasomsub E, Klungthong C, Chookajorn T, Chantratita W. Virus Res. 2021 Jan 15;292:198233. doi: 10.1016/j.virusres.2020.198233. Epub 2020 Nov 21. PMID: 33227343 Free PMC article.

9. CONVALESCENT plasma for COVID-19: A meta-analysis of clinical trials and real-world evidence. Kloypan C, Saesong M, Sangsuemoon J, Chantharit P, Mongkhon P. Eur J Clin Invest. 2021 Aug 10:e13663. doi: 10.1111/eci.13663. Online ahead of print. PMID: 34375445 Free PMC article.

10. Epidemiology, Risk Factors, and Outcome of Bloodstream Infection Within the First Year After Kidney Transplantation. Siritip N, Nongnuch A, Dajsakdipon T, Thongprayoon C, Cheungprasitporn W, Bruminhent J. Am J Med Sci. 2021 Mar;361(3):352-357. doi: 10.1016/j.amjms.2020.10.011. Epub 2020 Oct 12. PMID: 33309136

11. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people. Jongraksak T, Sobhonslidsuk A, Jatchavala J, Warodomwichit D, Kaewduang P, Sungkanuparph S. Int J STD AIDS. 2021 Mar;32(3):266-275. doi: 10.1177/0956462420960997. Epub 2020 Dec 18. PMID: 33334267

12. Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study. Eksombatchai D, Wongsinin T, Phongnarudech T, Thammavaranucupt K, Amornputtisathaporn N, Sungkanuparph S. PLoS One. 2021 Sep 2;16(9):e0257040. doi: 10.1371/journal.pone.0257040. eCollection 2021. PMID: 34473811 Free PMC article.

13. Effects of an intensive lifestyle intervention and the role of sleep in people living with HIV and prediabetes: a pilot and feasibility study. Nimitphong H, Sungkanuparph S, Areevut C, Saetung S, Jerawatana R, Hathaidechadusadee A, Somwang S, Tongchom W, Saibuathong N, Sakmanarit J, Pichitchaipitak O, Phuphuakrat A, Reutrakul S. BMC Res Notes. 2021 Apr 17;14(1):145. doi: 10.1186/s13104-021-05558-z. PMID: 33865450 Free PMC article.

14. Perceived roles and barriers to nurses' engagement in antimicrobial stewardship: A Thai qualitative case study. van Gulik N, Hutchinson A, Considine J, Driscoll A, Malathum K, Botti M. Infect Dis Health. 2021 Aug;26(3):218-227. doi: 10.1016/j.idh.2021.04.003. Epub 2021 May 11. PMID: 33994163

15. Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19).Surapat B, Sungkanuparph S, Kirdlarp S, Lekpittaya N, Chunnguleum K. J Clin Pharm Ther. 2021 Feb;46(1):236-239. doi: 10.1111/jcpt.13293. Epub 2020 Oct 21. PMID: 33085800

16. Nationwide Surveillance and Molecular Characterization of Critically Drug-Resistant Gram-Negative Bacteria: Results of the Research University Network Thailand Study. Yungyuen T, Chatsuwan T, Plongla R, Kanthawong S, Yordpratum U, Voravuthikunchai SP, Chusri S, Saeloh D, Samosornsuk W, Suwantarat N, Chaiwarith R, Wannalerdsakun S, Rotjanapan P, Chantharit P, Tulyaprawat O, Thaipisuttikul I, Kiratisin P; Research University Network Thailand Study Group. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0067521. doi: 10.1128/AAC.00675-21. Epub 2021 Aug 17. PMID: 34181474 Free PMC article.

17. The association between body mass index and severity of Coronavirus Disease 2019 (COVID-19): A cohort study. Jayanama K, Srichatrapimuk S, Thammavaranucupt K, Kirdlarp S, Suppadungsuk S, Wongsinin T, Nanthatanti N, Phusanti S, Pitidhammabhorn D, Sungkanuparph S. PLoS One. 2021 Feb 16;16(2):e0247023. doi: 10.1371/journal.pone.0247023. eCollection 2021. PMID: 33592042 Free PMC article.

18. Improving knowledge, attitudes and practice to prevent COVID-19 transmission in healthcare workers and the public in Thailand. Maude RR, Jongdeepaisal M, Skuntaniyom S, Muntajit T, Blacksell SD, Khuenpetch W, Pan-Ngum W, Taleangkaphan K, Malathum K, Maude RJ. BMC Public Health. 2021 Apr 18;21(1):749. doi: 10.1186/s12889-021-10768-y. PMID: 33865342 Free PMC article.

19. Comparison between blood hemoglobin concentration determined by point-of-care device and complete blood count in adult patients with dengue. Wisanuvej K, Boonyawat K, Savetamornkul C, Virapongsiri S, Krongvorakul J, Sungkanuparph S, Phuphuakrat A. PLoS Negl Trop Dis. 2021 Aug 16;15(8):e0009692. doi: 10.1371/journal.pntd.0009692. eCollection 2021 Aug. PMID: 34398882 Free PMC article.

20. Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity. Kirisri S, Vongsakulyanon A, Kantachuvesiri S, Razonable RR, Bruminhent J. Open Forum Infect Dis. 2021 Apr 17;8(6):ofab199. doi: 10.1093/ofid/ofab199. eCollection 2021 Jun. PMID: 34113686 Free PMC article.

21. Viral Tropism in Human Immunodeficiency Virus Type 1-Infected Children and Adolescents in Thailand. Arayapong N, Pasomsub E, Kanlayanadonkit R, Keatkla J, Techasaensiri C, Phuphuakrat A, Sungkanuparph S, Apiwattanakul N, Chaisavaneeyakorn S. J Pediatric Infect Dis Soc. 2021 Feb 13;10(1):1-6. doi: 10.1093/jpids/piaa004. PMID: 31981458

22. A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants. Bruminhent J, Autto S, Rotjanapan P, Ngarmjanyaporn P, Bushyakanist A, Kirdlarp S, O-Charoen P, Setthaudom C, Pisitkun P. Open Forum Infect Dis. 2021 May 16;8(6):ofab248. doi: 10.1093/ofid/ofab248. eCollection 2021 Jun. PMID: 34189173 Free PMC article.

23. Role of highly sensitive nucleic acid amplification testing for plasma cytomegalovirus DNA load in diagnosis of cytomegalovirus gastrointestinal disease among kidney transplant recipients. Taksinwarajarn T, Sobhonslidsuk A, Kantachuvesiri S, Thongprayoon C, Cheungpasitporn W, Bruminhent J; Ramathibodi Transplant Infectious Diseases (RTID) group. Transpl Infect Dis. 2021 May 13:e13635. doi: 10.1111/tid.13635. Online ahead of print. PMID: 33982825

24. Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2. Seephetdee C, Buasri N, Bhukhai K, Srisanga K, Manopwisedjaroen S, Lertjintanakit S, Phueakphud N, Pakiranay C, Kangwanrangsan N, Srichatrapimuk S, Kirdlarp S, Sungkanuparph S, Chutipongtanate S, Thitithanyanont A, Hongeng S, Wongtrakoongate P. Vaccines (Basel). 2021 May 12;9(5):498. doi: 10.3390/vaccines9050498. PMID: 34066016 Free PMC article.

25. Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study. Wacharachaisurapol N, Sukkummee W, Anunsittichai O, Srisan P, Sangkhamal S, Chantharit P, Vandepitte WP, Wattanavijitkul T, Puthanakit T. Int J Infect Dis. 2021 Aug;109:230-237. doi: 10.1016/j.ijid.2021.06.052. Epub 2021 Jun 27. PMID: 34192578 Free article.

26. Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia. Hongeng S, Anurathapan U, Songdej D, Phuphuakrat A, Jongrak K, Parsons G, Deary B, Bonner M, Veres G, Asmal M. Blood Adv. 2021 Jul 13;5(13):2701-2706. doi: 10.1182/bloodadvances.2020003680. PMID: 34196676 Free PMC article. Clinical Trial.

27. Assessment of atherosclerotic cardiovascular disease risks between people living with HIV receiving first-line and second-line antiretroviral therapy in a resource-limited setting. Tiarukkitsagul J, Sungkanuparph S. Int J STD AIDS. 2021 Apr;32(5):421-426. doi: 10.1177/0956462420972855. Epub 2021 Feb 3. PMID: 33533302

28. HIV treatment outcomes among people who acquired HIV via injecting drug use in the Asia-Pacific region: a longitudinal cohort study.

29. Han WM, Jiamsakul A, Salleh NAM, Choi JY, Huy BV, Yunihastuti E, Do CD, Merati TP, Gani YM, Kiertiburanakul S, Zhang F, Chan YJ, Lee MP, Chaiwarith R, Ng OT, Khusuwan S, Ditangco R, Kumarasamy N, Sangle S, Ross J, Avihingsanon A; TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific Group. J Int AIDS Soc. 2021 May;24(5):e25736. doi: 10.1002/jia2.25736. PMID: 34021711 Free PMC article.

30. Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis. Boettiger DC, Chattranukulchai P, Avihingsanon A, Chaiwarith R, Khusuwan S, Law MG, Ross J, Kiertiburanakul S. PLoS One. 2021 Sep 9;16(9):e0256926. doi: 10.1371/journal.pone.0256926. eCollection 2021. PMID: 34499685

31. CoronaVac induces lower neutralising activity against variants of concern than natural infection. Vacharathit V, Aiewsakun P, Manopwisedjaroen S, Srisaowakarn C, Laopanupong T, Ludowyke N, Phuphuakrat A, Setthaudom C, Ekronarongchai S, Srichatrapimuk S, Wongsirisin P, Sangrajrang S, Imsuwansri T, Kirdlarp S, Nualkaew S, Sensorn I, Sawaengdee W, Wichukchinda N, Sungkanuparph S, Chantratita W, Kunakorn M, Rojanamatin J, Hongeng S, Thitithanyanont A. Lancet Infect Dis. 2021 Aug 26:S1473-3099(21)00568-5. doi: 10.1016/S1473-3099(21)00568-5. Online ahead of print. PMID: 34454652 Free PMC article. No abstract available.

32. Anti-SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain Antibody to An Inactivated Whole-virus SARS-CoV-2 Vaccination in End-stage Kidney Disease Patients: An Initial Report. Boongird S, Chuengsaman P, Phanprasert S, Kitpermkiat R, Assanatham M, Nongnuch A, Kiertiburanakul S, Malathum K, Phuphuakrat A, Sethaudom C, Bruminhent J. Kidney Int. 2021 Aug 19:S0085-2538(21)00758-4. doi: 10.1016/j.kint.2021.08.007.

 

2020

 

1. Saliva sample pooling for the detection of SARS-CoV-2. Pasomsub E, Watcharananan SP, Watthanachockchai T, Rakmanee K, Tassaneetrithep B, Kiertiburanakul S, Phuphuakrat A. J Med Virol. 2021 Mar;93(3):1506-1511. doi: 10.1002/jmv.26460. Epub 2020 Sep 29. PMID: 32841429 Free PMC article.

2. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Pasomsub E, Watcharananan SP, Boonyawat K, Janchompoo P, Wongtabtim G, Suksuwan W, Sungkanuparph S, Phuphuakrat A. Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4. doi: 10.1016/j.cmi.2020.05.001. Epub 2020 May 15. PMID: 32422408 Free PMC article.

3. Clinical Characteristics of HIV-Associated Optic Neuritis. Jindahra P, Phuphuakrat A, Tangjaisanong T, Siriyotha S, Padungkiatsagul T, Vanikieti K, Preechawat P, Poonyathalang A, Sungkanuparph S, Pulkes T, Tunlayadechanont S. Int Med Case Rep J. 2020 Nov 11;13:609-616. doi: 10.2147/IMCRJ.S267867. eCollection 2020. PMID: 33204180 Free PMC article.

4. Economic Burden of Influenza in Thailand: A Systematic Review. Kiertiburanakul S, Phongsamart W, Tantawichien T, Manosuthi W, Kulchaitanaroaj P. Inquiry. 2020 Jan-Dec;57:46958020982925. doi: 10.1177/0046958020982925. PMID: 33355022 Free PMC article.

5. Recent update in diagnosis and treatment of human pythiosis. Chitasombat MN, Jongkhajornpong P, Lekhanont K, Krajaejun T. PeerJ. 2020 Feb 20;8:e8555. doi: 10.7717/peerj.8555. eCollection 2020. PMID: 32117626 Free PMC article.

6. Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific. Han WM, Bijker R, Chandrasekaran E, Pujari S, Ng OT, Ly PS, Lee MP, Van Nguyen K, Chan YJ, Do CD, Choi JY, Chaiwarith R, Merati TP, Kiertiburanakul S, Azwa I, Khusuwan S, Zhang F, Gani YM, Tanuma J, Sangle S, Ditangco R, Yunihastuti E, Ross J, Avihingsanon A; IeDEA Asia-Pacific. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):489-497. doi: 10.1097/QAI.0000000000002464. PMID: 33136750

7. Performance of real-time PCR and immunofluorescence assay for diagnosis of Pneumocystis pneumonia in real-world clinical practice. Chotiprasitsakul D, Pewloungsawat P, Setthaudom C, Santanirand P, Pornsuriyasak P. PLoS One. 2020 Dec 21;15(12):e0244023. doi: 10.1371/journal.pone.0244023. eCollection 2020. PMID: 33347478 Free PMC article.

8. Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis. Thongprayoon C, Khoury NJ, Bathini T, Aeddula NR, Boonpheng B, Lertjitbanjong P, Watthanasuntorn K, Leeaphorn N, Chesdachai S, Torres-Ortiz A, Kaewput W, Bruminhent J, Mao MA, Cheungpasitporn W. Urol Ann. 2020 Jul-Sep;12(3):241-247. doi: 10.4103/UA.UA_89_19. Epub 2020 Jun 10. PMID: 33100749 Free PMC article.

9. Clinical characteristics and risk factors for coronavirus disease 2019 (COVID-19) among patients under investigation in Thailand. Bruminhent J, Ruangsubvilai N, Nabhindhakara J, Ingsathit A, Kiertiburanakul S. PLoS One. 2020 Sep 15;15(9):e0239250. doi: 10.1371/journal.pone.0239250. eCollection 2020. PMID: 32931517 Free PMC article.

10. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Boonyawat K, Chantrathammachart P, Numthavaj P, Nanthatanti N, Phusanti S, Phuphuakrat A, Niparuck P, Angchaisuksiri P. Thromb J. 2020 Nov 23;18(1):34. doi: 10.1186/s12959-020-00248-5. PMID: 33292258 Free PMC article.

11. Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration. Nongnuch A, Ngampongpan W, Srichatrapimuk S, Wongsa A, Thongpraphai S, Boonarkart C, Sanmeema N, Chittaganpitch M, Auewarakul P, Tassaneetrithep B, Davenport A, Phuphuakrat A. PLoS One. 2020 Feb 3;15(2):e0227719. doi: 10.1371/journal.pone.0227719. eCollection 2020. PMID: 32012159 Free PMC article. Clinical Trial.

12. Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia. Boettiger DC, Law MG, Ross J, Huy BV, Heng B, Ditangco R, Kiertiburanakul S, Avihingsanon A, Cuong DD, Kumarasamy N, Kamarulzaman A, Ly PS, Yunihastuti E, Parwati Merati T, Zhang F, Khusuwan S, Chaiwarith R, Lee MP, Sangle S, Choi JY, Ku WW, Tanuma J, Ng OT, Sohn AH, Wester CW, Nash D, Mugglin C, Pujari S. J Virus Erad. 2020 Feb 20;6(1):11-18. PMID: 32175086 Free PMC article.

13. CHARACTERISTICS OF GRAVES DISEASE IN HIV-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY. Jariyawattanarat V, Sungkanuparph S, Sriphrapradang C. Endocr Pract. 2020 Jun 2;26(6):612-618. doi: 10.4158/EP-2019-0514. Epub 2020 Jan 22. PMID: 31968184

14. Switching protease inhibitors to rilpivirine in HIV-positive individuals with complete viral suppression and without prior HIV drug resistance in a resource-limited setting: a randomized controlled trial. Palanuphap K, Sungkanuparph S. J Int AIDS Soc. 2020 Apr;23(4):e25462. doi: 10.1002/jia2.25462. PMID: 32277868 Free PMC article. Clinical Trial.

15. Prediabetes among HIV-infected individuals receiving antiretroviral therapy: prevalence, diagnostic tests, and associated factors. Phuphuakrat A, Nimitphong H, Reutrakul S, Sungkanuparph S. AIDS Res Ther. 2020 May 24;17(1):25. doi: 10.1186/s12981-020-00284-1. PMID: 32448349 Free PMC article.

16. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality Within the First Year After Kidney Transplantation: An Analysis of the National Transplant Registry. Bruminhent J, Dajsakdipon T, Ingsathit A, Supaporn T, Prommool S, Watcharananan SP. Transplant Proc. 2020 Apr;52(3):829-835. doi: 10.1016/j.transproceed.2020.01.028. Epub 2020 Feb 27. PMID: 32113693

17. Causes of hypercalcemia in people living with HIV in the HAART era. Nongnuch A, Petcharut J, Suksuwan W, Davenport A, Phuphuakrat A. HIV Res Clin Pract. 2020 Oct;21(5):115-120. doi: 10.1080/25787489.2020.1836900. Epub 2020 Oct 19. PMID: 33076771

18. Correlation between plasma glucose and hemoglobin A1c in HIV-infected individuals receiving zidovudine and non-zidovudine containing antiretroviral therapy regimens. Saetang T, Sriphrapradang C, Phuphuakrat A, Sungkanuparph S. HIV Res Clin Pract. 2020 Apr-Jun;21(2-3):56-62. doi: 10.1080/25787489.2020.1766864. Epub 2020 May 20. PMID: 32431248

19. Vitamin D and Calcium Supplement Attenuate Bone Loss among HIVInfected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/ Efavirenz: An Open-Label, Randomized Controlled Trial. Boontanondha P, Nimitphong H, Musikarat S, Ragkho A, Kiertiburanakul S. Curr HIV Res. 2020;18(1):52-62. doi: 10.2174/1570162X18666200106150806. PMID: 31906840 Free PMC article. Clinical Trial.

20. Causes of Hospitalization and Death among Newly Diagnosed HIV-Infected Adults in Thailand. Chanto S, Kiertiburanakul S. J Int Assoc Provid AIDS Care. 2020 Jan-Dec;19:2325958220919266. doi: 10.1177/2325958220919266. PMID: 32336194 Free PMC article.

21. Clinical features of adult patients with a definite diagnosis of central nervous system tuberculosis in an endemic country: A 13-year retrospective review. Kirdlarp S, Srichatrapimuk S, Kiertiburanakul S, Phuphuakrat A. J Clin Tuberc Other Mycobact Dis. 2020 Sep 10;21:100190. doi: 10.1016/j.jctube.2020.100190. eCollection 2020 Dec. PMID: 32995572 Free PMC article.

22. Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID-19 in Thai patients. Nanthatanti N, Phusanti S, Chantrathammachart P, Thammavaranucupt K, Angchaisuksiri P, Sungkanuparph S. Res Pract Thromb Haemost. 2020 Oct 13;4(7):1224-1229. doi: 10.1002/rth2.12435. eCollection 2020 Oct. PMID: 33134788 Free PMC article.

23. Genetic Risk Surveillance for Invasive Aspergillosis in Hematology Patients: A Prospective Observational Study. Tanpaibule T, Jinawath N, Taweewongsounton A, Niparuck P, Rotjanapan P. Infect Dis Ther. 2020 Dec;9(4):807-821. doi: 10.1007/s40121-020-00331-4. Epub 2020 Aug 28. PMID: 32860206 Free PMC article.

24. Altered Patterns of Compositional and Functional Disruption of the Gut Microbiota in Typhoid Fever and Nontyphoidal Febrile Illness. Haak BW, de Jong HK, Kostidis S, Giera M, Maude RR, Samad R, Wijedoru L, Ghose A, Faiz MA, Parry CM, Wiersinga WJ. Open Forum Infect Dis. 2020 Jun 26;7(7):ofaa251. doi: 10.1093/ofid/ofaa251. eCollection 2020 Jul. PMID: 32715018 Free PMC article.

25. Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a. Joonlasak K, Batty EM, Kochakarn T, Panthan B, Kümpornsin K, Jiaranai P, Wangwiwatsin A, Huang A, Kotanan N, Jaru-Ampornpan P, Manasatienkij W, Watthanachockchai T, Rakmanee K, Jones AR, Fernandez S, Sensorn I, Sungkanuparph S, Pasomsub E, Klungthong C, Chookajorn T, Chantratita W. Virus Res. 2021 Jan 15;292:198233. doi: 10.1016/j.virusres.2020.198233. Epub 2020 Nov 21. PMID: 33227343 Free PMC article.

26. Mycobacterium haemophilum skin and soft tissue infection in a kidney transplant recipient: A case report and summary of the literature. Jurairattanaporn N, Vachiramon V, Bruminhent J. Transpl Infect Dis. 2020 Oct;22(5):e13315. doi: 10.1111/tid.13315. Epub 2020 May 23. PMID: 32386090

27. A family cluster of diagnosed coronavirus disease 2019 (COVID-19) kidney transplant recipient in Thailand. Sakulkonkij P, Bruminhent J, Pankongngam C, Chalermphunchai N. Immun Inflamm Dis. 2020 Dec;8(4):534-543. doi: 10.1002/iid3.337. Epub 2020 Aug 8. PMID: 32770646 Free PMC article.

28. Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies. Laisuan W, Pisitkun P, Ngamjanyaporn P, Suangtamai T, Rotjanapan P. Open Forum Infect Dis. 2020 Jan 31;7(2):ofaa035. doi: 10.1093/ofid/ofaa035. eCollection 2020 Feb. PMID: 32099846 Free PMC article.

29. PS-SiZer map to investigate significant features of body-weight profile changes in HIV infected patients in the IeDEA Collaboration. Harezlak J, Sarwat S, Wools-Kaloustian K, Schomaker M, Balestre E, Law M, Kiertiburanakul S, Fox M, Huis In 't Veld D, Musick BS, Yiannoutsos CT. PLoS One. 2020 May 1;15(5):e0220165. doi: 10.1371/journal.pone.0220165. eCollection 2020. PMID: 32357149 Free PMC article.

30. Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV. Han WM, Jiamsakul A, Jantarapakde J, Yunihastuti E, Choi JY, Ditangco R, Chaiwarith R, Sun LP, Khusuwan S, Merati TP, Do CD, Azwa I, Lee MP, Van Nguyen K, Chan YJ, Kiertiburanakul S, Ng OT, Tanuma J, Pujari S, Zhang F, Gani YM, Sangle S, Ross J, Kumarasamy N; the TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. HIV Med. 2021 Apr;22(4):294-306. doi: 10.1111/hiv.13017. Epub 2020 Nov 17. PMID: 33200864 Free PMC article.

31. Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis. Boettiger DC, Newall AT, Chattranukulchai P, Chaiwarith R, Khusuwan S, Avihingsanon A, Phillips A, Bendavid E, Law MG, Kahn JG, Ross J, Bautista-Arredondo S, Kiertiburanakul S. J Int AIDS Soc. 2020 Jun;23 Suppl 1(Suppl 1):e25494. doi: 10.1002/jia2.25494. PMID: 32562359 Free PMC article.

32. Infectious causes of acute meningitis among Thai adults in a university hospital. Aimbudlop K, Bruminhent J, Kiertiburanakul S. J Infect Chemother. 2021 Feb;27(2):198-204. doi: 10.1016/j.jiac.2020.09.002. Epub 2020 Sep 12. PMID: 32933857

33. Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage Optimization. Chantharit P, Tantasawat M, Kasai H, Tanigawara Y. Ther Drug Monit. 2020 Dec;42(6):872-879. doi: 10.1097/FTD.0000000000000799. PMID: 32947557

34. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes. Sukasem C, Pratoomwun J, Satapornpong P, Klaewsongkram J, Rerkpattanapipat T, Rerknimitr P, Lertpichitkul P, Puangpetch A, Nakkam N, Konyoung P, Khunarkornsiri U, Disphanurat W, Srisuttiyakorn C, Pattanacheewapull O, Kanjanawart S, Kongpan T, Chumworathayi P, Saksit N, Bruminhent J, Tassaneeyakul W, Chantratita W, Pirmohamed M. Clin Pharmacol Ther. 2020 Nov;108(5):1078-1089. doi: 10.1002/cpt.1915. Epub 2020 Jul 21. PMID: 32452529

35. An expanded HIV care cascade: ART uptake, viral load suppression and comorbidity monitoring among adults living with HIV in Asia. Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Ng OT, Sun LP, Merati TP, Van Nguyen K, Lee MP, Cuong DD, Chan YJ, Choi JY, Ross J, Law M; IeDEA Asia-Pacific. Antivir Ther. 2020;25(5):275-285. doi: 10.3851/IMP3379. PMID: 33464222 Free PMC article.

36. Epidemiology, Risk Factors, and Outcome of Bloodstream Infection Within the First Year After Kidney Transplantation. Siritip N, Nongnuch A, Dajsakdipon T, Thongprayoon C, Cheungprasitporn W, Bruminhent J. Am J Med Sci. 2021 Mar;361(3):352-357. doi: 10.1016/j.amjms.2020.10.011. Epub 2020 Oct 12. PMID: 33309136

37. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people. Jongraksak T, Sobhonslidsuk A, Jatchavala J, Warodomwichit D, Kaewduang P, Sungkanuparph S. Int J STD AIDS. 2021 Mar;32(3):266-275. doi: 10.1177/0956462420960997. Epub 2020 Dec 18. PMID: 33334267

38. Survival after long-term ART exposure: findings from an Asian patient population retained in care beyond 5 years on ART. Bijker R, Kiertiburanakul S, Kumarasamy N, Pujari S, Sun LP, Ng OT, Lee MP, Choi JY, Nguyen KV, Chan YJ, Merati TP, Cuong DD, Ross J, Jiamsakul A; IeDEA Asia-Pacific. Antivir Ther. 2020;25(3):131-142. doi: 10.3851/IMP3358. PMID: 32369040 Free PMC article.

39. Microbial epidemiology and risk factors for relapse in gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy. Surapat B, Montakantikul P, Malathum K, Kiertiburanakul S, Santanirand P, Chindavijak B. BMC Infect Dis. 2020 Aug 17;20(1):604. doi: 10.1186/s12879-020-05312-z. PMID: 32807092 Free PMC article. Clinical Trial.

40. Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey. Tan BH, Chakrabarti A, Patel A, Chua MMM, Sun PL, Liu Z, Rotjanapan P, Li R, Wahyuningsih R, Chayakulkeeree M, Chen YC; Asia Fungal Working Group (AFWG). Int J Infect Dis. 2020 Jun;95:471-480. doi: 10.1016/j.ijid.2020.01.007. Epub 2020 Jan 13. PMID: 31945491 Free article.

41. Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis. Birnie E, Koh GCKW, Löwenberg EC, Meijers JCM, Maude RR, Day NPJ, Peacock SJ, van der Poll T, Wiersinga WJ. PLoS Negl Trop Dis. 2020 Sep 1;14(9):e0008722. doi: 10.1371/journal.pntd.0008722. eCollection 2020 Sep. PMID: 32870904 Free PMC article.

42. Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific. Rupasinghe D, Kiertiburanakul S, Kamarulzaman A, Zhang F, Kumarasamy N, Chaiwarith R, Merati TP, Do CD, Khusuwan S, Avihingsanon A, Lee MP, Ly PS, Yunihastuti E, Nguyen KV, Ditangco R, Chan YJ, Pujari S, Ng OT, Choi JY, Sim B, Tanuma J, Sangle S, Ross J, Law M. HIV Med. 2020 Jul;21(6):397-402. doi: 10.1111/hiv.12836. Epub 2019 Dec 18. PMID: 31852025 Free PMC article.

43. Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19). Surapat B, Sungkanuparph S, Kirdlarp S, Lekpittaya N, Chunnguleum K. J Clin Pharm Ther. 2021 Feb;46(1):236-239. doi: 10.1111/jcpt.13293. Epub 2020 Oct 21. PMID: 33085800

44. Treatment modification after second-line failure among people living with HIV in the Asia-Pacific. Jiamsakul A, Azwa I, Zhang F, Yunihastuti E, Ditangco R, Kumarasamy N, Ng OT, Chan YJ, Ly PS, Choi JY, Lee MP, Pujari S, Kiertiburanakul S, Chaiwarith R, Merati TP, Sangle S, Khusuwan S, Sim BL, Avihingsanon A, Duy C, Tanuma J, Ross J, Law M, Asia-Pacific TAHODOI. Antivir Ther. 2020;25(7):377-387. doi: 10.3851/IMP3388. PMID: 33843656 Free PMC article.

 

2019

 

1. Epidemiology and outcomes of dengue in kidney transplant recipients: A 20-year retrospective analysis and comparative literature review. Pinsai S, Kiertiburanakul S, Watcharananan SP, Kantachuvessiri S, Boongird S, Bruminhent J. Clin Transplant. 2019 Jan;33(1):e13458. doi: 10.1111/ctr.13458. Epub 2018 Dec 26. PMID: 30506903 Review.

2. Diabetes mellitus burden among people living with HIV from the Asia-Pacific region. Han WM, Jiamsakul A, Kiertiburanakul S, Ng OT, Sim BL, Sun LP, Van Nguyen K, Choi JY, Lee MP, Wong WW, Kamarulzaman A, Kumarasamy N, Zhang F, Tanuma J, Do CD, Chaiwarith R, Merati TP, Yunihastuti E, Pujari S, Ditangco R, Khusuwan S, Ross J, Avihingsanon A; IeDEA Asia-Pacific. J Int AIDS Soc. 2019 Jan;22(1):e25236. doi: 10.1002/jia2.25236. PMID: 30697944 Free PMC article.

3. Rhodotorula infection in haematological patient: Risk factors and outcome. Potenza L, Chitasombat MN, Klimko N, Bettelli F, Dragonetti G, Del Principe MI, Nucci M, Busca A, Fracchiolla N, Sciumè M, Spolzino A, Delia M, Mancini V, Nadali GP, Dargenio M, Shadrivova O, Bacchelli F, Aversa F, Sanguinetti M, Luppi M, Kontoyiannis DP, Pagano L. Mycoses. 2019 Mar;62(3):223-229. doi: 10.1111/myc.12875. Epub 2018 Dec 28. PMID: 30525252

4. Spatiotemporal epidemiology, environmental correlates, and demography of malaria in Tak Province, Thailand (2012-2015). Mercado CEG, Lawpoolsri S, Sudathip P, Kaewkungwal J, Khamsiriwatchara A, Pan-Ngum W, Yimsamran S, Lawawirojwong S, Ho K, Ekapirat N, Maude RR, Wiladphaingern J, Carrara VI, Day NPJ, Dondorp AM, Maude RJ. Malar J. 2019 Jul 16;18(1):240. doi: 10.1186/s12936-019-2871-2. PMID: 31311606 Free PMC article.

5. Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD). Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Lam W, Chaiwarith R, Wong WW, Kamarulzaman A, Kantipong P, Avihingsanon A, Nguyen KV, Tanuma J, Ng OT, Sim BL, Merati TP, Choi JY, Ditangco R, Yunihastuti E, Sun LP, Do CD, Ross J, Law M; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Antivir Ther. 2019;24(4):271-279. doi: 10.3851/IMP3298. PMID: 30833516 Free PMC article.

6. Attrition and treatment outcomes among adolescents and youths living with HIV in the Thai National AIDS Program. Teeraananchai S, Puthanakit T, Kerr SJ, Chaivooth S, Kiertiburanakul S, Chokephaibulkit K, Bhakeecheep S, Teeraratkul A, Law M, Ruxrungtham K. J Virus Erad. 2019 Jan 1;5(1):33-40. PMID: 30800424 Free PMC article.

7. PCR-Dipstick-Oriented Surveillance and Characterization of mcr-1- and Carbapenemase-Carrying Enterobacteriaceae in a Thai Hospital. Shanmugakani RK, Akeda Y, Sugawara Y, Laolerd W, Chaihongsa N, Sirichot S, Yamamoto N, Hagiya H, Morii D, Fujiya Y, Nishi I, Yoshida H, Takeuchi D, Sakamoto N, Malathum K, Santanirand P, Tomono K, Hamada S. Front Microbiol. 2019 Feb 8;10:149. doi: 10.3389/fmicb.2019.00149. eCollection 2019. PMID: 30800104 Free PMC article.

8. Brief Report: Malignancies in Adults Living With HIV in Asia. Jiamsakul A, Polizzotto M, Wen-Wei Ku S, Tanuma J, Hui E, Chaiwarith R, Kiertiburanakul S, Avihingasanon A, Yunihastuti E, Kumarasamy N, Ly PS, Pujari S, Ditangco R, Do CD, Merati TP, Kantipong P, Zhang F, Van Nguyen K, Kamarulzaman A, Choi JY, Sim BLH, Ng OT, Ross J, Wong W. J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):301-307. doi: 10.1097/QAI.0000000000001918. PMID: 30531303 Free PMC article.

9. Epidemiology and Outcomes of Early-Onset and Late-Onset Adenovirus Infections in Kidney Transplant Recipients. Bruminhent J, Worawichawong S, Tongsook C, Pasomsub E, Boongird S, Watcharananan SP. Open Forum Infect Dis. 2019 Nov 13;6(12):ofz489. doi: 10.1093/ofid/ofz489. eCollection 2019 Dec. PMID: 32128332 Free PMC article.

10. Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital. Chotiprasitsakul D, Srichatrapimuk S, Kirdlarp S, Pyden AD, Santanirand P. Infect Drug Resist. 2019 Feb 20;12:461-468. doi: 10.2147/IDR.S192540. eCollection 2019. PMID: 30863128 Free PMC article.

11. Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand. Prakobsrikul N, Malathum K, Santanirand P, Chumnumwat S, Piebpien P, Montakantikul P. J Clin Pharm Ther. 2019 Apr;44(2):292-299. doi: 10.1111/jcpt.12791. Epub 2018 Dec 21. PMID: 30578578

12. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV. Ku SW, Jiamsakul A, Joshi K, Pasayan MKU, Widhani A, Chaiwarith R, Kiertiburanakul S, Avihingsanon A, Ly PS, Kumarasamy N, Do CD, Merati TP, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Khusuwan S, Sim BLH, Ng OT, Ratanasuwan W, Ross J, Wong WW; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. J Int AIDS Soc. 2019 Mar;22(3):e25264. doi: 10.1002/jia2.25264. PMID: 30924281 Free PMC article.

13. Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients. Singkham N, Avihingsanon A, Thammajaruk N, Ruxrungtham K, Bunupuradah T, Kiertiburanakul S, Chetchotisakd P, Burger DM, Emery S, Punyawudho B. Pharmacogenomics. 2019 May;20(7):517-527. doi: 10.2217/pgs-2018-0196. PMID: 31124411

14. A Fatal Case of Disseminated Microsporidiosis Due to Anncaliia algerae in a Renal and Pancreas Allograft Recipient. Anderson NW, Muehlenbachs A, Arif S, Bruminhent J, Deziel PJ, Razonable RR, Wilhelm MP, Metcalfe MG, Qvarnstrom Y, Pritt BS. Open Forum Infect Dis. 2019 Jul 8;6(7):ofz285. doi: 10.1093/ofid/ofz285. eCollection 2019 Jul. PMID: 31304191 Free PMC article.

15. Absolute lymphocyte count and human adenovirus-specific T-cell immune restoration of human adenovirus infection after kidney transplantation. Bruminhent J, Apiwattanakul N, Hongeng S, Kantachuvesiri S, Watcharananan SP. J Med Virol. 2019 Aug;91(8):1432-1439. doi: 10.1002/jmv.25468. Epub 2019 Apr 3. PMID: 30905076

16. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand. Phodha T, Riewpaiboon A, Malathum K, Coyte PC. Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):305-312. doi: 10.1080/14737167.2019.1537123. Epub 2018 Oct 19. PMID: 30321493

17. Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. Zürcher K, Ballif M, Kiertiburanakul S, Chenal H, Yotebieng M, Grinsztejn B, Michael D, Sterling TR, Ngonyani KM, Mandalakas AM, Egger M, Pettit AC, Fenner L; International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. J Int AIDS Soc. 2019 Sep;22(9):e25392. doi: 10.1002/jia2.25392. PMID: 31507083 Free PMC article.

18. Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality. Pasayan MKU, S Mationg ML, Boettiger D, Lam W, Zhang F, Ku SW, Merati TP, Chaiwarith R, Cuong DD, Yunihastuti E, Kiertiburanakul S, Van Kinh N, Avihingsanon A, Sun LP, Kamarulzaman A, Kantipong P, Kumarasamy N, Pujari S, Heng Sim BL, Ng OT, Choi JY, Tanuma J, Ross J, A Ditangco R. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):436-443. doi: 10.1097/QAI.0000000000001933. PMID: 30550488 Free PMC article.

19. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy. Bruminhent J, Srisala S, Klinmalai C, Pinsai S, Watcharananan SP, Kantachuvesiri S, Hongeng S, Apiwattanakul N. BMC Infect Dis. 2019 Nov 19;19(1):974. doi: 10.1186/s12879-019-4615-x. PMID: 31744480 Free PMC article.

20. BK polyomavirus genotypes in renal transplant recipients in the United States: A meta-analysis. Thongprayoon C, Khoury NJ, Bathini T, Aeddula NR, Boonpheng B, Leeaphorn N, Ungprasert P, Bruminhent J, Lertjitbanjong P, Watthanasuntorn K, Chesdachai S, Mao MA, Cheungpasitporn W. J Evid Based Med. 2019 Nov;12(4):291-299. doi: 10.1111/jebm.12366. PMID: 31769221

21. A Nationwide Survey of Cytomegalovirus Prevention Strategies in Kidney Transplant Recipients in a Resource-Limited Setting. Bruminhent J, Bushyakanist A, Kantachuvesiri S, Kiertiburanakul S. Open Forum Infect Dis. 2019 Jul 8;6(9):ofz322. doi: 10.1093/ofid/ofz322. eCollection 2019 Sep. PMID: 31660402 Free PMC article.

22. Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD). Bijker R, Jiamsakul A, Uy E, Kumarasamy N, Ditango R, Chaiwarith R, Wong WW, Avihingsanon A, Sun LP, Yunihastuti E, Pujari S, Do CD, Merati TP, Kantipong P, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Ng OT, Sim B, Ross J, Kiertiburanakul S; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. HIV Med. 2019 Mar;20(3):183-191. doi: 10.1111/hiv.12687. Epub 2019 Jan 8. PMID: 30620108 Free PMC article.

23. Annual relative increased in inpatient mortality from antimicrobial resistant nosocomial infections in Thailand. Phodha T, Riewpaiboon A, Malathum K, Coyte PC. Epidemiol Infect. 2019 Jan;147:e133. doi: 10.1017/S0950268818003436. PMID: 30868996 Free PMC article.

24. Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial. Petchkum P, Sungkanuparph S, Kiertiburanakul S, Phuphuakrat A. Open Forum Infect Dis. 2019 Mar 25;6(4):ofz155. doi: 10.1093/ofid/ofz155. eCollection 2019 Apr. PMID: 31041351 Free PMC article.

25. The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV. Ahn MY, Jiamsakul A, Khusuwan S, Khol V, Pham TT, Chaiwarith R, Avihingsanon A, Kumarasamy N, Wong WW, Kiertiburanakul S, Pujari S, Nguyen KV, Lee MP, Kamarulzaman A, Zhang F, Ditangco R, Merati TP, Yunihastuti E, Ng OT, Sim BLH, Tanuma J, Ratanasuwan W, Ross J, Choi JY; IeDEA Asia-Pacific. J Int AIDS Soc. 2019 Feb;22(2):e25228. doi: 10.1002/jia2.25228. PMID: 30803162 Free PMC article.

26. Rapid screening and early precautions for carbapenem-resistant Acinetobacter baumannii carriers decreased nosocomial transmission in hospital settings: a quasi-experimental study. Yamamoto N, Hamaguchi S, Akeda Y, Santanirand P, Chaihongsa N, Sirichot S, Chiaranaicharoen S, Hagiya H, Yamamoto K, Kerdsin A, Okada K, Yoshida H, Hamada S, Oishi K, Malathum K, Tomono K. Antimicrob Resist Infect Control. 2019 Jun 27;8:110. doi: 10.1186/s13756-019-0564-9. eCollection 2019. PMID: 31297191 Free PMC article.

27. Diabetes, mortality and glucose monitoring rates in the TREAT Asia HIV Observational Database Low Intensity Transfer (TAHOD-LITE) study. Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Sun LP, Ng OT, Lee MP, Choi JY, Nguyen KV, Chan YJ, Merati TP, Do CD, Ross J, Law M; TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific group. HIV Med. 2019 Oct;20(9):615-623. doi: 10.1111/hiv.12779. Epub 2019 Jul 23. PMID: 31338975 Free PMC article.

28. Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific. Rupasinghe D, Kiertiburanakul S, Kamarulzaman A, Zhang F, Kumarasamy N, Chaiwarith R, Merati TP, Do CD, Khusuwan S, Avihingsanon A, Lee MP, Ly PS, Yunihastuti E, Nguyen KV, Ditangco R, Chan YJ, Pujari S, Ng OT, Choi JY, Sim B, Tanuma J, Sangle S, Ross J, Law M. HIV Med. 2020 Jul;21(6):397-402. doi: 10.1111/hiv.12836. Epub 2019 Dec 18. PMID: 31852025 Free PMC article.

29. Absence of cutaneous involvement in disseminated Talaromyces marneffei infection in an AIDS patient: a case report and literature review. Pongpech N, Rotjanapan P. Infect Drug Resist. 2019 Jun 4;12:1493-1499. doi: 10.2147/IDR.S207819. eCollection 2019. PMID: 31239726 Free PMC article.

30. Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD). Jiamsakul A, Kiertiburanakul S, Ng OT, Chaiwarith R, Wong W, Ditangco R, Nguyen KV, Avihingsanon A, Pujari S, Do CD, Lee MP, Ly PS, Yunihastuti E, Kumarasamy N, Kamarulzaman A, Tanuma J, Zhang F, Choi JY, Kantipong P, Sim B, Ross J, Law M, Merati TP; TREAT Asia HIV Observational Database of IeDEA Asia-Pacific. HIV Med. 2019 Aug;20(7):439-449. doi: 10.1111/hiv.12734. Epub 2019 Apr 12. PMID: 30980495 Free PMC article.

31. Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials. Kim YS, Oka S, Chetchotisakd P, Clarke A, Supparatpinyo K, Avihingsanon A, Ratanasuwan W, Kiertiburanakul S, Ruxrungtham K, Yang S, Guo S, Liu Y, Das M, Tran D, McColl D, Corales R, Nguyen C, Piontkowsky D. HIV Res Clin Pract. 2019 Jul 8:1-9. doi: 10.1080/15284336.2019.1589232. Online ahead of print. PMID: 31303140

32. Impact of an Antibiotic Stewardship Program on Antibiotic Prescription for Acute Respiratory Tract Infections in Children: A Prospective Before-After Study. Aoybamroong N, Kantamalee W, Thadanipon K, Techasaensiri C, Malathum K, Apiwattanakul N. Clin Pediatr (Phila). 2019 Oct;58(11-12):1166-1174. doi: 10.1177/0009922819870248. Epub 2019 Aug 20. PMID: 31431068

33. Switching Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) to TDF/FTC/Rilpivirine vs Continuing TDF/FTC/EFV in HIV-Infected Patients With Virological Suppression: A Randomized Controlled Trial. Wiriyatanakorn S, Sungkanuparph S. Open Forum Infect Dis. 2019 Jun 26;6(7):ofz297. doi: 10.1093/ofid/ofz297. eCollection 2019 Jul. PMID: 31341931 Free PMC article.

34. Response to Screening of diabetes mellitus among people living with HIV - a comment on "Diabetes mellitus burden among people living with HIV from the Asia-Pacific region" (Han et al. 2019). Han WM, Jiamsakul A, Kiertiburanakul S, Ross J, Avihingsanon A. J Int AIDS Soc. 2019 Jun;22(6):e25334. doi: 10.1002/jia2.25334.

 

2018

1. Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort. Chotiprasitsakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Conley AT, Tolomeo P, Wise J, Tamma PD; Antibacterial Resistance Leadership Group. Clin Infect Dis. 2018 Jan 6;66(2):172-177. doi: 10.1093/cid/cix767. PMID: 29190320 Free PMC article.

2. Clinicopathological features and outcomes of pythiosis. Chitasombat MN, Larbcharoensub N, Chindamporn A, Krajaejun T. Int J Infect Dis. 2018 Jun;71:33-41. doi: 10.1016/j.ijid.2018.03.021. Epub 2018 Apr 10. PMID: 29653202 Free article.

3. Epidemiology and outcomes of dengue in kidney transplant recipients: A 20-year retrospective analysis and comparative literature review. Pinsai S, Kiertiburanakul S, Watcharananan SP, Kantachuvessiri S, Boongird S, Bruminhent J. Clin Transplant. 2019 Jan;33(1):e13458. doi: 10.1111/ctr.13458. Epub 2018 Dec 26. PMID: 30506903 Review.

4. Thai clinicians' attitudes toward antimicrobial stewardship programs. Sutthiruk N, Considine J, Hutchinson A, Driscoll A, Malathum K, Botti M. Am J Infect Control. 2018 Apr;46(4):425-430. doi: 10.1016/j.ajic.2017.09.022. Epub 2017 Nov 10. PMID: 29132695

5. Rhodotorula infection in haematological patient: Risk factors and outcome. Potenza L, Chitasombat MN, Klimko N, Bettelli F, Dragonetti G, Del Principe MI, Nucci M, Busca A, Fracchiolla N, Sciumè M, Spolzino A, Delia M, Mancini V, Nadali GP, Dargenio M, Shadrivova O, Bacchelli F, Aversa F, Sanguinetti M, Luppi M, Kontoyiannis DP, Pagano L. Mycoses. 2019 Mar;62(3):223-229. doi: 10.1111/myc.12875. Epub 2018 Dec 28. PMID: 30525252

6. BK Virus-Associated Nephropathy: Current Situation in a Resource-Limited Country. Yooprasert P, Rotjanapan P. Transplant Proc. 2018 Jan-Feb;50(1):130-136. doi: 10.1016/j.transproceed.2017.11.007. PMID: 29407295 Free article.

7. Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand. Prakobsrikul N, Malathum K, Santanirand P, Chumnumwat S, Piebpien P, Montakantikul P. J Clin Pharm Ther. 2019 Apr;44(2):292-299. doi: 10.1111/jcpt.12791. Epub 2018 Dec 21. PMID: 30578578

8. A Multicenter Study of Clinical Presentations and Predictive Factors for Severe Manifestation of Dengue in Adults. Temprasertrudee S, Thanachartwet V, Desakorn V, Keatkla J, Chantratita W, Kiertiburanakul S. Jpn J Infect Dis. 2018 May 24;71(3):239-243. doi: 10.7883/yoken.JJID.2017.457. Epub 2018 Apr 27. PMID: 29709965 Free article.

9. Early suboptimal ART adherence was associated with missed clinical visits in HIV-infected patients in Asia. Jiamsakul A, Kerr SJ, Kiertiburanakul S, Azwa I, Zhang F, Chaiwarith R, Wong W, Ly PS, Kumarasamy N, Ditangco R, Pujari S, Yunihastuti E, Do CD, Merati TP, Nguyen KV, Lee MP, Choi JY, Oka S, Kantipong P, Sim BLH, Ng OT, Ross J, Law M; TREAT Asia HIV Observational Database (TAHOD). AIDS Care. 2018 Dec;30(12):1560-1566. doi: 10.1080/09540121.2018.1499859. Epub 2018 Jul 18. PMID: 30021450 Free PMC article.

10. Activation of coagulation and endothelium with concurrent impairment of anticoagulant mechanisms in patients with typhoid fever. de Jong HK, Parry CM, van der Vaart TW, Kager LM, van den Ende SJ, Maude RR, Wijedoru L, Ghose A, Hassan MU, Hossain MA, Dondorp AM, Baker S, Faiz MA, Meijers JCM, Wiersinga WJ. J Infect. 2018 Jul;77(1):60-67. doi: 10.1016/j.jinf.2018.03.008. Epub 2018 May 7. PMID: 29746945 Free article.

11. Epidemiology and clinical characteristics of invasive mould infections: A multicenter, retrospective analysis in five Asian countries. Rotjanapan P, Chen YC, Chakrabarti A, Li RY, Rudramurthy SM, Yu J, Kung HC, Watcharananan S, Tan AL, Saffari SE, Tan BH. Med Mycol. 2018 Feb 1;56(2):186-196. doi: 10.1093/mmy/myx029. PMID: 28525619

12. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand. Phodha T, Riewpaiboon A, Malathum K, Coyte PC. Expert Rev Pharmacoecon Outcomes Res. 2019 Jun;19(3):305-312. doi: 10.1080/14737167.2019.1537123. Epub 2018 Oct 19. PMID: 30321493

13. Prevalence of HIV infection, access to HIV care, and response to antiretroviral therapy among artners of HIV-infected individuals in Thailand. Kiertiburanakul S, Wongprasit P, Phuphuakrat A, Chotiprasitsakul D, Sungkanuparph S. PLoS One. 2018 Jun 27;13(6):e0198654. doi: 10.1371/journal.pone.0198654. eCollection 2018. PMID: 29949594 Free PMC article.

14. Disseminated extrapulmonary Legionella pneumophila infection presenting with panniculitis: case report and literature review. Chitasombat MN, Ratchatanawin N, Visessiri Y. BMC Infect Dis. 2018 Sep 17;18(1):467. doi: 10.1186/s12879-018-3378-0. PMID: 30223775 Free PMC article. Review.

15. Socio-economic status and risk of tuberculosis: a case-control study of HIV-infected patients in Asia. Jiamsakul A, Lee MP, Nguyen KV, Merati TP, Cuong DD, Ditangco R, Yunihastuti E, Ponnampalavanar S, Zhang F, Kiertiburanakul S, Avihingasanon A, Ng OT, Sim BLH, Wong WW, Ross J, Law M. Int J Tuberc Lung Dis. 2018 Feb 1;22(2):179-186. doi: 10.5588/ijtld.17.0348. PMID: 29506614 Free PMC article.

16. External Quality Assessment Scheme for HIV-1 Drug-Resistance Genotyping in Thailand. Saeng-Aroon S, Saipradit N, Loket R, Klamkhai N, Boonmuang R, Kaewprommal P, Prommajan K, Takeda N, Sungkanuparph S, Shioda T, Sangkitporn S, Motomura K. AIDS Res Hum Retroviruses. 2018 Dec;34(12):1028-1035. doi: 10.1089/AID.2017.0299. Epub 2018 Nov 10. PMID: 30215266

17. Prediction Model of Pre-treatment HIV RNA Levels in Naïve Thai HIV-infected Patients: Application for Resource-limited Settings. Pongpech N, Avihingsanon A, Chaiwarith R, Kantipong P, Boettiger D, Ross J, Kiertiburanakul S. Southeast Asian J Trop Med Public Health. 2018 Nov;49(6):965-974. PMID: 30930503 Free PMC article.

18. Implementing national strategies on antimicrobial resistance in Thailand: potential challenges and solutions. Sommanustweechai A, Tangcharoensathien V, Malathum K, Sumpradit N, Kiatying-Angsulee N, Janejai N, Jaroenpoj S. Public Health. 2018 Apr;157:142-146. doi: 10.1016/j.puhe.2018.01.005. Epub 2018 Mar 20. PMID: 29524812

19. Vascular pythiosis of carotid artery with meningitis and cerebral septic emboli: A case report and literature review. Chitasombat MN, Petchkum P, Horsirimanont S, Sornmayura P, Chindamporn A, Krajaejun T. Med Mycol Case Rep. 2018 May 7;21:57-62. doi: 10.1016/j.mmcr.2018.05.003. eCollection 2018 Sep. PMID: 30013898 Free PMC article.

20. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia. Joshi K, Boettiger D, Kerr S, Nishijima T, Van Nguyen K, Ly PS, Lee MP, Kumarasamy N, Wong W, Kantipong P, Cuong DD, Kamarulzaman A, Choi JY, Zhang F, Chaiwarith R, Ng OT, Kiertiburanakul S, Sim BLH, Merati TP, Yunihastuti E, Ditangco R, Ross J, Pujari S. Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1209-1216. doi: 10.1002/pds.4657. Epub 2018 Sep 24. PMID: 30246898 Free PMC article.

21. Cardiac implantable electronic device infection in the cardiac referral center in Thailand: incidence, microbiology, risk factors, and outcomes. Korkerdsup T, Ngarmukos T, Sungkanuparph S, Phuphuakrat A. J Arrhythm. 2018 Sep 27;34(6):632-639. doi: 10.1002/joa3.12123. eCollection 2018 Dec. PMID: 30555607 Free PMC article.

22. A case report of Tubo-ovarian abscess caused by Burkholderia pseudomallei. Nernsai P, Sophonsritsuk A, Lertvikool S, Jinawath A, Chitasombat MN. BMC Infect Dis. 2018 Feb 8;18(1):73. doi: 10.1186/s12879-018-2986-z. PMID: 29422033 Free PMC article.

23. Predictive factors of catheter-related bloodstream infection in patients receiving home parenteral nutrition. Pichitchaipitak O, Ckumdee S, Apivanich S, Chotiprasitsakul D, Shantavasinkul PC. Nutrition. 2018 Feb;46:1-6. doi: 10.1016/j.nut.2017.08.002. Epub 2017 Aug 7. PMID: 29290346

24. Deferiprone as adjunctive treatment for patients with invasive mucormycosis: A retrospective case series. Chitasombat MN, Niparuck P. Infect Dis Rep. 2018 Sep 25;10(2):7765. doi: 10.4081/idr.2018.7765. eCollection 2018 Sep 5. PMID: 30344970 Free PMC article.

25. Burden of cytomegalovirus reactivation post kidney transplant with antithymocyte globulin use in Thailand: A retrospective cohort study. Chitasombat MN, Watcharananan SP. F1000Res. 2018 Sep 28;7:1568. doi: 10.12688/f1000research.16321.1. eCollection 2018. PMID: 30473779 Free PMC article.

26. Incidence of Newly Diagnosed Tuberculosis among Healthcare Workers in a Teaching Hospital, Thailand. Pongwittayapanu P, Anothaisintawee T, Malathum K, Wongrathanandha C. Ann Glob Health. 2018 Aug 31;84(3):342-347. doi: 10.29024/aogh.2304. PMID: 30835396 Free PMC article.

27. The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients. Chotiprasitsakul D, Tamma PD, Gadala A, Cosgrove SE. Infect Control Hosp Epidemiol. 2018 Mar;39(3):290-296. doi: 10.1017/ice.2017.308. Epub 2018 Jan 28. PMID: 29374504

28. Mortality following diagnosis of tuberculosis in HIV-infected patients in Asia. Jiamsakul A, Yunihastuti E, Van Nguyen K, Merati TP, Do CD, Ditangco R, Ponnampalavanar S, Zhang F, Kiertiburanakul S, Lee MP, Avihingasanon A, Ng OT, Sim BL, Wong W, Ross J, Law M. HIV Med. 2018 Apr 23:10.1111/hiv.12621. doi: 10.1111/hiv.12621. Online ahead of print. PMID: 29683253 Free PMC article. No abstract available.

2017

1. Thai clinicians' attitudes toward antimicrobial stewardship programs. Sutthiruk N, Considine J, Hutchinson A, Driscoll A, Malathum K, Botti M. Am J Infect Control. 2018 Apr;46(4):425-430. doi: 10.1016/j.ajic.2017.09.022. Epub 2017 Nov 10. PMID: 29132695

2. Expression of intra- and extracellular granzymes in patients with typhoid fever. de Jong HK, Garcia-Laorden MI, Hoogendijk AJ, Parry CM, Maude RR, Dondorp AM, Faiz MA, van der Poll T, Wiersinga WJ. PLoS Negl Trop Dis. 2017 Jul 27;11(7):e0005823. doi: 10.1371/journal.pntd.0005823. eCollection 2017 Jul. PMID: 28749963 Free PMC article.

3. Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis. Birnie E, Koh GC, Löwenberg EC, Meijers JC, Maude RR, Day NP, Peacock SJ, van der Poll T, Wiersinga WJ. PLoS Negl Trop Dis. 2017 Mar 15;11(3):e0005468. doi: 10.1371/journal.pntd.0005468. eCollection 2017 Mar. PMID: 28296884 Free PMC article.

4. Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients. Bruminhent J, Cawcutt KA, Thongprayoon C, Petterson TM, Kremers WK, Razonable RR. Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12968. Epub 2017 Apr 17. PMID: 28314071

5. An evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid fever. Tran Vu Thieu N, Trinh Van T, Tran Tuan A, Klemm EJ, Nguyen Ngoc Minh C, Voong Vinh P, Pham Thanh D, Ho Ngoc Dan T, Pham Duc T, Langat P, Martin LB, Galan J, Liang L, Felgner PL, Davies DH, de Jong HK, Maude RR, Fukushima M, Wijedoru L, Ghose A, Samad R, Dondorp AM, Faiz A, Darton TC, Pollard AJ, Thwaites GE, Dougan G, Parry CM, Baker S. J Infect. 2017 Aug;75(2):104-114. doi: 10.1016/j.jinf.2017.05.007. Epub 2017 May 25. PMID: 28551371 Free PMC article.

6. ACUTE CHOLECYSTITIS AS AN UNUSUAL PRESENTATION OF SCRUB TYPHUS: A REPORT OF TWO CASES AND REVIEW OF THE LITERATURE. Charoenphak S, Rattanawong P, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2017 Jan;48(1):143-9. PMID: 29644830 Review.

7. The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD). Jung IY, Boettiger D, Wong WW, Lee MP, Kiertiburanakul S, Chaiwarith R, Avihingsanon A, Tanuma J, Kumarasamy N, Kamarulzaman A, Zhang F, Kantipong P, Ng OT, Sim BLH, Law M, Ross J, Choi JY. J Int AIDS Soc. 2017 Dec;20(4):e25016. doi: 10.1002/jia2.25016. PMID: 29243388 Free PMC article.

8. CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy. Petoumenos K, Choi JY, Hoy J, Kiertiburanakul S, Ng OT, Boyd M, Rajasuriar R, Law M; Australian HIV Observational Database; TREATAsia HIV Observational Database. Antivir Ther. 2017;22(8):659-668. doi: 10.3851/IMP3155. PMID: 28291735 Free PMC article.

9. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts. Bijker R, Jiamsakul A, Kityo C, Kiertiburanakul S, Siwale M, Phanuphak P, Akanmu S, Chaiwarith R, Wit FW, Sim BL, Boender TS, Ditangco R, Rinke De Wit TF, Sohn AH, Hamers RL. J Int AIDS Soc. 2017 Mar 3;20(1):21218. doi: 10.7448/IAS.20.1.21218. PMID: 28362063 Free PMC article.

10. Cardiovascular Disease and Cardiovascular Disease Risk in HIV-Positive Populations in the Asian Region. Bijker R, Choi JY, Ditangco R, Kiertiburanakul S, Lee MP, Siwamogsatham S, Pujari S, Ross J, Wong CY, Wong WW, Yunihastuti E, Law M. Open AIDS J. 2017 Aug 21;11:52-66. doi: 10.2174/1874613601711010052. eCollection 2017. PMID: 29302277 Free PMC article.

11. A case report of intravenous posaconazole in hepatic and renal impairment patient with invasive Aspergillus terreus infection: safety and role of therapeutic drug monitoring. Dilokpattanamongkol P, Panusitthikorn P, Boonprasert R, Chayakulkeeree M, Rotjanapan P. BMC Pharmacol Toxicol. 2017 Jan 31;18(1):8. doi: 10.1186/s40360-017-0115-z. PMID: 28143591 Free PMC article.

12. The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000-2014. Chaivooth S, Bhakeecheep S, Ruxrungtham K, Teeraananchai S, Kerr SJ, Teeraratkul A, Sirinirund P, Ongwandee S, Avihingsanon A, Benjarattanaporn P, Phanuphak N, Sungkanuparph S, Mekthon S, Phanuphak P. J Virus Erad. 2017 Oct 1;3(4):192-199. PMID: 29057081 Free PMC article.

13. Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings. Kiertiburanakul S, Boettiger D, Ng OT, Van Kinh N, Merati TP, Avihingsanon A, Wong WW, Lee MP, Chaiwarith R, Kamarulzaman A, Kantipong P, Zhang F, Choi JY, Kumarasamy N, Ditangco R, Cuong DD, Oka S, Sim BLH, Ratanasuwan W, Ly PS, Yunihastuti E, Pujari S, Ross JL, Law M, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD). AIDS Res Ther. 2017 May 5;14:27. doi: 10.1186/s12981-017-0151-1. eCollection 2017. PMID: 28484509 Free PMC article.

14. Reproducible diagnostic metabolites in plasma from typhoid fever patients in Asia and Africa. Näsström E, Parry CM, Vu Thieu NT, Maude RR, de Jong HK, Fukushima M, Rzhepishevska O, Marks F, Panzner U, Im J, Jeon H, Park S, Chaudhury Z, Ghose A, Samad R, Van TT, Johansson A, Dondorp AM, Thwaites GE, Faiz A, Antti H, Baker S. Elife. 2017 May 9;6:e15651. doi: 10.7554/eLife.15651. PMID: 28483042 Free PMC article.

15. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection. Phoompoung P, Ankasekwinai N, Pithukpakorn M, Foongladda S, Umrod P, Suktitipat B, Mahasirimongkol S, Kiertiburanakul S, Suputtamongkol Y. PLoS One. 2017 Apr 24;12(4):e0176342. doi: 10.1371/journal.pone.0176342. eCollection 2017. PMID: 28437431 Free PMC article.

16. Long-Term Liver Diseases after Initiation of Antiretroviral Therapy in HIV-Infected Patients with and without HBV or HCV Coinfection. Phusanti S, Manosudprasit K, Sungkanuparph S. J Int Assoc Provid AIDS Care. 2017 Mar/Apr;16(2):194-200. doi: 10.1177/2325957416686838. Epub 2017 Jan 10. PMID: 28071205 Free article.

17. A randomized controlled trial of sitafloxacin vs. ertapenem as a switch therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli: A pilot study. Malaisri C, Phuphuakrat A, Wibulpolprasert A, Santanirand P, Kiertiburanakul S. J Infect Chemother. 2017 Aug;23(8):556-562. doi: 10.1016/j.jiac.2017.05.005. Epub 2017 Jun 3. PMID: 28587974 Clinical Trial.

18. Predictive factors of catheter-related bloodstream infection in patients receiving home parenteral nutrition. Pichitchaipitak O, Ckumdee S, Apivanich S, Chotiprasitsakul D, Shantavasinkul PC. Nutrition. 2018 Feb;46:1-6. doi: 10.1016/j.nut.2017.08.002. Epub 2017 Aug 7. PMID: 29290346

19. Mammary subcutaneous basidiobolomycosis in a male. Rermluk N, Laolerd W, Chantharit P, Lertsithichai P, Wiratkapun C, Larbcharoensub N. Breast J. 2017 Nov;23(6):751-753. doi: 10.1111/tbj.12817. Epub 2017 Apr 10. PMID: 28397341 No abstract available.

20. Thai national guidelines for the prevention of mother-to-child transmission of human immunodeficiency virus 2017. Lolekha R, Chokephaibulkit K, Phanuphak N, Chaithongwongwatthana S, Kiertiburanakul S, Chetchotisakd P, Boonsuk S; Thai national prevention of mother-to-child transmission (PMTCT) Guidelines Working Group. Asian Biomed (Res Rev News). 2017 Apr;11(2):145-159. doi: 10.5372/1905-7415.1102.547. PMID: 29861798 Free PMC article.

21. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand. Bruminhent J, Rotjanapan P, Watcharananan SP. Transplant Proc. 2017 Jun;49(5):1048-1052. doi: 10.1016/j.transproceed.2017.03.053. PMID: 28583524

22. CLINICAL OUTCOMES OF CRYPTOCOCCAL MENINGITIS AMONG HIV-INFECTED PATIENTS IN THE ERA OF ANTIRETROVIRAL THERAPY. Kobayashi T, Pitisuttithum P, Kaewkingwal J, Phuphuakrat A, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2017 Jan;48(1):56-64. PMID: 29644820

23. Primary Prophylaxis for Cryptococcosis With Fluconazole in Human Immunodeficiency Virus-Infected Patients With CD4 T-Cell Counts <100 Cells/µL and Receiving Antiretroviral Therapy. Sungkanuparph S, Savetamornkul C, Pattanapongpaiboon W. Clin Infect Dis. 2017 Apr 1;64(7):967-970. doi: 10.1093/cid/cix036. PMID: 28362939

24. Absence of JC polyomavirus (JCPyV) viremia in early post-transplant JCPyV nephropathy: A case report. Janphram C, Worawichawong S, Disthabanchong S, Sumethkul V, Rotjanapan P. Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12761. Epub 2017 Oct 24.

 

2016

1. Integrated therapy for HIV and cryptococcosis. Srichatrapimuk S, Sungkanuparph S. AIDS Res Ther. 2016 Nov 29;13(1):42. doi: 10.1186/s12981-016-0126-7. PMID: 27906037 Free PMC article. Review.

2. Integrated therapy for HIV and tuberculosis. Manosuthi W, Wiboonchutikul S, Sungkanuparph S. AIDS Res Ther. 2016 May 12;13:22. doi: 10.1186/s12981-016-0106-y. eCollection 2016. PMID: 27182275 Free PMC article. Review.

3. Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort. Do TC, Boettiger D, Law M, Pujari S, Zhang F, Chaiwarith R, Kiertiburanakul S, Lee MP, Ditangco R, Wong WW, Nguyen KV, Merati TP, Pham TT, Kamarulzaman A, Oka S, Yunihastuti E, Kumarasamy N, Kantipong P, Choi JY, Ng OT, Durier N, Ruxrungtham K. HIV Med. 2016 Aug;17(7):542-9. doi: 10.1111/hiv.12358. PMID: 27430354 Free PMC article.

4. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents. Chitasombat MN, Kontoyiannis DP. Curr Opin Infect Dis. 2016 Aug;29(4):340-5. doi: 10.1097/QCO.0000000000000277. PMID: 27191199 Review.

5. A prospective study of the importance of enteric fever as a cause of non-malarial febrile illness in patients admitted to Chittagong Medical College Hospital, Bangladesh. Maude RR, Ghose A, Samad R, de Jong HK, Fukushima M, Wijedoru L, Hassan MU, Hossain MA, Karim MR, Sayeed AA, van den Ende S, Pal S, Zahed AS, Rahman W, Karnain R, Islam R, Tran DT, Ha TT, Pham AH, Campbell JI, van Doorn HR, Maude RJ, van der Poll T, Wiersinga WJ, Day NP, Baker S, Dondorp AM, Parry CM, Faiz MA. BMC Infect Dis. 2016 Oct 13;16(1):567. doi: 10.1186/s12879-016-1886-3. PMID: 27737634 Free PMC article.

6. Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD. Jeong SJ, Italiano C, Chaiwarith R, Ng OT, Vanar S, Jiamsakul A, Saphonn V, Nguyen KV, Kiertiburanakul S, Lee MP, Merati TP, Pham TT, Yunihastuti E, Ditangco R, Kumarasamy N, Zhang F, Wong W, Sim BL, Pujari S, Kantipong P, Phanuphak P, Ratanasuwan W, Oka S, Mustafa M, Durier N, Choi JY. AIDS Res Hum Retroviruses. 2016 Mar;32(3):255-61. doi: 10.1089/AID.2015.0058. Epub 2015 Oct 15. PMID: 26414065 Free PMC article.

7. Tuberculous Panophthalmitis with Lymphadenitis and Central Nervous System Tuberculoma. Srichatrapimuk S, Wattanatranon D, Sungkanuparph S. Case Rep Infect Dis. 2016;2016:6785382. doi: 10.1155/2016/6785382. Epub 2016 Mar 9. PMID: 27051539 Free PMC article.

8. Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific. Tanuma J, Jiamsakul A, Makane A, Avihingsanon A, Ng OT, Kiertiburanakul S, Chaiwarith R, Kumarasamy N, Nguyen KV, Pham TT, Lee MP, Ditangco R, Merati TP, Choi JY, Wong WW, Kamarulzaman A, Yunihastuti E, Sim BL, Ratanasuwan W, Kantipong P, Zhang F, Mustafa M, Saphonn V, Pujari S, Sohn AH; TREAT Asia HIV Observational Databases (TAHOD). PLoS One. 2016 Aug 25;11(8):e0161562. doi: 10.1371/journal.pone.0161562. eCollection 2016. PMID: 27560968 Free PMC article.

9. Prevalence of Primary HIV Drug Resistance in Thailand Detected by Short Reverse Transcriptase Genotypic Resistance Assay. Kiertiburanakul S, Pinsai S, Chantratita W, Pasomsub E, Leechawengwongs M, Thipmontree W, Siriyakorn N, Sungkanuparph S. PLoS One. 2016 Feb 1;11(2):e0147945. doi: 10.1371/journal.pone.0147945. eCollection 2016. PMID: 26828876 Free PMC article.

10. Incidence of syphilis seroconversion among HIV-infected persons in Asia: results from the TREAT Asia HIV Observational Database. Ahn JY, Boettiger D, Kiertiburanakul S, Merati TP, Huy BV, Wong WW, Ditangco R, Lee MP, Oka S, Durier N, Choi JY; Treat Asia HIV Observational Database. J Int AIDS Soc. 2016 Oct 21;19(1):20965. doi: 10.7448/IAS.19.1.20965. eCollection 2016. PMID: 27774955 Free PMC article.

11. Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study. Wongprikorn A, Sukasem C, Puangpetch A, Numthavej P, Thakkinstian A, Kiertiburanakul S. PLoS One. 2016 Jun 15;11(6):e0157531. doi: 10.1371/journal.pone.0157531. eCollection 2016. PMID: 27304841 Free PMC article. Clinical Trial.

12. Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals. Jiamsakul A, Chaiwarith R, Durier N, Sirivichayakul S, Kiertiburanakul S, Van Den Eede P, Ditangco R, Kamarulzaman A, Li PC, Ratanasuwan W, Sirisanthana T; TREAT Asia Studies to Evaluate Resistance--Monitoring Study TASER-M. J Med Virol. 2016 Feb;88(2):234-43. doi: 10.1002/jmv.24320. Epub 2015 Jul 17. PMID: 26147742 Free PMC article.

13. Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial. Bunupuradah T, Kiertiburanakul S, Avihingsanon A, Chetchotisakd P, Techapornroong M, Leerattanapetch N, Kantipong P, Bowonwatanuwong C, Banchongkit S, Klinbuayaem V, Mekviwattanawong S, Nimitvilai S, Jirajariyavej S, Prasithsirikul W, Munsakul W, Bhakeecheep S, Chaivooth S, Phanuphak P, Cooper DA, Apornpong T, Kerr SJ, Emery S, Ruxrungtham K; LASA Study Group. Lancet HIV. 2016 Aug;3(8):e343-e350. doi: 10.1016/S2352-3018(16)30010-8. Epub 2016 May 24. PMID: 27470026 Clinical Trial.

14. Tenofovir-based antiretroviral therapy in 
HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Boettiger DC, Kerr S, Ditangco R, Chaiwarith R, Li PC, Merati TP, Pham TT, Kiertiburanakul S, Kumarasamy N, Vonthanak S, Lee CK, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Law M; TREAT Asia HIV Observational Database. Antivir Ther. 2016;21(1):27-35. doi: 10.3851/IMP2972. Epub 2015 Jun 12. PMID: 26069150 Free PMC article.

15. EPIDEMIOLOGY AND CONTROL OF THE FIRST REPORTED VANCOMYCIN-RESISTANT ENTEROCOCCUS OUTBREAK AT A TERTIARY-CARE HOSPITAL IN BANGKOK, THAILAND. Chotiprasitsakul D, Santanirand P, Thitichai P, Rotjanapan P, Watcharananan S, Siriarayapon P, Chaihongsa N, Sirichot S, Chitasombat M, Chantharit P, Malathum K. Southeast Asian J Trop Med Public Health. 2016 May;47(3):494-502. PMID: 27405133

16. Prevalence and Outcome of Disseminated Varicella Zoster Infection Post Kidney Transplantation. Chitasombat MN, Watcharananan SP. J Med Assoc Thai. 2016 Apr;99(4):381-5. PMID: 27396221

17. Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD. Jiamsakul A, Kerr SJ, Ng OT, Lee MP, Chaiwarith R, Yunihastuti E, Van Nguyen K, Pham TT, Kiertiburanakul S, Ditangco R, Saphonn V, Sim BL, Merati TP, Wong W, Kantipong P, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Oka S, Mustafa M, Ratanasuwan W, Petersen B, Law M, Kumarasamy N; TREAT Asia HIV Observational Database (TAHOD). Trop Med Int Health. 2016 May;21(5):662-74. doi: 10.1111/tmi.12690. Epub 2016 Mar 29. PMID: 26950901 Free PMC article.

18. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival. Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R, Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM. PLoS One. 2016 Mar 2;11(3):e0150512. doi: 10.1371/journal.pone.0150512. eCollection 2016. PMID: 26933963 Free PMC article.

19. A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis. Chuwongwattana S, Jantararoungtong T, Chitasombat MN, Puangpetch A, Prommas S, Dilokpattanamongkol P, Watcharananan SP, Sukasem C. Drug Metab Pharmacokinet. 2016 Apr;31(2):117-22. doi: 10.1016/j.dmpk.2015.12.005. Epub 2016 Jan 12. PMID: 26861072

20. Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy. Ku NS, Jiamsakul A, Ng OT, Yunihastuti E, Cuong DD, Lee MP, Sim BLH, Phanuphak P, Wong WW, Kamarulzaman A, Zhang F, Pujari S, Chaiwarith R, Oka S, Mustafa M, Kumarasamy N, Van Nguyen K, Ditangco R, Kiertiburanakul S, Merati TP, Durier N, Choi JY; TREAT Asia HIV Observational Databases (TAHOD). Medicine (Baltimore). 2016 Aug;95(32):e4570. doi: 10.1097/MD.0000000000004570. PMID: 27512885 Free PMC article.

21. Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials. Choi JY, Sungkanuparph S, Anekthananon T, Sax P, DeJesus E, Edelstein H, Nelson M, DeMorin J, Liu HC, Swamy R, Bahn J, Hwang S, Yang SY, Ng C, Piontkowsky D. Infect Chemother. 2016 Sep;48(3):219-224. doi: 10.3947/ic.2016.48.3.219. PMID: 27704731 Free PMC article.

22. The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database. Jiamsakul A, Kerr SJ, Chandrasekaran E, Huelgas A, Taecharoenkul S, Teeraananchai S, Wan G, Ly PS, Kiertiburanakul S, Law M; TREAT Asia HIV Observational Database (TAHOD). J Clin Epidemiol. 2016 Aug;76:183-92. doi: 10.1016/j.jclinepi.2016.01.030. Epub 2016 Feb 4. PMID: 26854260 Free PMC article.

23. Rate of CD4 Decline and Factors Associated with Rapid CD4 Decline in Asymptomatic HIV-Infected Patients. Chaiyasin N, Sungkanuparph S. J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):3-6. doi: 10.1177/2325957415616493. Epub 2015 Nov 13. PMID: 26567226 Free article.

24. Pituitary tuberculoma: A consideration in the differential diagnosis in a patient manifesting with pituitary apoplexy-like syndrome. Srisukh S, Tanpaibule T, Kiertiburanakul S, Boongird A, Wattanatranon D, Panyaping T, Sriphrapradang C. IDCases. 2016 Jul 29;5:63-6. doi: 10.1016/j.idcr.2016.07.012. eCollection 2016. PMID: 27516966 Free PMC article.

25. Anti-IFN-γ autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia. Ku CL, Lin CH, Chang SW, Chu CC, Chan JF, Kong XF, Lee CH, Rosen EA, Ding JY, Lee WI, Bustamante J, Witte T, Shih HP, Kuo CY, Chetchotisakd P, Kiertiburanakul S, Suputtamongkol Y, Yuen KY, Casanova JL, Holland SM, Doffinger R, Browne SK, Chi CY. J Allergy Clin Immunol. 2016 Mar;137(3):945-8.e8. doi: 10.1016/j.jaci.2015.09.018. Epub 2015 Oct 29. PMID: 26522403 No abstract available.

26. Selective IgM deficiency in an adult presenting with Streptococcus pneumoniae septic arthritis. Phuphuakrat A, Ngamjanyaporn P, Nantiruj K, Luangwedchakarn V, Malathum K. J Microbiol Immunol Infect. 2016 Feb;49(1):150-3. doi: 10.1016/j.jmii.2013.01.009. Epub 2013 Mar 20. PMID: 23523054 Free article.

27. Antibiotic prophylaxis for cardiac surgery in a setting with high prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria. Phuphuakrat A, Choomai A, Kiertiburanakul S, Malathum K. J Hosp Infect. 2016 Aug;93(4):362-3. doi: 10.1016/j.jhin.2016.03.025. Epub 2016 Apr 19. PMID: 27184088 No abstract available.

28. Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial. Wangpatharawanit P, Sungkanuparph S. Clin Infect Dis. 2016 Sep 15;63(6):818-20. doi: 10.1093/cid/ciw395. Epub 2016 Jul 11.

2015

1. Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis. Thongprayoon C, Cheungpasitporn W, Phatharacharukul P, Edmonds PJ, Kaewpoowat Q, Mahaparn P, Bruminhent J, Erickson SB. Int J Clin Pract. 2015 Sep;69(9):998-1006. doi: 10.1111/ijcp.12672. Epub 2015 Jul 5. PMID: 26147121 Free PMC article. Review.

2. The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis. Phatharacharukul P, Thongprayoon C, Cheungpasitporn W, Edmonds PJ, Mahaparn P, Bruminhent J. Dig Dis Sci. 2015 Oct;60(10):2913-22. doi: 10.1007/s10620-015-3714-9. Epub 2015 May 19. PMID: 25986528 Review.

3. The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections. Chitasombat MN, Kontoyiannis DP. Expert Opin Pharmacother. 2015;16(10):1543-58. doi: 10.1517/14656566.2015.1057500. Epub 2015 Jun 23. PMID: 26100603 Review.

4. Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A. Parry CM, Thieu NT, Dolecek C, Karkey A, Gupta R, Turner P, Dance D, Maude RR, Ha V, Tran CN, Thi PL, Be BP, Phi LT, Ngoc RN, Ghose A, Dongol S, Campbell JI, Thanh DP, Thanh TH, Moore CE, Sona S, Gaind R, Deb M, Anh HV, Van SN, Tinh HT, Day NP, Dondorp A, Thwaites G, Faiz MA, Phetsouvanh R, Newton P, Basnyat B, Farrar JJ, Baker S. Antimicrob Agents Chemother. 2015 May;59(5):2756-64. doi: 10.1128/AAC.04729-14. Epub 2015 Mar 2. PMID: 25733500 Free PMC article. Clinical Trial.

5. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis. Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW. PLoS Med. 2015 Apr 7;12(4):e1001810. doi: 10.1371/journal.pmed.1001810. eCollection 2015 Apr. PMID: 25849352 Free PMC article.

6. Clinical Specimen-Direct LAMP: A Useful Tool for the Surveillance of blaOXA-23-Positive arbapenem-Resistant Acinetobacter baumannii. Yamamoto N, Hamaguchi S, Akeda Y, Santanirand P, Kerdsin A, Seki M, Ishii Y, Paveenkittiporn W, Bonomo RA, Oishi K, Malathum K, Tomono K. PLoS One. 2015 Jul 28;10(7):e0133204. doi: 10.1371/journal.pone.0133204. eCollection 2015. PMID: 26218925 Free PMC article.

7. Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Boender TS, Sigaloff KC, McMahon JH, Kiertiburanakul S, Jordan MR, Barcarolo J, Ford N, Rinke de Wit TF, Bertagnolio S. Clin Infect Dis. 2015 Nov 1;61(9):1453-61. doi: 10.1093/cid/civ556. Epub 2015 Jul 8. PMID: 26157050 Free PMC article. Review.

8. The effectiveness and safety of rituximab as induction therapy in ABO-compatible non-sensitized renal transplantation: a systematic review and meta-analysis of randomized controlled trials. Cheungpasitporn W, Thongprayoon C, Edmonds PJ, Bruminhent J, Tangdhanakanond K. Ren Fail. 2015;37(9):1522-6. doi: 10.3109/0886022X.2015.1077310. Epub 2015 Sep 3. PMID: 26337918 Review.

9. The diagnostic accuracy of three rapid diagnostic tests for typhoid fever at Chittagong Medical College Hospital, Chittagong, Bangladesh. Maude RR, de Jong HK, Wijedoru L, Fukushima M, Ghose A, Samad R, Hossain MA, Karim MR, Faiz MA, Parry CM; CMCH Typhoid Study Group. Trop Med Int Health. 2015 Oct;20(10):1376-84. doi: 10.1111/tmi.12559. Epub 2015 Jul 15. PMID: 26094960 Free PMC article.

10. Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD. Jeong SJ, Italiano C, Chaiwarith R, Ng OT, Vanar S, Jiamsakul A, Saphonn V, Nguyen KV, Kiertiburanakul S, Lee MP, Merati TP, Pham TT, Yunihastuti E, Ditangco R, Kumarasamy N, Zhang F, Wong W, Sim BL, Pujari S, Kantipong P, Phanuphak P, Ratanasuwan W, Oka S, Mustafa M, Durier N, Choi JY. AIDS Res Hum Retroviruses. 2016 Mar;32(3):255-61. doi: 10.1089/AID.2015.0058. Epub 2015 Oct 15. PMID: 26414065 Free PMC article.

11. Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture. Burbelo PD, Keller J, Wagner J, Klimavicz JS, Bayat A, Rhodes CS, Diarra B, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Holland SM, Browne SK, Siddiqui S, Kovacs JA. BMC Microbiol. 2015 Oct 8;15:205. doi: 10.1186/s12866-015-0545-y. PMID: 26449888 Free PMC article.

12. Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression. Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, Lee MP, Sim BL, Oka S, Wong W, Kamarulzaman A, Kantipong P, Phanuphak P, Ng OT, Kiertiburanakul S, Zhang F, Pujari S, Ditangco R, Ratanasuwan W, Merati TP, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Databases (TAHOD). J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):e85-92. doi: 10.1097/QAI.0000000000000634. PMID: 25850606 Free PMC article.

13. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome? Bruminhent J, Thongprayoon C, Dierkhising RA, Kremers WK, Theel ES, Razonable RR. Liver Transpl. 2015 Apr;21(4):539-46. doi: 10.1002/lt.24078. Epub 2015 Mar 12. PMID: 25597303 Free article.

14. EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE. Pornsinchai P, Chongtrakool P, Diraphat P, Siripanichgon K, Malathum K. Southeast Asian J Trop Med Public Health. 2015 Jan;46(1):51-62. PMID: 26513905

15. Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals. Jiamsakul A, Chaiwarith R, Durier N, Sirivichayakul S, Kiertiburanakul S, Van Den Eede P, Ditangco R, Kamarulzaman A, Li PC, Ratanasuwan W, Sirisanthana T; TREAT Asia Studies to Evaluate Resistance--Monitoring Study TASER-M. J Med Virol. 2016 Feb;88(2):234-43. doi: 10.1002/jmv.24320. Epub 2015 Jul 17. PMID: 26147742 Free PMC article.

16. High Mortality Risk in Chronic Kidney Disease and End Stage Kidney Disease Patients with Clostridium Difficile Infection: A Systematic Review and Meta-analysis. Thongprayoon C, Cheungpasitporn W, Phatharacharukul P, Mahaparn P, Bruminhent J. J Nat Sci. 2015 Apr;1(4):e85. PMID: 25879082 Free PMC article.

17. Tenofovir-based antiretroviral therapy in 
HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Boettiger DC, Kerr S, Ditangco R, Chaiwarith R, Li PC, Merati TP, Pham TT, Kiertiburanakul S, Kumarasamy N, Vonthanak S, Lee CK, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Law M; TREAT Asia HIV Observational Database. Antivir Ther. 2016;21(1):27-35. doi: 10.3851/IMP2972. Epub 2015 Jun 12. PMID: 26069150 Free PMC article.

18. A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study. Damronglerd P, Sukasem C, Thipmontree W, Puangpetch A, Kiertiburanakul S. Pharmgenomics Pers Med. 2015 Oct 3;8:155-62. doi: 10.2147/PGPM.S86446. eCollection 2015. PMID: 26622191 Free PMC article.

19. The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand. Bushyakanist A, Puangpetch A, Sukasem C, Kiertiburanakul S. Pharmgenomics Pers Med. 2015 Nov 5;8:163-70. doi: 10.2147/PGPM.S86444. eCollection 2015. PMID: 26604812 Free PMC article.

20. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand Manosuthi W, Ongwandee S, Bhakeecheep S, Leechawengwongs M, Ruxrungtham K, Phanuphak P, Hiransuthikul N, Ratanasuwan W, Chetchotisakd P, Tantisiriwat W, Kiertiburanakul S, Avihingsanon A, Sukkul A, Anekthananon T; Adults and Adolescents Committee of the Thai National HIV Guidelines Working Group. AIDS Res Ther. 2015 Apr 24;12:12. doi: 10.1186/s12981-015-0053-z. eCollection 2015. PMID: 25908935 Free PMC article.

21. Diagnostic Value of Percutaneous Liver Biopsy in Fever of Unkown Origin in Patients with Human Immunodeficiency Virus Infection. Wiboonchutikul S, Manosuthi W, Kowadisaiburana B, Sungkanuparph S. Jpn J Infect Dis. 2015;68(4):296-300. doi: 10.7883/yoken.JJID.2014.043. Epub 2015 Feb 13. PMID: 25720639 Free article.

22. COMPARISON OF THAI GOVERNMENT MANUFACTURED TENOFOVIR (TENOFOVIR GPO300) WITH PRIVATELY MANUFACTURED TENOFOVIR (VIREAD) USED ALONG WITH LAMIVUDINE AND EFAVIRENZ TO TREAT THAI HIV PATIENTS. Manosuthi W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2015 Jan;46(1):19-26. PMID: 26513901

23. Factors Associated with Immunological Discordance in HIV-Infected Patients Receiving Antiretroviral Therapy with Complete Viral Suppression in a Resource-Limited Setting. Mingbunjerdsuk P, Asdamongkol N, Sungkanuparph S. Jpn J Infect Dis. 2015;68(4):301-4. doi: 10.7883/yoken.JJID.2014.062. Epub 2015 Feb 13. PMID: 25720640 Free article.

24. Rate of CD4 Decline and Factors Associated with Rapid CD4 Decline in Asymptomatic HIV-Infected Patients. Chaiyasin N, Sungkanuparph S. J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):3-6. doi: 10.1177/2325957415616493. Epub 2015 Nov 13. PMID: 26567226 Free article.

25. Rate of and predicting factors for virologic failure in HIV-infected patients with persistent low-level viremia under antiretroviral therapy. Charuratananon S, Sungkanuparph S. J Int Assoc Provid AIDS Care. 2015 Jan-Feb;14(1):12-6. doi: 10.1177/2325957414527168. Epub 2014 Mar 20. PMID: 24651510 Free article.

26. Risk group characteristics and viral transmission clusters in South-East Asian patients infected with human immunodeficiency virus-1 (HIV-1) circulating recombinant form (CRF) 01_AE and subtype B. Oyomopito RA, Chen YJ, Sungkanuparph S, Kantor R, Merati T, Yam WC, Sirisanthana T, Li PC, Kantipong P, Phanuphak P, Lee CK, Kamarulzaman A, Ditangco R, Huang SW, Sohn AH, Law M, Chen YM. Kaohsiung J Med Sci. 2015 Sep;31(9):445-53. doi: 10.1016/j.kjms.2015.07.002. Epub 2015 Aug 21. PMID: 26362956 Free PMC article.

27. Erratum for Parry et al., Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A. Parry CM, Thieu NT, Dolecek C, Karkey A, Gupta R, Turner P, Dance D, Maude RR, Ha V, Tran CN, Thi PL, Be BP, Phi LT, Ngoc RN, Ghose A, Dongol S, Campbell JI, Thanh DP, Thanh TH, Moore CE, Sona S, Gaind R, Deb M, Anh HV, Van SN, Tinh HT, Day NP, Dondorp A, Thwaites G, Faiz MA, Phetsouvanh R, Newton P, Basnyat B, Farrar JJ, Baker S. Antimicrob Agents Chemother. 2015 Jul;59(7):4364. doi: 10.1128/AAC.01014-15. PMID: 26071570 Free PMC article. No abstract available.

28. Disseminated adenovirus disease in heart transplant recipient presenting with conjunctivitis. Bruminhent J, Athas DM, Hess BD, Flomenberg P. Transpl Infect Dis. 2015 Feb;17(1):125-8. doi: 10.1111/tid.12342. Epub 2015 Jan 9. PMID: 25571908

29. Disseminated Mycobacterium Simiae with Pelvic Malakoplakia in an AIDS Patient. Chitasombat MN, Wattanatranon D. Clin Med Insights Case Rep. 2015 Oct 12;8:89-91. doi: 10.4137/CCRep.S31751. eCollection 2015. PMID: 26483613 Free PMC article.

30. Anti-IFN-γ autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia. Ku CL, Lin CH, Chang SW, Chu CC, Chan JF, Kong XF, Lee CH, Rosen EA, Ding JY, Lee WI, Bustamante J, Witte T, Shih HP, Kuo CY, Chetchotisakd P, Kiertiburanakul S, Suputtamongkol Y, Yuen KY, Casanova JL, Holland SM, Doffinger R, Browne SK, Chi CY. J Allergy Clin Immunol. 2016 Mar;137(3):945-8.e8. doi: 10.1016/j.jaci.2015.09.018. Epub 2015 Oct 29. PMID: 26522403 No abstract available.

31. Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis. Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW. PLoS Med. 2015 Jun 1;12(6):e1001845. doi: 10.1371/journal.pmed.1001845. eCollection 2015 Jun. PMID: 26030872 Free PMC article. No abstract available.

32. Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia. Tee KK, Kantor R, Sungkanuparph S, Takebe Y, Li P, Ditangco R, Phanuphak P, Sirisanthana T, Sim B, Ratanasuwan W, Kantipong P, Kamarulzaman A; TREAT Asia Studies to Evaluate Resistance-Monitoring (TASER-M) Database. J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e28-30. doi: 10.1097/QAI.0000000000000614. PMID: 25835606 Free PMC article. No abstract available.

33. Aggressive calciphylaxis in end-stage renal disease after a failed kidney allograft. Thongprayoon C, Cheungpasitporn W, Bruminhent J. Indian J Dermatol Venereol Leprol. 2015 Jan-Feb;81(1):50. doi: 10.4103/0378-6323.148569. PMID: 25566898 Free article. No abstract available.

34. Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database. Lee MP, Zhou J, Messerschmidt L, Honda M, Ditangco R, Sirisanthana T, Kumarasamy N, Phanuphak P, Chen YM, Zhang F, Saphonn V, Kiertiburanakul S, Lee CK, Pujari S, Choi JY, Kamarulzaman A, Yunihastuti E, Merati TP, Lim PL, Li PC; TREAT Asia HIV Observational Database. AIDS Patient Care STDS. 2015 May;29(5):229-31. doi: 10.1089/apc.2014.0232. Epub 2015 Mar 16.

2014

1. Geohelminths: public health significance. Ojha SC, Jaide C, Jinawath N, Rotjanapan P, Baral P. J Infect Dev Ctries. 2014 Jan 15;8(1):5-16. doi: 10.3855/jidc.3183. PMID: 24423707 Free article. Review.

2. Management of cytomegalovirus infection and disease in liver transplant recipients. Bruminhent J, Razonable RR. World J Hepatol. 2014 Jun 27;6(6):370-83. doi: 10.4254/wjh.v6.i6.370. PMID: 25018848 Free PMC article. Review.

3. Arcanobacterium pyogenes endocarditis: a case report and literature review. Chesdachai S, Larbcharoensub N, Chansoon T, Chalermsanyakorn P, Santanirand P, Chotiprasitsakul D, Ratanakorn D, Boonbaichaiyapruck S. Southeast Asian J Trop Med Public Health. 2014 Jan;45(1):142-8. PMID: 24964663 Review.

4. Factors associated with suboptimal adherence to antiretroviral therapy in Asia. Jiamsakul A, Kumarasamy N, Ditangco R, Li PC, Phanuphak P, Sirisanthana T, Sungkanuparph S, Kantipong P, K C Lee C, Mustafa M, Merati T, Kamarulzaman A, Singtoroj T, Law M; TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M). J Int AIDS Soc. 2014 May 16;17(1):18911. doi: 10.7448/IAS.17.1.18911. eCollection 2014. PMID: 24836775 Free PMC article.

5. Development of multiplex pyrosequencing for HLA-B*57:01 screening using single nucleotide polymorphism haplotype. Sankuntaw N, Chantarangsu S, Chantratita W, Sungkanuparph S, Kiertiburanakul S, Lulitanond V. J Clin Pharm Ther. 2014 Oct;39(5):545-50. doi: 10.1111/jcpt.12175. Epub 2014 May 26. PMID: 24861233

6. Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO). Wohl DA, Orkin C, Doroana M, Pilotto JH, Sungkanuparph S, Yeni P, Vanveggel S, Deckx H, Boven K. Antivir Ther. 2014;19(2):191-200. doi: 10.3851/IMP2721. Epub 2014 Jan 16. PMID: 24430534 Clinical Trial.

7. Clinical characteristics and mortality risk factors of cryptococcal infection among HIV-negative patients. Pongmekin P, Chongtrakool P, Santanirand P, Kiertiburanakul S. J Med Assoc Thai. 2014 Jan;97(1):36-43. PMID: 24701727

8. Coreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominates. Phuphuakrat A, Phawattanakul S, Pasomsub E, Kiertiburanakul S, Chantratita W, Sungkanuparph S. HIV Med. 2014 May;15(5):269-75. doi: 10.1111/hiv.12108. Epub 2013 Nov 11. PMID: 24215399 Free article.

9. Magnetic resonance imaging of the brain in adults with severe falciparum malaria. Maude RJ, Barkhof F, Hassan MU, Ghose A, Hossain A, Abul Faiz M, Choudhury E, Rashid R, Abu Sayeed A, Charunwatthana P, Plewes K, Kingston H, Maude RR, Silamut K, Day NP, White NJ, Dondorp AM. Malar J. 2014 May 9;13:177. doi: 10.1186/1475-2875-13-177. PMID: 24884982 Free PMC article.

10. Serosurveillance of Orientia tsutsugamushi and Rickettsia typhi in Bangladesh. Maude RR, Maude RJ, Ghose A, Amin MR, Islam MB, Ali M, Bari MS, Majumder MI, Tanganuchitcharnchai A, Dondorp AM, Paris DH, Bailey RL, Faiz MA, Blacksell SD, Day NPJ. Am J Trop Med Hyg. 2014 Sep;91(3):580-583. doi: 10.4269/ajtmh.13-0570. Epub 2014 Aug 4. PMID: 25092819 Free PMC article.

11. HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia. Jiamsakul A, Sungkanuparph S, Law M, Kantor R, Praparattanapan J, Li PC, Phanuphak P, Merati T, Ratanasuwan W, Lee CK, Ditangco R, Mustafa M, Singtoroj T, Kiertiburanakul S; TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M). J Int AIDS Soc. 2014 Aug 19;17(1):19053. doi: 10.7448/IAS.17.1.19053. eCollection 2014. PMID: 25141905 Free PMC article.

12. CYP2B6 18492T->C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype *1/*1. Manosuthi W, Sukasem C, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Antimicrob Agents Chemother. 2014;58(4):2268-73. doi: 10.1128/AAC.02384-13. Epub 2014 Feb 3. PMID: 24492364 Free PMC article.

13. Prevalence of positive syphilis serology among HIV-infected patients: role for routine screening in Thailand. Kukanok S, Kiertiburanakul S. Southeast Asian J Trop Med Public Health. 2014 Mar;45(2):435-41. PMID: 24968686

14. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation. Bruminhent J, Wang ZX, Hu C, Wagner J, Sunday R, Bobik B, Hegarty S, Keith S, Alpdogan S, Carabasi M, Filicko-O'Hara J, Flomenberg N, Kasner M, Outschoorn UM, Weiss M, Flomenberg P. Biol Blood Marrow Transplant. 2014 Sep;20(9):1329-34. doi: 10.1016/j.bbmt.2014.04.026. Epub 2014 May 2. PMID: 24792871 Free article.

15. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients. Kiertiburanakul S, Boettiger D, Lee MP, Omar SF, Tanuma J, Ng OT, Durier N, Phanuphak P, Ditangco R, Chaiwarith R, Kantipong P, Lee CK, Mustafa M, Saphonn V, Ratanasuwan W, Merati TP, Kumarasamy N, Wong WW, Zhang F, Pham TT, Pujari S, Choi JY, Yunihastuti E, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD); TREAT Asia Studies to Evaluate Resistance (TASER). J Int AIDS Soc. 2014 Mar 14;17(1):18804. doi: 10.7448/IAS.17.1.18804. eCollection 2014. PMID: 24598459 Free PMC article.

16. Comparisons of clinical characteristics between adult patients with 2009 H1N1 influenza and those with seasonal influenza during the 2009 epidemic in Thailand. Kiertiburanakul S, Morasert T, Sirinavin S, Chantratita W. Jpn J Infect Dis. 2014;67(1):33-9. doi: 10.7883/yoken.67.33. PMID: 24451099 Free article.

17. ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen. Manosuthi W, Sukasem C, Thongyen S, Nilkamhang S, Sungkanuparph S. J Antimicrob Chemother. 2014 Aug;69(8):2195-201. doi: 10.1093/jac/dku129. Epub 2014 Apr 30. PMID: 24788661

18. Severe "sweet" pleural effusion in a continuous ambulatory peritoneal dialysis patient. Maude RR, Barretti M. Respir Med Case Rep. 2014 May 20;13:1-3. doi: 10.1016/j.rmcr.2014.04.005. eCollection 2014. PMID: 26029545 Free PMC article.

19. CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy. Manosuthi W, Sukasem C, Lueangniyomkul A, Mankatitham W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Int J Antimicrob Agents. 2014 Mar;43(3):292-6. doi: 10.1016/j.ijantimicag.2013.10.022. Epub 2013 Nov 25. PMID: 24359841

20. Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database. Boettiger DC, Kerr S, Ditangco R, Merati TP, Pham TT, Chaiwarith R, Kiertiburanakul S, Li CK, Kumarasamy N, Vonthanak S, Lee C, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Sohn A, Law M. PLoS One. 2014 Sep 3;9(9):e106525. doi: 10.1371/journal.pone.0106525. eCollection 2014. PMID: 25184314 Free PMC article.

21. Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries. Ballif M, Nhandu V, Wood R, Dusingize JC, Carter EJ, Cortes CP, McGowan CC, Diero L, Graber C, Renner L, Hawerlander D, Kiertiburanakul S, Du QT, Sterling TR, Egger M, Fenner L; International epidemiological Databases to Evaluate AIDS (IeDEA). Int J Tuberc Lung Dis. 2014 Nov;18(11):1327-36. doi: 10.5588/ijtld.14.0106. PMID: 25299866 Free PMC article.

22. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. IeDEA and ART Cohort Collaborations, Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, Nash D, Gsponer T, Sungkanuparph S, McGowan C, May M, Cooper D, Chimbetete C, Wolff M, Collier A, McManus H, Davies MA, Costagliola D, Crabtree-Ramirez B, Chaiwarith R, Cescon A, Cornell M, Diero L, Phanuphak P, Sawadogo A, Ehmer J, Eholie SP, Li PC, Fox MP, Gandhi NR, González E, Lee CK, Hoffmann CJ, Kambugu A, Keiser O, Ditangco R, Prozesky H, Lampe F, Kumarasamy N, Kitahata M, Lugina E, Lyamuya R, Vonthanak S, Fink V, d'Arminio Monforte A, Luz PM, Chen YM, Minga A, Casabona J, Mwango A, Choi JY, Newell ML, Bukusi EA, Ngonyani K, Merati TP, Otieno J, Bosco MB, Phiri S, Ng OT, Anastos K, Rockstroh J, Santos I, Oka S, Somi G, Stephan C, Teira R, Wabwire D, Wandeler G, Boulle A, Reiss P, Wood R, Chi BH, Williams C, Sterne JA, Egger M. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-16. doi: 10.1097/QAI.0b013e3182a39979. PMID: 24419071 Free PMC article.

23. Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism. Sukasem C, Manosuthi W, Koomdee N, Santon S, Jantararoungtong T, Prommas S, Chamnanphol M, Puangpetch A, Sungkanuparph S. Infection. 2014 Jun;42(3):469-74. doi: 10.1007/s15010-013-0560-6. Epub 2013 Nov 30. PMID: 24293076

24. Cutaneous Mycobacterium haemophilum infections in immunocompromised patients in a tertiary hospital in Bangkok, Thailand: under-reported/under-recognized infection. Tangkosakul T, Hongmanee P, Malathum K. JMM Case Rep. 2014 Dec 1;1(4):e002618. doi: 10.1099/jmmcr.0.002618. eCollection 2014 Dec. PMID: 28663805 Free PMC article.

25. Current status of HIV treatment in Asia and the Pacific region. Phuphuakrat A, Kiertiburanakul S, Sungkanuparph S. Sex Health. 2014 Jul;11(2):119-25. doi: 10.1071/SH13045. PMID: 24433878

26. Rate of and predicting factors for virologic failure in HIV-infected patients with persistent low-level viremia under antiretroviral therapy. Charuratananon S, Sungkanuparph S. J Int Assoc Provid AIDS Care. 2015 Jan-Feb;14(1):12-6. doi: 10.1177/2325957414527168. Epub 2014 Mar 20. PMID: 24651510 Free article.

27. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database. Han SH, Zhou J, Lee MP, Zhao H, Chen YM, Kumarasamy N, Pujari S, Lee C, Omar SF, Ditangco R, Phanuphak N, Kiertiburanakul S, Chaiwarith R, Merati TP, Yunihastuti E, Tanuma J, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Database. HIV Med. 2014 Feb;15(2):77-85. doi: 10.1111/hiv.12073. Epub 2013 Aug 28. PMID: 23980589 Free PMC article.

28. An unusual presentation of childhood vasculitis presenting in adulthood: a challenging diagnosis of henoch-schönlein purpura. Thongprayoon C, Cheungpasitporn W, Thamcharoen N, Bruminhent J. N Am J Med Sci. 2014 Oct;6(10):543-4. doi: 10.4103/1947-2714.143289. PMID: 25489569 Free PMC article.

29. Disseminated cryptococcosis in an HIV-seronegative pregnant woman with transient T-lymphocytopenia: a case report and review of the literature. Meesing A, Jittjareon A, Pornpetchpracha A, Tassaneetrithep B, Phuphuakrat A, Kiertiburanakul S. Southeast Asian J Trop Med Public Health. 2014 May;45(3):647-53. PMID: 24974649 Review.

30. Outcomes of patients with cytomegalovirus viremia at the time of liver transplantation. Bruminhent J, Razonable RR. Liver Transpl. 2014 Sep;20(9):1029-33. doi: 10.1002/lt.23915. Epub 2014 Aug 4. PMID: 24838342 Free article.

31. Surveillance of transmitted HIV drug resistance in antiretroviral-naive patients aged less than 25 years, in Bangkok, Thailand. Sungkanuparph S, Pasomsub E, Chantratita W. J Int Assoc Provid AIDS Care. 2014 Jan-Feb;13(1):12-4. doi: 10.1177/2325957413488200. Epub 2013 May 24. PMID: 23708678 Free article.

32. Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia. Phanuphak P, Sirivichayakul S, Jiamsakul A, Sungkanuparph S, Kumarasamy N, Lee MP, Sirisanthana T, Kantipong P, Lee C, Kamarulzaman A, Mustafa M, Ditangco R, Merati T, Ratanasuwan W, Singtoroj T, Kantor R. J Acquir Immune Defic Syndr. 2014 May 1;66(1):74-9. doi: 10.1097/QAI.0000000000000108. PMID: 24413039 Free PMC article.

33. Prolonged shedding of pandemic influenza A (H1N1) 2009 virus in a pancreas-after-kidney transplant recipient. Bruminhent J, Deziel PJ, Wotton JT, Binnicker MJ, Razonable RR. J Clin Virol. 2014 Oct;61(2):302-4. doi: 10.1016/j.jcv.2014.07.004. Epub 2014 Jul 16. PMID: 25081940

34. Relationship between hyperglycemia and the risk of tuberculosis in Asian HIV-positive individuals in the antiretroviral therapy era: cohort study. Achhra AC, Pujari S, Choi JY, Khusuwan S, Kinh NV, Phanuphak P, Chaiwarith R, Lee MP, Saphonn V, Kiertiburanakul S, Thuy PT, Law MG; TREAT Asia HIV Observational Database (TAHOD) Cohort. J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):e108-11. doi: 10.1097/QAI.0000000000000217. PMID: 24853312 Free PMC article. No abstract available.

35. A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort. Boettiger DC, Saphonn V, Lee MP, Phanuphak P, Pham TT, Heng Sim BL, Kumarasamy N, Van Nguyen K, Kantipong P, Kamarulzaman A, Chaiwarith R, Kiertiburanakul S, Law MG. J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):e131-3. doi: 10.1097/QAI.0000000000000338. PMID: 25197829 Free PMC article. No abstract available.

36. The impact of wild-type reversion on transmitted resistance surveillance. Boettiger DC, Kiertiburanakul S, Sungkanuparph S, Law MG; TREAT Asia Studies to Evaluate Resistance. Antivir Ther. 2014;19(7):719-22. doi: 10.3851/IMP2746. Epub 2014 Feb 17. PMID: 24535375 Free PMC article. No abstract available.

37. Acute respiratory failure secondary to eosinophilic pneumonia following influenza vaccination in an elderly man with chronic obstructive pulmonary disease. Pornsuriyasak P, Suwatanapongched T, Klaewsongkram J, Buranapraditkun S, Rotjanapan P. Int J Infect Dis. 2014 Sep;26:14-6. doi: 10.1016/j.ijid.2014.04.019. Epub 2014 Jun 27. PMID: 24981428 Free PMC article.

38. Investigation of a Clostridium difficile cluster by multilocus sequence typing in a bone marrow transplant unit. Hu C, Sunday R, Bruminhent J, Bobik B, Wagner J, Weiss M, Flomenberg P, Wang ZX. Am J Infect Control. 2014 Jun;42(6):691-3. doi: 10.1016/j.ajic.2014.02.008. Epub 2014 Mar 29.

2013

1. Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for 'test and treat' prevention strategy. Guy R, Wand H, McManus H, Vonthanak S, Woolley I, Honda M, Read T, Sirisanthana T, Zhou J, Carr A; Australia HIV Observational Database (AHOD) and Treat Asia HIV Observation Database (TAHOD).. AIDS Patient Care STDS. 2013 Dec;27(12):681-91.
2. Factors determining the appropriateness of ceftriaxone usage at the emergency room of a university hospital in Thailand. Phuphuakrat A, Kiertiburanakul S, Malathum K. J Med Assoc Thai. 2013 Jul;96(7):773-81.
3. Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism. Sukasem C, Manosuthi W, Koomdee N, Santon S, Jantararoungtong T, Prommas S, Chamnanphol M, Puangpetch A, Sungkanuparph S. Infection. 2014 Jun;42(3):469-74.  
4. Low plasma zinc levels and immunological responses to zinc supplementation in HIV-infected patients with immunological discordance after antiretroviral therapy. Asdamongkol N, Phanachet P, Sungkanuparph S. Jpn J Infect Dis. 2013;66(6):469-74.
5. Coreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominates. Phuphuakrat A, Phawattanakul S, Pasomsub E, Kiertiburanakul S, Chantratita W, Sungkanuparph S. HIV Med. 2014 May;15(5):269-75.  
6. Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. Fenner L, Ballif M, Graber C, Nhandu V, Dusingize JC, Cortes CP, Carriquiry G, Anastos K, Garone D, Jong E, Gnokoro JC, Sued O, Ajayi S, Diero L, Wools-Kaloustian K, Kiertiburanakul S, Castelnuovo B, Lewden C, Durier N, Sterling TR, Egger M; International epidemiological Databases to Evaluate AIDS (IeDEA).. PLoS One. 2013 Oct 17;8(10):e77697.
7. Fungal appendicitis: a case series and review of the literature. Larbcharoensub N, Boonsakan P, Kanoksil W, Wattanatranon D, Phongkitkarun S, Molagool S, Watcharananan SP. Southeast Asian J Trop Med Public Health. 2013 Jul 4;44(4):681-9. Review.
8. Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient. Larbcharoensub N, Chongtrakool P, Wirojtananugoon C, Watcharananan SP, Sumethkul V, Boongird A, Jirasiritham S. Southeast Asian J Trop Med Public Health. 2013 May;44(3):484-9.
9. Small-dense LDL cholesterol/large-buoyant LDL cholesterol ratio as an excellent marker for indicating lipodystrophy in HIV-infected patients. Srisawasdi P, Suwalak T, Sukasem C, Chittamma A, Pocathikorn A, Vanavanan S, Puangpetch A, Santon S, Chantratita W, Kiertiburanakul S, Kroll MH. Am J Clin Pathol. 2013 Oct;140(4):506-15.
10. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database. Han SH, Zhou J, Lee MP, Zhao H, Chen YM, Kumarasamy N, Pujari S, Lee C, Omar SF, Ditangco R, Phanuphak N, Kiertiburanakul S, Chaiwarith R, Merati TP, Yunihastuti E, Tanuma J, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Database.. HIV Med. 2014 Feb;15(2):77-85.  
11. Rilpivirine resistance-associated mutations among antiretroviral-naive patients infected with HIV-1 in Asia. Sungkanuparph S, Jiamsakul A, Kiertiburanakul S, Sirivichayakul S, Praparattanapan J, Kantor R; TREAT Asia Studies to Evaluate Resistance.. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):e98-100.  
12. Clinical and radiologic manifestations of pulmonary cryptococcosis in immunocompetent patients and their outcomes after treatment. Suwatanapongched T, Sangsatra W, Boonsarngsuk V, Watcharananan SP, Incharoen P. Diagn Interv Radiol. 2013 Nov-Dec;19(6):438-46.  
13. Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region. Wright S, Boyd MA, Yunihastuti E, Law M, Sirisanthana T, Hoy J, Pujari S, Lee MP, Petoumenos K; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific HIV Observational Database (APHOD).. PLoS One. 2013 Jun 28;8(6):e64902.
14. Would a CYP2B6 test help HIV patients being treated with efavirenz? Sukasem C, Sungkanuparph S. Pharmacogenomics. 2013 Jul;14(9):999-1001.
15. Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients. Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, Jiamsakul A, Li PC, Kantipong P, Lee C, Ratanasuwan W, Kamarulzaman A, Sohn AH, Sungkanuparph S; TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies.. PLoS One. 2013 Jun 27;8(6):e62057.
16. Surveillance of transmitted HIV drug resistance in antiretroviral-naive patients aged less than 25 years, in Bangkok, Thailand. Sungkanuparph S, Pasomsub E, Chantratita W. J Int Assoc Provid AIDS Care. 2014 Jan-Feb;13(1):12-4.
17. Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand. Kyaw NL, Thanachartwet V, Kiertiburanakul S, Desakorn V, Chamnanchanunt S, Chierakul W, Manosuthi W, Pitisuttithum P, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2013 Mar;44(2):232-43.
18. Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H; BENCHMRK Study Teams.. Lancet Infect Dis. 2013 Jul;13(7):587-96.
19. Evaluation of multiplex PCR with enhanced spore germination for detection of Clostridium difficile from stool samples of the hospitalized patients. Chankhamhaengdecha S, Hadpanus P, Aroonnual A, Ngamwongsatit P, Chotiprasitsakul D, Chongtrakool P, Janvilisri T. Biomed Res Int. 2013;2013:875437.  
20. Selective IgM deficiency in an adult presenting with Streptococcus pneumoniae septic arthritis. Phuphuakrat A, Ngamjanyaporn P, Nantiruj K, Luangwedchakarn V, Malathum K. J Microbiol Immunol Infect. 2016 Feb;49(1):150-3. D
21. Rothia mucilaginosa prosthetic device infections: a case of prosthetic valve endocarditis. Bruminhent J, Tokarczyk MJ, Jungkind D, DeSimone JA Jr. J Clin Microbiol. 2013 May;51(5):1629-32.
22. Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study. Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM; INSIGHT SMART Study Group.. PLoS One. 2013;8(2):e56249.
23. Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database. Byakwaga H, Petoumenos K, Ananworanich J, Zhang F, Boyd MA, Sirisanthana T, Li PC, Lee C, Mean CV, Saphonn V, Omar SF, Pujari S, Phanuphak P, Lim PL, Kumarasamy N, Chen YM, Merati TP, Sungkanuparph S, Ditangco R, Oka S, Tau G, Zhou J, Law MG, Emery S. J Int Assoc Provid AIDS Care. 2013 Jul-Aug;12(4):270-7.
24. Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. Rockstroh JK, DeJesus E, Lennox JL, Yazdanpanah Y, Saag MS, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P; STARTMRK Investigators.. J Acquir Immune Defic Syndr. 2013 May 1;63(1):77-85.
25. Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients. Manosuthi W, Sukasem C, Lueangniyomkul A, Mankatitham W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Antimicrob Agents Chemother. 2013 Feb;57(2):1019-24.
26. Listeria monocytogenes cholecystitis: a possible new syndrome. Bruminhent J, Lynch TK, Gefen J, Santoro J. Am J Med Sci. 2013 May;345(5):414-7.  
27. Transmitted HIV drug resistance in Asia. Sohn AH, Srikantiah P, Sungkanuparph S, Zhang F. Curr Opin HIV AIDS. 2013 Jan;8(1):27-33.
28. HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection. Manosuthi W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. J Med Virol. 2013 Feb;85(2):194-9.
29. A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections. Matthews P, Alpert M, Rahav G, Rill D, Zito E, Gardiner D, Pedersen R, Babinchak T, McGovern PC; Tigecycline 900 cSSSI Study Group.. BMC Infect Dis. 2012 Nov 12;12:297.
30. Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; TREAT Asia Studies to Evaluate Resistance (TASER) and The TREAT Asia HIV Observational Database.. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):293-300.  
31. Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis. Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M).. BMC Res Notes. 2012 Oct 24;5:582.  
32. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting. Than NN, Sungkanuparph S, Maek-A-Nantawat W, Kaewkungwal J, Pitisuttithum P. Southeast Asian J Trop Med Public Health. 2012 May;43(3):646-51.
33. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavej S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Kerr SJ, Sophonphan J, Bhakeecheep S, Hirschel B, Ruxrungtham K; HIV STAR Study Group.. Antivir Ther. 2012;17(7):1351-61. doi: 10.3851/IMP2443. Erratum in: Antivir Ther. 2012;17(7):1389-90.
34. Adult-onset immunodeficiency in Thailand and Taiwan. Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool K, Zaman R, Ding L, Hsu AP, Patel SY, Olivier KN, Lulitanond V, Mootsikapun P, Anunnatsiri S, Angkasekwinai N, Sathapatayavongs B, Hsueh PR, Shieh CC, Brown MR, Thongnoppakhun W, Claypool R, Sampaio EP, Thepthai C, Waywa D, Dacombe C, Reizes Y, Zelazny AM, Saleeb P, Rosen LB, Mo A, Iadarola M, Holland SM. N Engl J Med. 2012 Aug 23;367(8):725-34.
35. Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK. DeJesus E, Rockstroh JK, Lennox JL, Saag MS, Lazzarin A, Zhao J, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P; STARTMRK Investigators.. HIV Clin Trials. 2012 Jul-Aug;13(4):228-32.
36. A superior test for diagnosis of Clostridium difficile-associated diarrhea in resource-limited settings. Chotiprasitsakul D, Janvilisri T, Kiertiburanakul S, Watcharananun S, Chankhamhaengdecha S, Hadpanus P, Malathum K. Jpn J Infect Dis. 2012 Jul;65(4):326-9.
37. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, Henderson FL, Pathak SR, Soud FA, Chillag KL, Mutanhaurwa R, Chirwa LI, Kasonde M, Abebe D, Buliva E, Gvetadze RJ, Johnson S, Sukalac T, Thomas VT, Hart C, Johnson JA, Malotte CK, Hendrix CW, Brooks JT; TDF2 Study Group.. N Engl J Med. 2012 Aug 2;367(5):423-34.
38. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial. DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP; GS-236-0103 Study Team.. Lancet. 2012 Jun 30;379(9835):2429-38.
39. Clinical characteristics of HIV-infected patients who survive after the diagnosis of HIV infection for more than 10 years in a resource-limited setting. Kiertiburanakul S, Luengroongroj P, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec;11(6):361-5.
40. HIV-1 drug resistance at virological failure versus immunological failure among patients failing first-line antiretroviral therapy in a resource-limited setting. Sungkanuparph S, Win MM, Kiertiburanakul S, Phonrat B, Maek-a-nantawat W. Int J STD AIDS. 2012 May;23(5):316-8.
41. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study. Manosuthi W, Mankatitham W, Lueangniyomkul A, Thongyen S, Likanonsakul S, Suwanvattana P, Thawornwan U, Suntisuklappon B, Nilkamhang S, Sungkanuparph S; TIME Study Team.. J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):377-83. D
42. Population pharmacokinetics of vancomycin in Thai patients. Purwonugroho TA, Chulavatnatol S, Preechagoon Y, Chindavijak B, Malathum K, Bunuparadah P. ScientificWorldJournal. 2012;2012:762649.
43. Influenza A (H1N1) 2009 reinfection in Thailand. Trakulsrichai S, Watcharananan SP, Chantratita W. J Infect Public Health. 2012 Apr;5(2):211-4.  
44. Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials. Nelson M, Amaya G, Clumeck N, Arns da Cunha C, Jayaweera D, Junod P, Li T, Tebas P, Stevens M, Buelens A, Vanveggel S, Boven K; ECHO and THRIVE Study Groups.. J Antimicrob Chemother. 2012 Aug;67(8):2020-8.  
45. Evaluation of real-time polymerase chain reaction for detection of the 16S ribosomal RNA gene of Mycobacterium tuberculosis and the diagnosis of cervical tuberculous lymphadenitis in a country with a high tuberculosis incidence. Linasmita P, Srisangkaew S, Wongsuk T, Bhongmakapat T, Watcharananan SP. Clin Infect Dis. 2012 Aug;55(3):313-21.  
46. HIV drug resistance interpreted by cumulative versus last genotypes in HIV-infected patients with multiple treatment failures. Punyacam P, Iemwimangsa N, Chantratita W, Sukasem C, Sungkanuparph S. Curr HIV Res. 2012 Apr;10(3):271-4.
47. Cytomegalovirus viremia after kidney transplantation in Thailand: predictors of symptomatic infection and outcome. Watcharananan SP, Louhapanswat S, Chantratita W, Jirasiritham S, Sumethkul V. Transplant Proc. 2012 Apr;44(3):701-5.  
48. Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD. Zhou J, Tanuma J, Chaiwarith R, Lee CK, Law MG, Kumarasamy N, Phanuphak P, Chen YM, Kiertiburanakul S, Zhang F, Vonthanak S, Ditangco R, Pujari S, Choi JY, Parwati Merati T, Yunihastuti E, Li PC, Kamarulzaman A, Nguyen VK, Thuy Pham TT, Lim PL. AIDS Res Treat. 2012;2012:375217.
49. Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand. Sungkanuparph S, Sukasem C, Kiertiburanakul S, Pasomsub E, Chantratita W. J Int AIDS Soc. 2012 Mar 12;15(1):12.
50. Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure. Manosuthi W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. AIDS Res Ther. 2012 Mar 13;9(1):8.  
51. Severe nonfebrile dengue infection in an adolescent after postoperative kidney transplantation: a case report. Tangnararatchakit K, Tirapanich W, Tapaneya-Olarn W, Sumethkul V, Sirachainan N, Watcharananan S, Leenanupunth C, Yoksan S, Chuansumrit A. Transplant Proc. 2012 Jan;44(1):303-6.
52. Adrenal histoplasmosis: a case series and review of the literature. Larbcharoensub N, Boonsakan P, Aroonroch R, Rochanawutanon M, Nitiyanant P, Phongkitkarun S, Poonvutikul S, Watcharananan SP, Ngarmukos C. Southeast Asian J Trop Med Public Health. 2011 Jul;42(4):920-5.
53. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. Zhou J, Jaquet A, Bissagnene E, Musick B, Wools-Kaloustian K, Maxwell N, Boulle A, Wehbe F, Masys D, Iriondo-Perez J, Hemingway-Foday J, Law M; Western Africa, Eastern Africa, Southern Africa, Caribbean and Central and South America, and Asia Pacific Regions of the International Epidemiologic Databases to Evaluate AIDS-IeDEA.. J Int AIDS Soc. 2012 Jan 30;15(1):5.
54. Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database.Lim PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database.. J Int AIDS Soc. 2012 Jan 26;15(1):1.
55. Epidemiology of bloodstream infections and predictive factors of mortality among HIV-infected adult patients in Thailand in the era of highly active antiretroviral therapy. Kiertiburanakul S, Watcharatipagorn S, Chongtrakool P, Santanirand P. Jpn J Infect Dis. 2012;65(1):28-32.
56. Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting. Wiboonchutikul S, Sungkanuparph S, Kiertiburanakul S, Chailurkit LO, Charoenyingwattana A, Wangsomboonsiri W, Chantratita W, Ongphiphadhanakul B. J Int Assoc Physicians AIDS Care (Chic). 2012 Sep-Oct;11(5):305-10.
57. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients. Khawcharoenporn T, Apisarnthanarak A, Manosuthi W, Sungkanuparph S, Mundy LM. Int J Tuberc Lung Dis. 2012;16(3):336-41
58. Five-year prospective study of tuberculin skin testing among new healthcare personnel at a university hospital in Thailand. Kiertiburanakul S, Suebsing S, Kehachindawat P, Apivanich S, Somsakul S, Sathapatayavongs B, Malathum K. J Hosp Infect. 2012 Feb;80(2):173-5.
59. Discrepancies between WHO 2009 and IAS-USA 2009 lists for determining the rate of transmitted HIV-1 drug resistance: a prospective study. Sungkanuparph S, Kiertiburanakul S, Sukasem C, Chantratita W. J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):e3-5
60. Optimal timing of antiretroviral therapy initiation in patients coinfected with HIV and tuberculosis. Kiertiburanakul S, Manosuthi W, Sungkanuparph S. Expert Rev Clin Pharmacol. 2011 Mar;4(2):143-6.  
61. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. J Infect. 2012 Jan;64(1):68-75. doi: 10.1016/j.jinf.2011.11.002.

2012

1. Impact of Pharmacogenetic Markers of CYP2B6, Clinical Factors, and Drug-Drug Interaction on Efavirenz Concentrations in HIV/Tuberculosis-Coinfected Patients. Manosuthi W, Sukasem C, Lueangniyomkul A, Mankatitham W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Antimicrob Agents Chemother. 2013 Feb;57(2):1019-24.
2. HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection.Manosuthi W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. J Med Virol. 2013 Feb;85(2):194-9.
3. Evaluating immunologic response and clinical deterioration in treatment-naïve patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; on behalf of the TREAT Asia Studies to Evaluate Resistance (TASER) and the TREAT Asia HIV Observational Database. J Acquir Immune Defic Syndr. 2012 Nov 7.
4. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study.Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavej S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Kerr SJ, Sophonphan J, Bhakeecheep S, Hirschel B, Ruxrungtham K; HIV STAR Study Group. Antivir Ther. 2012;17(7):1389-90.
5. Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis.Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M). BMC Res Notes. 2012 Oct 24;5:582.
6. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting. Than NN, Sungkanuparph S, Maek-A-Nantawat W, Kaewkungwal J, Pitisuttithum P. Southeast Asian J Trop Med Public Health. 2012 May;43(3):646-51.
7. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study.Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavej S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Kerr SJ, Sophonphan J, Bhakeecheep S, Hirschel B, Ruxrungtham K; HIV STAR Study Group. Antivir Ther. 2012;17(7):1351-61.
8. Adult-onset immunodeficiency in Thailand and Taiwan.Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool K, Zaman R, Ding L, Hsu AP, Patel SY, Olivier KN, Lulitanond V, Mootsikapun P, Anunnatsiri S, Angkasekwinai N, Sathapatayavongs B, Hsueh PR, Shieh CC, Brown MR, Thongnoppakhun W, Claypool R, Sampaio EP, Thepthai C, Waywa D, Dacombe C, Reizes Y, Zelazny AM, Saleeb P, Rosen LB, Mo A, Iadarola M, Holland SM. N Engl J Med. 2012 Aug 23;367(8):725-34.
9. A superior test for diagnosis of Clostridium difficile-associated diarrhea in resource-limited settings.Chotiprasitsakul D, Janvilisri T, Kiertiburanakul S, Watcharananun S, Chankhamhaengdecha S, Hadpanus P, Malathum K. Jpn J Infect Dis. 2012 Jul;65(4):326-9.
10. A randomized comparison of second-line lopinavir/ritonavir monotherapy vs. tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI-regimens: the HIV STAR study.Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavej S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Kerr SJ, Sophonphan J, Bhakeecheep S, Hirschel B, Ruxrungtham K; the HIV STAR Study Group. Antivir Ther. 2012 Jul 2.
11. Clinical Characteristics of HIV-Infected Patients Who Survive after the Diagnosis of HIV Infection for More Than 10 Years in a Resource-Limited Setting.Kiertiburanakul S, Luengroongroj P, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec;11(6):361-5.
12. HIV-1 drug resistance at virological failure versus immunological failure among patients failing first-line antiretroviral therapy in a resource-limited setting.Sungkanuparph S, Win MM, Kiertiburanakul S, Phonrat B, Maek-a-nantawat W. Int J STD AIDS. 2012 May;23(5):316-8.
13. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.Manosuthi W, Mankatitham W, Lueangniyomkul A, Thongyen S, Likanonsakul S, Suwanvattana P, Thawornwan U, Suntisuklappon B, Nilkamhang S, Sungkanuparph S; TIME Study Team. J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):377-83.
14. Population pharmacokinetics of vancomycin in Thai patients.Purwonugroho TA, Chulavatnatol S, Preechagoon Y, Chindavijak B, Malathum K, Bunuparadah P. ScientificWorldJournal. 2012;2012:762649.
15. Influenza A (H1N1) 2009 reinfection in Thailand.Trakulsrichai S, Watcharananan SP, Chantratita W. J Infect Public Health. 2012 Apr;5(2):211-4.
16. Evaluation of real-time polymerase chain reaction for detection of the 16S ribosomal RNA gene of Mycobacterium tuberculosis and the diagnosis of cervical tuberculous lymphadenitis in a country with a high tuberculosis incidence.Linasmita P, Srisangkaew S, Wongsuk T, Bhongmakapat T, Watcharananan SP. Clin Infect Dis. 2012 Aug;55(3):313-21.
17. HIV drug resistance interpreted by cumulative versus last genotypes in HIV-infected patients with multiple treatment failures.Punyacam P, Iemwimangsa N, Chantratita W, Sukasem C, Sungkanuparph S. Curr HIV Res. 2012 Apr;10(3):271-4.
18. Cytomegalovirus viremia after kidney transplantation in Thailand: predictors of symptomatic infection and outcome.Watcharananan SP, Louhapanswat S, Chantratita W, Jirasiritham S, Sumethkul V. Transplant Proc. 2012 Apr;44(3):701-5.
19. Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD.Zhou J, Tanuma J, Chaiwarith R, Lee CK, Law MG, Kumarasamy N, Phanuphak P, Chen YM, Kiertiburanakul S, Zhang F, Vonthanak S, Ditangco R, Pujari S, Choi JY, Parwati Merati T, Yunihastuti E, Li PC, Kamarulzaman A, Nguyen VK, Thuy Pham TT, Lim PL. AIDS Res Treat. 2012;2012:375217.
20. Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand.Sungkanuparph S, Sukasem C, Kiertiburanakul S, Pasomsub E, Chantratita W. J Int AIDS Soc. 2012 Mar 12;15(1):12.
21. Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure.Manosuthi W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. AIDS Res Ther. 2012 Mar 13;9(1):8.
22. Severe nonfebrile dengue infection in an adolescent after postoperative kidney transplantation: a case report.Tangnararatchakit K, Tirapanich W, Tapaneya-Olarn W, Sumethkul V, Sirachainan N, Watcharananan S, Leenanupunth C, Yoksan S, Chuansumrit A. Transplant Proc. 2012 Jan;44(1):303-6.
23. Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database.im PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database. J Int AIDS Soc. 2012 Jan 26;15(1):1.
24. Epidemiology of bloodstream infections and predictive factors of mortality among HIV-infected adult patients in Thailand in the era of highly active antiretroviral therapy.Kiertiburanakul S, Watcharatipagorn S, Chongtrakool P, Santanirand P. Jpn J Infect Dis. 2012;65(1):28-32.
25. Vitamin D Insufficiency and Deficiency among HIV-1-Infected Patients in a Tropical Setting.Wiboonchutikul S, Sungkanuparph S, Kiertiburanakul S, Chailurkit LO, Charoenyingwattana A, Wangsomboonsiri W, Chantratita W, Ongphiphadhanakul B. J Int Assoc Physicians AIDS Care (Chic). 2012 Sep-Oct;11(5):305-10.
26. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.Khawcharoenporn T, Apisarnthanarak A, Manosuthi W, Sungkanuparph S, Mundy LM. Int J Tuberc Lung Dis. 2012;16(3):336-41.
27. Five-year prospective study of tuberculin skin testing among new healthcare personnel at a university hospital in Thailand.Kiertiburanakul S, Suebsing S, Kehachindawat P, Apivanich S, Somsakul S, Sathapatayavongs B, Malathum K. J Hosp Infect. 2012 Feb;80(2):173-5.
28. Discrepancies between WHO 2009 and IAS-USA 2009 lists for determining the rate of transmitted HIV-1 drug resistance: a prospective study.Sungkanuparph S, Kiertiburanakul S, Sukasem C, Chantratita W. J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):e3-5. 
29. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. J Infect. 2012 Jan;64(1):68-75.
30. HIV type 1 integrase polymorphisms in treatment-naive and treatment-experienced HIV type 1-infected patients in Thailand where HIV type 1 subtype A/E predominates. Phuphuakrat A, Pasomsub E, Kiertiburanakul S, Chantratita W, Sungkanuparph S. AIDS Res Hum Retroviruses. 2012 Aug;28(8):937-43.
31. Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance. Int J Epidemiol. 2012 Feb;41(1):43-54.

2011  [Abstract]

1. Five-year prospective study of tuberculin skin testing among new healthcare personnel at a university hospital in Thailand. Kiertiburanakul S, Suebsing S, Kehachindawat P, Apivanich S, Somsakul S, Sathapatayavongs B, Malathum K. J Hosp Infect. 2011 Dec 20.

2. Optimal timing of antiretroviral therapy initiation in patients coinfected with HIV and tuberculosis.Kiertiburanakul S, Manosuthi W, Sungkanuparph S. Expert Rev Clin Pharmacol. 2011 Mar;4(2):143-6. 

3. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. J Infect. 2012 Jan;64(1):68-75. Epub 2011 Nov 11.

4. Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients. Anekthananon T, Manosuthi W, Chetchotisakd P, Kiertiburanakul S, Supparatpinyo K, Ratanasuwan W, Pappas PG, Filler SG, Kopetskie HA, Nolen TL, Kendrick AS, Larsen RA; BAMSG 3-01 Study Team. Int J STD AIDS. 2011 Nov;22(11):665-70.

5. GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals.Overton ET, Sungkanuparph S, Klebert M, Royal M, Demarco-Shaw D, Powderly WG, Aberg JA. Open Virol J. 2011;5:109-13. Epub 2011 Oct 14.

6. Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens.Bunupuradah T, Ananworanich J, Chetchotisakd P, Kantipong P, Jirajariyavej S, Sirivichayakul S, Munsakul W, Prasithsirikul W, Sungkanuparph S, Bowonwattanuwong C, Klinbuayaem V, Petoumenos K, Hirschel B, Bhakeecheep S, Ruxrungtham K. Antivir Ther. 2011;16(7):1113-21.

7. HIV Type 1 Integrase Polymorphisms in Treatment-Naive and Treatment-Experienced HIV Type 1-Infected Patients in Thailand Where HIV Type 1 Subtype A/E Predominates.Phuphuakrat A, Pasomsub E, Kiertiburanakul S, Chantratita W, Sungkanuparph S. AIDS Res Hum Retroviruses. 2011 Nov 22.

8. Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients with Connective Tissue Diseases.Vananuvat P, Suwannalai P, Sungkanuparph S, Limsuwan T, Ngamjanyaporn P, Janwityanujit S. Semin Arthritis Rheum. 2011 Dec;41(3):497-502. Epub 2011 Sep 29.

9. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.Kanchana S, Kanchana S, Chuntrakul C, Malathum K, Prachayangprecha S, Poovorawan Y. J Infect. 2011 Oct;63(4):295-9. Epub 2011 Aug 9.

10. Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?McManus H, Li PC, Nolan D, Bloch M, Kiertiburanakul S, Choi JY, Mulhall B, Petoumenos K, Zhou J, Law M, Brew BJ, Wright E. HIV Med. 2011 Nov;12(10):610-9.  Epub 2011 Aug 7.

11. Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash.Chantarangsu S, Mushiroda T, Mahasirimongkol S, Kiertiburanakul S, Sungkanuparph S, Manosuthi W, Tantisiriwat W, Charoenyingwattana A, Sura T, Takahashi A, Kubo M, Kamatani N, Chantratita W, Nakamura Y. Clin Infect Dis. 2011 Aug;53(4):341-8.

12. Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting. Manosuthi W, Prasithsirikul W, Tantanathip P, Chimsuntorn S, Nilkamhang S, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2011 May;42(3):643-50.

13. Simultaneous detection and subtyping of H274Y-positive influenza A (H1N1) using pyrosequencing.Chantratita W, Sukasem C, Sirinavin S, Sankuntaw N, Srichantaratsamee C, Pasomsub E, Malathum K. J Infect Dev Ctries. 2011 May 28;5(5):348-52.

14. High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand.Kiertiburanakul S, Malathum K, Watcharananan SP, Bunupuradah P, Piebpien P, Rujiraviroj U, Likitsinsipon W, Apivanich S, Kehachindawat P, Burakitcharoen R, Leelaudomlipi S, Wananukul W. Am J Infect Control. 2011 Aug;39(6):525-8. Epub 2011 May 25.

15. Monitoring of Renal Function among HIV-Infected Patients Receiving Tenofovir in a Resource-Limited Setting.Kiertiburanakul S, Chaisiri K, Kasettratat N, Visuttimak P, Bowonwatanuwong C. J Int Assoc Physicians AIDS Care (Chic). 2011 Sep-Oct;10(5):297-302. Epub 2011 May 23.

16. Serum antioxidant levels and nutritional status in early and advanced stage lung cancer patients.Klarod K, Hongsprabhas P, Khampitak T, Wirasorn K, Kiertiburanakul S, Tangrassameeprasert R, Daduang J, Yongvanit P, Boonsiri P. Nutrition. 2011 Nov-Dec;27(11-12):1156-60. Epub 2011 May 6.

17. Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD). Han SH, Zhou J, Saghayam S, Vanar S, Phanuphak N, Chen YM, Sirisanthana T, Sungkanuparph S, Lee CK, Pujari S, Li PC, Oka S, Saphonn V, Zhang F, Merati TP, Law MG, Choi JY; TREAT Asia HIV Observational Database. Endocr J. 2011;58(6):475-84. Epub 2011 Apr 27.

18. HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P; TREAT Asia Studies to Evaluate Resistance-Monitoring Study (TASER-M). Clin Infect Dis. 2011 Apr 15;52(8):1053-7.

19. Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery. Watcharananan SP, Avery R, Ingsathit A, Malathum K, Chantratita W, Mavichak V, Chalermsanyakorn P, Jirasiritham S, Sumethkul V. Am J Transplant. 2011 Jun;11(6):1308-14.  Epub 2011 Mar 30.

20. Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: a prospective study. Manosuthi W, Lueangniyomkul A, Mankatitham W, Chimsuntorn S, Tantanathip P, Thongyen S, Suntisuklappon B, Nilkamhang S, Sungkanuparph S. J Infect. 2011 May;62(5):406-9. Epub 2011 Mar 5. 

21. Virologic and Immunologic Outcomes of the Second-Line Regimens of Antiretroviral Therapy Among HIV-Infected Patients in Thailand. Win MM, Maek-A-Nantawat W, Phonrat B, Kiertiburanakul S, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic). 2011 Jan-Feb;10(1):57-63.

22. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. Khawcharoenporn T, Apisarnthanarak A, Sungkanuparph S, Woeltje KF, Fraser VJ. Int J Tuberc Lung Dis. 2011 Jan;15(1):14-23. Review.

23. Single-Boosted Protease Inhibitor versus Double-Boosted Protease Inhibitors for the Salvage Therapy in HIV-Infected Patients. Manosuthi W, Chimsuntorn S, Thongyen S, Nilkamhang S, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic). 2011 Mar-Apr;10(2):105-10. Epub 2011 Jan 24.

24. Late and low compliance with hepatitis B serology screening among HIV-infected patients in a resource-limited setting: an issue to improve HIV care.  Kiertiburanakul S, Chotiprasitsakul D, Atamasirikul K, Sungkanuparph S. Curr HIV Res. 2011 Jan 1;9(1):54-60.

25. Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, Vugt MV, Rinke de Wit TF; on behalf of the PharmAccess African (PASER) and TREAT Asia (TASER) Studies to Evaluate Resistance. Int J Epidemiol. 2011 Apr 21.  

26. Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA).Wisniewski T, Klimko N, Laverdiere M, Kiertiburanakul S, Kliasova G, Trenschel R, Kumar RN. Mycoses. 2011 Jul;54(4):e148-53.  Epub 2010 Feb 24.

2010 [Abstract]

1. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. Zhou J, Sirisanthana T, Kiertiburanakul S, Chen YM, Han N, Lim PL, Kumarasamy N, Choi JY, Merati TP, Yunihastuti E, Oka S, Kamarulzaman A, Phanupak P, Lee CK, Li PC, Pujari S, Saphonn V, Law MG. BMC Infect Dis. 2010 Dec 23;10(1):361.
2. Adenovirus infection after kidney transplantation in Thailand: seasonal distribution and potential route of acquisition. Watcharananan SP, Junchotikul P, Srichanrusmi C, Chanchompoo P, Mavichak V, Kantachuvessiri S, Chantratita W. Transplant Proc. 2010 Dec;42(10):4091-3.
3. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. Petoumenos K, Hui E, Kumarasamy N, Kerr SJ, Choi JY, Chen YM, Merati T, Zhang F, Lim PL, Sungkanuparph S, Pujari S, Ponnampalavanar S, Ditangco R, Lee CK, Grulich A, Law MG, Asia Hiv Observational Database T. J Int AIDS Soc. 2010 Dec 10;13(1):51.
4. Prevalence of and risk factors for pre-diabetes in HIV-1-infected patients in Bangkok, Thailand. Srivanich N, Ngarmukos C, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic). 2010 Nov-Dec;9(6):358-61. Epub 2010 Nov 12.
5. Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight. Chaisiri K, Bowonwatanuwong C, Kasettratat N, Kiertiburanakul S.Curr HIV Res. 2010 Oct 1;8(7):504-9.
6. Rhinofacial entomophthoramycosis; a case series and review of the literature. Leopairut J, Larbcharoensub N, Cheewaruangroj W, Sungkanuparph S, Sathapatayavongs B.Southeast Asian J Trop Med Public Health. 2010 Jul;41(4):928-35. Review.
7. Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, Vugt MV, Rinke de Wit TF; on behalf of the PharmAccess African (PASER) and TREAT Asia (TASER) Studies to Evaluate Resistance.Int J Epidemiol. 2010 Nov 10.
8. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, Bohjanen PR, Sungkanuparph S, Easterbrook PJ, French MA, Boulware DR; International Network for the Study of HIV-associated IRIS (INSHI). Lancet Infect Dis. 2010 Nov;10(11):791-802.
9. Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens. Manosuthi W, Mankatitham W, Lueangniyomkul A, Prasithsirikul W, Tantanathip P, Suntisuklappon B, Narkksoksung A, Nilkamhang S, Sungkanuparph S. AIDS Res Ther. 2010 Oct 11;7:37.
10. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study. Manosuthi W, Tantanathip P, Chimsuntorn S, Eampokarap B, Thongyen S, Nilkamhang S, Sungkanuparph S. Int J Infect Dis. 2010 Nov;14(11):e1013-7. Epub 2010 Sep 28.         
11. Intravascular B-cell lymphoma presenting with cauda equina syndrome: the role of skin biopsy. Piyatanont K, Bamrungrak K, Watcharananan S, Sathapatayavongs B, Chuncharunee S, Larbcharoensub N, Witoonpanich R. Eur J Dermatol. 2010 Nov-Dec;20(6):821-2. Epub 2010 Sep 27.           
12. Epidemiology and risk factors of catheter-associated bloodstream infections among intensive care unit patients: an experience from a tertiary care hospital in Thailand. Kiertiburanakul S, Apivanich S, Muntajit T, Somsakul S, Malathum K. J Hosp Infect. 2010 Dec;76(4):369-71. Epub 2010 Sep 17. 
13. Comparison of protease inhibitor (PI) resistance-associated mutations between PI-naïve and PI-experienced HIV-1 infected patients in Thailand Where subtype A/E is predominant. Wiboonchutikul S, Sungkanuparph S, Sukasem C, Wathipthun C, Chantratita W. Curr HIV Res. 2010 Sep 1;8(6):456-60.        
14. Cytomegalovirus, adenovirus, and polyomavirus co-infection among pediatric recipients of allogeneic stem cell transplantation: characteristics and outcome. Watcharananan SP, Kiertiburanakul S, Piyatuctsanawong W, Anurathapan U, Sungkanuparph S, Pakakasama S, Chantratita W, Hongeng S. Pediatr Transplant. 2010 Aug;14(5):675-81. Epub 2010 Apr 13.    
15. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy. Wongprasit P, Manosuthi W, Kiertiburanakul S, Sungkanuparph S. AIDS Patient Care STDS. 2010 Apr;24(4):205-9.       
16. Mortality rates in HIV-infected patients with second failure of antiretroviral therapy are still high: a lesson from NA-ACCORD. Sungkanuparph S. Expert Rev Anti Infect Ther. 2010 Apr;8(4):371-3.     
17. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. Pongsai P, Atamasirikul K, Sungkanuparph S. J Infect. 2010 Jun;60(6):474-7. Epub 2010 Mar 27.    
18. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J, Sirisanthana T, Chen YM, Pujari S, Kumarasamy N, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang FJ, Mean CV, Merati T, Tau G, Smith J, Li PC; TREAT Asia HIV Observational Database. HIV Med. 2010 Sep;11(8):519-29. Epub 2010 Mar 21.       
19. The application of artificial neural networks for phenotypic drug resistance prediction: evaluation and comparison with other interpretation systems. Pasomsub E, Sukasem C, Sungkanuparph S, Kijsirikul B, Chantratita W. Jpn J Infect Dis. 2010 Mar;63(2):87-94.                
20. Immune reconstitution inflammatory syndrome in HIV-infected patients with tuberculosis. Kiertiburanakul S. J Med Assoc Thai. 2010 Feb;93(2):257-64. Review.  
21. Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA). Wisniewski T, Klimko N, Laverdiere M, Kiertiburanakul S, Kliasova G, Trenschel R, Kumar RN. Mycoses. 2010 Feb 24.  
22. Using of nevirapine is associated with intermediate and reduced response to etravirine among HIV-infected patients who experienced virologic failure in a resource-limited setting. Kiertiburanakul S, Wiboonchutikul S, Sukasem C, Chantratita W, Sungkanuparph S. J Clin Virol. 2010 Apr;47(4):330-4. Epub 2010 Feb 25.   
23. H1N1 2009 influenza among healthcare workers in a tertiary care hospital in Thailand. Kiertiburanakul S, Apivanich S, Muntajit T, Sukkra S, Sirinavin S, Leelaudomlipi S, Wananukul W, Satapattayavong B, Malathum K. J Hosp Infect. 2010 Mar;74(3):300-2. Epub 2010 Feb 10.         
24. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure. Watcharananan SP, Suwatanapongched T, Wacharawanichkul P, Chantratitaya W, Mavichak V, Mossad SB. Transpl Infect Dis. 2010 Apr;12(2):127-31. Epub 2010 Jan 20.         
25. Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen. Wangsomboonsiri W, Mahasirimongkol S, Chantarangsu S, Kiertiburanakul S, Charoenyingwattana A, Komindr S, Thongnak C, Mushiroda T, Nakamura Y, Chantratita W, Sungkanuparph S. Clin Infect Dis. 2010 Feb 15;50(4):597-604.                 
26. Successful Viral Suppression With Subsequent Efavirenz-Based Regimen in HIV-1-Infected Patients Who Stop Nevirapine Prior to Discontinuation of the NRTI Backbone. Chimsuntorn S, Sungkanuparph S, Manosuthi W. J Int Assoc Physicians AIDS Care (Chic). 2010 Jan-Feb;9(1):43-5.   
27. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients. Manosuthi W, Chetchotisakd P, Nolen TL, Wallace D, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Pappas PG, Larsen RA, Filler SG, Andes D; BAMSG 3-01 Study Team. HIV Med. 2010 Apr;11(4):276-81. Epub 2009 Dec 8.    
28. Rapid influenza diagnostic test during the outbreak of the novel influenza A/H1N1 2009 in Thailand: an experience with better test performance in resource limited setting. Watcharananan S, Kiertiburanakul S, Chantratita W. J Infect. 2010 Jan;60(1):86-7. Epub 2009 Oct 27.       
29. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD). Zhou J, Li PC, Kumarasamy N, Boyd M, Chen YM, Sirisanthana T, Sungkanuparph S, Oka S, Tau G, Phanuphak P, Saphonn V, Zhang FJ, Omar SF, Lee CK, Ditangco R, Merati TP, Lim PL, Choi JY, Law MG, Pujari S; TREAT Asia HIV Observational Database. HIV Med. 2010 Jan;11(1):31-9. Epub 2009 Jul 6.

2009

• Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure. Manosuthi W, Kiertiburanakul S, Amornnimit W, Prasithsirikul W, Thongyen S, Nilkamhang S, Ruxrungtham K, Sungkanuparph S. AIDS Res Ther. 2009 Dec 23;6(1):30.

• Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients. Manosuthi W, Chetchotisakd P, Nolen T, Wallace D, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Pappas P, Larsen R, Filler S, Andes D; on behalf of the BAMSG 3-01 Study Team. HIV Med.

• Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. Manosuthi W, Van Tieu H, Mankatitham W, Lueangniyomkul A, Ananworanich J, Avihingsanon A, Siangphoe U, Klongugkara S, Likanonsakul S, Thawornwan U, Suntisuklappon B, Sungkanuparph S; N2R Study Team.AIDS. 2009 Nov 27;23(18):2467-71.

• Rapid influenza diagnostic test during the outbreak of the novel influenza A/H1N1 2009 in Thailand: An Experience with Better Test Performance in Resource Limited Setting. Watcharananan S, Kiertiburanakul S, Chantratita W.J Infect. 2009 Oct 27.

• The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients. Nüesch R, Gayet-Ageron A, Chetchotisakd P, Prasithsirikul W, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawasdikul S, Chautrakarn S, Ruxrungtham K, Hirschel B, Anaworanich J; STACCATO study group. Open AIDS J. 2009 Sep 15;3:38-45.

• Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Sungkanuparph S, Filler SG, Chetchotisakd P, Pappas PG, Nolen TL, Manosuthi W, Anekthananon T, Morris MI, Supparatpinyo K, Kopetskie H, Kendrick AS, Johnson PC, Sobel JD, Larsen RA. Clin Infect Dis. 2009 Sep 15;49(6):931-4.

• Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin. Manosuthi W, Sungkanuparph S, Tantanathip P, Mankatitham W, Lueangniyomkul A, Thongyen S, Eampokarap B, Uttayamakul S, Suwanvattana P, Kaewsaard S, Ruxrungtham K; N2R Study Team. Antimicrob Agents Chemother. 2009 Oct;53(10):4545-8.

• A model and risk score for predicting nevirapine-associated rash among HIV-infected patients: in settings of low CD4 cell counts and resource limitation. Kiertiburanakul S, Sungkanuparph S, Malathum K, Watcharananan S, Sathapatayavongs B, Charoenyingwattana A, Mahasirimongkol S, Chantratita W. Open AIDS J. 2009 Jul 8;3:24-30.

• Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD). Zhou J, Li P, Kumarasamy N, Boyd M, Chen Y, Sirisanthana T, Sungkanuparph S, Oka S, Tau G, Phanuphak P, Saphonn V, Zhang F, Omar S, Lee C, Ditangco R, Merati T, Lim P, Choi J, Law M, Pujari S; on behalf of the TREAT Asia HIV Observational Database. HIV Med. 2009 Jul 6.

• Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis. Manosuthi W, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Nolen TL, Zimmer LO, Pappas PG, Larsen RA, Filler SG, Chetchotisakd P; BAMSG 3-01 Study Team. Int J Antimicrob Agents. 2009 Nov;34(5):494-6.

• Emerging of HIV drug resistance: epidemiology, diagnosis, treatment and prevention. Kiertiburanakul S, Sungkanuparph S. Curr HIV Res. 2009 May;7(3):273-8.

• A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Pappas PG, Chetchotisakd P, Larsen RA, Manosuthi W, Morris MI, Anekthananon T, Sungkanuparph S, Supparatpinyo K, Nolen TL, Zimmer LO, Kendrick AS, Johnson P, Sobel JD, Filler SG. Clin Infect Dis. 2009 Jun 15;48(12):1775-83.

• A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study. Manosuthi W, Sungkanuparph S, Tantanathip P, Lueangniyomkul A, Mankatitham W, Prasithsirskul W, Burapatarawong S, Thongyen S, Likanonsakul S, Thawornwa U, Prommool V, Ruxrungtham K; N2R Study Team. Clin Infect Dis. 2009 Jun 15;48(12):1752-9.

• Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region. Hsueh PR, Graybill JR, Playford EG, Watcharananan SP, Oh MD, Ja'alam K, Huang S, Nangia V, Kurup A, Padiglione AA. Int J Antimicrob Agents. 2009 Sep;34(3):205-9.

• Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD). Egger S, Petoumenos K, Kamarulzaman A, Hoy J, Sungkanuparph S, Chuah J, Falster K, Zhou J, Law MG; Asia Pacific HIV Observational Database (APHOD). J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):513-20.

• Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. Zhou J, Elliott J, Li PC, Lim PL, Kiertiburanakul S, Kumarasamy N, Merati TP, Pujari S, Chen YM, Phanuphak P, Vonthanak S, Sirisanthana T, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang F, Tau G, Ditangco R. BMC Infect Dis. 2009 Apr 21;9:46.

• HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Sungkanuparph S, Apiwattanakul N, Thitithanyanont A, Chantratita W, Sirinavin S. Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):83-8.

• Predicting factors for unsuccessful switching from nevirapine to efavirenz in HIV-infected patients who developed nevirapine-associated skin rash. Kiertiburanakul S, Malathum K, Watcharananan S, Sathapatayavongs B, Sungkanuparph S. Int J STD AIDS. 2009 Mar;20(3):176-9.

• Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Clin Infect Dis. 2009 Apr 1;48(7):940-50.

• HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients. Chantarangsu S, Mushiroda T, Mahasirimongkol S, Kiertiburanakul S, Sungkanuparph S, Manosuthi W, Tantisiriwat W, Charoenyingwattana A, Sura T, Chantratita W, Nakamura Y. Pharmacogenet Genomics. 2009 Feb;19(2):139-46.

2008 

• A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand. Poonpiriya V, Sungkanuparph S, Leechanachai P, Pasomsub E, Watitpun C, Chunhakan S, Chantratita W. J Virol Methods. 2008 Jul;151(1):79-86.

• Clinical Presentations of Newly Diagnosed HIV-Infected Patients at a University Hospital in Bangkok, Thailand. Kiertiburanakul S, Boonyarattaphun K, Atamasirikul K, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic Ill). 2008 Jun;7(2):82-7.

• Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S. Jpn J Infect Dis. 2008 Mar;61(2):111-5.

• Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting. Sungkanuparph S, Wongprasit P, Manosuthi W, Atamasirikul K. Southeast Asian J Trop Med Public Health. 2008 Sep;39(5):863-6.

• Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: a 144-week prospective study. Manosuthi W, Tantanathip P, Prasithisirikul W, Likanonsakul S, Sungkanuparph S. BMC Infect Dis. 2008 Oct 14;8:136.

• Effect of Postpartum HIV Treatment Discontinuation on Long-Term Maternal Outcome. Onen NF, Nurutdinova D, Sungkanuparph S, Gase D, Mondy K, Overton ET. J Int Assoc Physicians AIDS Care (Chic Ill). 2008 Sep-Oct;7(5):245-51. Epub 2008 Sep 23.

• Evaluating the role of etravirine in the second-line antiretroviral therapy after failing an initial non-nucleoside reverse transcriptase inhibitor-based regimen in a resource-limited setting. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chantratita W. Curr HIV Res. 2008 Sep;6(5):474-6.

• Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL. Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Chottanapund S, Mankatitham W, Chimsuntorn S, Sittibusaya C, Moolasart V, Chaovavanich A. J Med Assoc Thai. 2008 Feb;91(2):159-65.

• Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. Ananworanich J, Gayet-Ageron A, Ruxrungtham K, Chetchotisakd P, Prasithsirikul W, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, LeBraz M, Jupimai T, Ubolyam S, Schutz M, Hirschel B; Staccato Thailand Study Group. Antivir Ther. 2008;13(3):375-80.

• Mortality rate of early versus deferred initiation of antiretroviral therapy in HIV-1-infected patients with cryptococcal meningitis. Manosuthi W, Chottanapund S, Sungkanuparph S. J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):508-9. No abstract available.

• Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir. Manosuthi W, Sungkanuparph S, Ruxrungtham K, Prasithsirikul W, Athichathanabadi C, Tantisiriwat W, Bowonwatanuwong C, Chumpathat N, Chaovavanich A. J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):127-9. No abstract available.

• Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Saekang N, Pairoj W, Chantratita W. J Clin Virol. 2008 Apr;41(4):310-3. Epub 2008 Mar 7.

• Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting. Manosuthi W, Prasithsirikul W, Chumpathat N, Suntisuklappon B, Athichathanabadi C, Chimsuntorn S, Sungkanuparph S. Int J Infect Dis. 2008 Nov;12(6):582-6. Epub 2008 Mar 11.

• Risk factors for nevirapine-associated rash among HIV-infected patients with low CD4 cell counts in resource-limited settings. Kiertiburanakul S, Sungkanuparph S, Charoenyingwattana A, Mahasirimongkol S, Sura T, Chantratita W. Curr HIV Res. 2008 Jan;6(1):65-9.

• Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin. Manosuthi W, Mankatitham W, Lueangniyomkul A, Chimsuntorn S, Sungkanuparph S. HIV Med. 2008 May;9(5):294-9.

• Streptococcus suis infection and risk factors for mortality. Wangsomboonsiri W, Luksananun T, Saksornchai S, Ketwong K, Sungkanuparph S. J Infect. 2008 Nov;57(5):392-396. Epub 2008 Oct 2.

• Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis. Manosuthi W, Sungkanuparph S, Chottanapund S, Tansuphaswadikul S, Chimsuntorn S, Limpanadusadee P, Pappas PG. Int J STD AIDS. 2008 Apr;19(4):268-71.

• Tipranavir resistance associated mutations in protease inhibitor-naïve patients with HIV-1 subtype A/E infection. Sungkanuparph S, Sukasem C, Manosuthi W, Wiboonchutikul S, Piyavong B, Chantratita W. J Clin Virol. 2008 Nov;43(3):284-6. Epub 2008 Aug 13.

2007 

• Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome. Sungkanuparph S, Chakriyanuyok T, Butthum B. J Infect. 2008 Jan;56(1):40-3. Nov 26.

• Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy. Sungkanuparph S, Eampokalap B, Chottanapund S, Bed ST, Manosuthi W. J Med Assoc Thai. 2007 May;90(5):884-8.

• Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S. Clin Infect Dis. 2007 Aug 15;45(4):421-7.

• Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors. Chetchotisakd P, Anunnatsiri S, Mootsikapun P, Kiertiburanakul S, Anekthananon T, Bowonwatanuwong C, Kowadisaiburana B, Supparatpinyo K, Ruxrungtham K; Study Team. HIV Med. 2007 Nov;8(8):529-35.

• Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients. Kiertiburanakul S, Khongnorasat S, Rattanasiri S, Sungkanuparph S. J Med Assoc Thai. 2007 Feb;90(2):237-43.

• Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients. Ungulkraiwit P, Jongjirawisan Y, Atamasirikul K, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2007 Jul;38(4):680-5.

• HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen. Sungkanuparph S, Kiertiburanakul S, Apisarnthanarak A, Malathum K, Sathapatayavongs B. Int J STD AIDS. 2007 Dec;18(12):832-4.

• Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIV-infected patients with cryptococcal infection. Jongwutiwes U, Kiertiburanakul S, Sungkanuparph S. Curr HIV Res. 2007 May;5(3):355-60.

• Impact of drug-resistant tuberculosis on the survival of HIV-infected patients. Sungkanuparph S, Eampokalap B, Chottanapund S, Thongyen S, Manosuthi W. Int J Tuberc Lung Dis. 2007 Mar;11(3):325-30.

• Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S. J Infect. 2007 Nov;55(5):464-9.

• Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microL. Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Inthong Y, Prasithsirikul W, Chottanapund S, Mankatitham W, Chimsuntorn S, Sittibusaya C, Moolasart V, Chumpathat N, Termvises P, Chaovavanich A. Int J STD AIDS. 2007 Nov;18(11):782-6.

• Incidence and time trend of surgical site infection in Ramathibodi Hospital during the years 2003-2005. Kehachindawat P, Malathum K, Boonsaeng K, Siripornpinyo N, Bhumisirikul P, Kolkalkul J, Lertsithichai P. J Med Assoc Thai. 2007 Jul;90(7):1356-62.

• Invasive aspergillosis in a tertiary-care hospital in Thailand. Kiertiburanakul S, Thibbadee C, Santanirand P. J Med Assoc Thai. 2007 May;90(5):895-902.

• Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response. Jongjirawisan Y, Ungulkraiwit P, Sungkanuparph S. J Med Assoc Thai. 2006 Dec;89(12):2028-34.

• Lipodystrophy and dyslipidemia in human immunodeficiency virus-infected Thai patients receiving antiretroviral therapy. Chuapai Y, Kiertiburanakul S, Malathum K, Sungkanuparph S. J Med Assoc Thai. 2007 Mar;90(3):452-8.

• Logistic regression analysis to predict Medical Licensing Examination of Thailand (MLET) Step1 success or failure. Wanvarie S, Sathapatayavongs B. Ann Acad Med Singapore. 2007 Sep;36(9):770-3.

• Malignancies in HIV-infected Thai patients. Kiertiburanakul S, Likhitpongwit S, Ratanasiri S, Sungkanuparph S. HIV Med. 2007 Jul;8(5):322-3.

• Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis. Manosuthi W, Ruxrungtham K,  Likanonsakul S, Prasithsirikul W, Inthong Y, Phoorisri T, Sungkanuparph S. Clin Infect Dis. 2007 Jan 1;44(1):141-4.

• Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W. Clin Infect Dis. 2007 Feb 1;44(3):447-52.

• Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients. Manosuthi W, Kiertiburanakul S, Chaovavanich A, Sungkanuparph S. J Med Assoc Thai. 2007 Feb;90(2):244-50.

• Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole. Manosuthi W, Athichathanabadi C, Uttayamakul S, Phoorisri T, Sungkanuparph S. BMC Infect Dis. 2007 Mar 12;7:14.

• Predictors of immunity after hepatitis A vaccination in HIV-infected persons. Overton ET, Nurutdinova D, Sungkanuparph S, Seyfried W, Groger RK, Powderly WG. J Viral Hepat. 2007 Mar;14(3):189-93.

• Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting. Sungkanuparph S, Kiertiburanakul S, Apisarnthanarak A, Malathum K, Watcharananan S, Sathapatayavongs B. AIDS Res Ther. 2007 Nov 21;4:26.

• Risk factors for strongyloidiasis hyperinfection and clinical outcomes. Asdamongkol N, Pornsuriyasak P, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2006 Sep;37(5):875-84.

• Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 > or = 50 cells/mm3. Manosuthi W, Chimsuntorn S, Likanonsakul S, Sungkanuparph S.  AIDS Res Ther. 2007 Mar 13;4:6.

• Tenofovir resistance among HIV-infected patients failing a fixed-dose combination of stavudine, lamivudine, and nevirapine in a resource-limited setting. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Chantratitra W. AIDS Patient Care STDS. 2007 Oct;21(10):711-4.

• Timing of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis. Sungkanuparph S, Jongwutiwes U, Kiertiburanakul S. J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):595-6.  

2006 

• Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir. Ananworanich J, Hirschel B, Sirivichayakul S, Ubolyam S, Jupimai T, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, Schutz M, Snowden W, Ruxrungtham K; Staccato Study Team. Antivir Ther. 2006;11(5):631-5.

• Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis. Manosuthi W, Sungkanuparph S, Thongyen S, Chumpathat N, Eampokalap B, Thawornwan U, Foongladda S. J Med Assoc Thai. 2006 Jun;89(6):795-802.

• CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Ananworanich J, Gayet-Ageron A, Le Braz M, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawasdikul S, Sirivichayakul S, Cavassini M, Karrer U, Genné D, Nüesch R, Vernazza P, Bernasconi E, Leduc D, Satchell C, Yerly S, Perrin L, Hill A, Perneger T, Phanuphak P, Furrer H, Cooper D, Ruxrungtham K, Hirschel B; Staccato Study Group; Swiss HIV Cohort Study. Lancet. 2006 Aug 5;368(9534):459-65.

• Clinical and epidemiological analyses of human pythiosis in Thailand. Krajaejun T, Sathapatayavongs B, Pracharktam R, Nitiyanant P, Leelachaikul P, Wanachiwanawin W, Chaiprasert A, Assanasen P, Saipetch M, Mootsikapun P, Chetchotisakd P, Lekhakula A, Mitarnun W, Kalnauwakul S, Supparatpinyo K, Chaiwarith R, Chiewchanvit S, Tananuvat N, Srisiri S, Suankratay C, Kulwichit W, Wongsaisuwan M, Somkaew S. Clin Infect Dis. 2006 Sep 1;43(5):569-76.

• Cryptococcosis in human immunodeficiency virus-negative patients. Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Int J Infect Dis. 2006 Jan;10(1):72-8.

• Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results. Manosuthi W, Kiertiburanakul S, Sungkanuparph S, Ruxrungtham K, Vibhagool A, Rattanasiri S, Thakkinstian A. AIDS. 2006 Jan 2;20(1):131-2.

• Evidence-based medicine in clinical curriculum. Wanvarie S, Sathapatayavongs B, Sirinavin S, Ingsathit A, Ungkanont A, Sirinan C. Ann Acad Med Singapore. 2006 Sep;35(9):615-8.

• High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant. Chetchotisakd P, Anunnatsiri S, Kiertiburanakul S, Sutthent R, Anekthananon T, Bowonwatanuwong C, Kowadisaiburana B, Supparatpinyo K, Horsakulthai M, Chasombat S, Ruxrungtham K; Study  Team. J Int Assoc Physicians AIDS Care (Chic Ill). 2006 Dec;5(4):152-6.

• Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database. Zhou J, Phanupak P, Kiertiburanakul S, Ditangco R, Kamarulzaman A, Pujary S; TREAT Asia HIV Observational Database. J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):501-3.

• Identification of a novel 74-kiloDalton immunodominant antigen of Pythium insidiosum recognized by sera from human patients with pythiosis. Krajaejun T, Kunakorn M, Pracharktam R, Chongtrakool P, Sathapatayavongs B, Chaiprasert A, Vanittanakom N, Chindamporn A, Mootsikapun P. J Clin Microbiol. 2006 May;44(5):1674-80.

• Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S. J Infect. 2006 Dec;53(6):357-63.

• Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash. Manosuthi W, Thongyen S, Chumpathat N, Muangchana K, Sungkanuparph S. HIV Med. 2006 Sep;7(6):378-82.

• Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A. J Infect. 2006 Mar;52(3):188-94.

• Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy. Sungkanuparph S, Groger RK, Overton ET, Fraser VJ, Powderly WG.  HIV Med. 2006 Oct;7(7):437-41.

• Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin. Manosuthi W, Sungkanuparph S, Thakkinstian A, Rattanasiri S, Chaovavanich A, Prasithsirikul W, Likanonsakul S, Ruxrungtham K. Clin Infect Dis. 2006 Jul 15;43(2):253-5.

• Prevalence of thyroid dysfunction in Thai HIV-infected patients. Ketsamathi C, Jongjaroenprasert W, Chailurkit LO, Udomsubpayakul U, Kiertiburanakul S. Curr HIV Res. 2006 Oct;4(4):463-7.

• Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. J Acquir Immune Defic Syndr. 2006 Sep;43(1):42-6.

• Tolerability of HIV postexposure prophylaxis among healthcare workers. Kiertiburanakul S, Wannaying B, Tonsuttakul S, Kehachindawat P, Apivanich S, Somsakul S, Malathum K. J Hosp Infect. 2006 Jan;62(1):112-4.

• Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 > or = 100 cells/mm3. Kiertiburanakul S, Sungkanuparph S, Rattanasiri S, Manosuthi W, Vibhagool A, Thakkinstian A. J Med Assoc Thai. 2006 Sep;89(9):1381-7.

2005 

• A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients. Ananworanich J, Hill A, Siangphoe U, Ruxrungtham K, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, Nuesch R, Cooper DA, Hirschel B; Staccato Study Group. Antivir Ther. 2005;10(6):761-7.

• Antiretroviral resistance among HIV-positive pregnant women who have antiretroviral experience from previous pregnancy. Overton ET, Sungkanuparph S, Nurutdinova D, Powderly WG. AIDS. 2005 Sep 2;19(13):1439.

• Chronic neck ulcer in an immunocompetent host. Manosuthi W, Malathum K, Sungkanuparph S, Laothamatah J, Vorachit M, Nitiyanant P. Lancet Infect Dis. 2005 Mar;5(3):190. No abstract available.

• Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin. Manosuthi W, Sungkanuparph S, Thakkinstian A, Vibhagool A, Kiertiburanakul S, Rattanasiri S, Prasithsirikul W, Sankote J, Mahanontharit A, Ruxrungtham K. AIDS. 2005 Sep 23;19(14):1481-6.

• Initiation of highly active antiretroviral therapy in advanced AIDS with CD4 < 50 cells/mm3 in a resource-limited setting: efficacy and tolerability. Sungkanuparph S, Kiertiburanakul S, Manosuthi W, Kiatatchasai W, Vibhagool A. Int J STD AIDS. 2005 Mar;16(3):243-6.

• Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis. Sungkanuparph S, Overton ET, Seyfried W, Groger RK, Fraser VJ, Powderly WG. Clin Infect Dis. 2005 Nov 1;41(9):1326-32. Epub 2005 Sep 29.

• Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study. Manosuthi W, Chumpathat N, Chaovavanich A, Sungkanuparph S. BMC Infect Dis. 2005 Aug 24;5:67.

• Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Overton ET, Sungkanuparph S, Powderly WG, Seyfried W, Groger RK, Aberg JA. Clin Infect Dis. 2005 Oct 1;41(7):1045-8. Epub 2005 Aug 22.

2004 

• A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency. Chetchotisakd P, Sungkanuparph S, Thinkhamrop B, Mootsikapun P, Boonyaprawit P. HIV Med. 2004 May;5(3):140-3.

• Aspergillosis of the central nervous system: a catastrophic opportunistic infection. Pongbhaesaj P, Dejthevaporn C, Tunlayadechanont S, Witoonpanich R, Sungkanuparph S, Vibhagool A. Southeast Asian J Trop Med Public Health. 2004 Mar;35(1):119-25.

• Case report: Brucellosis: a re-emerging disease in Thailand. Manosuthi W, Thummakul T, Vibhagool A, Vorachit M, Malathum K. Southeast Asian J Trop Med Public Health. 2004 Mar;35(1):109-12.

• Clinical experience with high success rate of antiretroviral therapy in elderly HIV-infected patients. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A. Age Ageing. 2004 Sep;33(5):520-1.

• Concurrent chromomycosis and aspergillosis of the maxillary sinus. Manosuthi W, Sungkanuparph S, Hongmanee P, Sornmayura P, Laothamatah J, Praneetvatakul V. J Med Assoc Thai. 2004 Sep;87(9):1112-5.

• Cryptococcuria as a manifestation of disseminated cryptococcosis and isolated urinary tract infection. Kiertiburanakul S, Sungkanuparph S, Buabut B, Pracharktam R. Jpn J Infect Dis. 2004 Oct;57(5):203-5.

• Efficacy of immunotherapy using antigens of Pythium insidiosum in the treatment of vascular pythiosis in humans. Wanachiwanawin W, Mendoza L, Visuthisakchai S, Mutsikapan P, Sathapatayavongs B, Chaiprasert A, Suwanagool P, Manuskiatti W, Ruangsetakit C, Ajello L. Vaccine. 2004 Sep 9;22(27-28):3613-21.

• Nevirapine- versus efavirenz-based highly active antiretroviral therapy regimens in antiretroviral-naïve patients with advanced HIV infection. Manosuthi W, Sungkanuparph S, Vibhagool A, Rattanasiri S, Thakkinstian A. HIV Med. 2004 Mar;5(2):105-9.

• Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study. Sungkanuparph S, Vibhagool A, Manosuthi W, Kiertiburanakul S, Atamasirikul K, Aumkhyan A, Thakkinstian A. J Med Assoc Thai. 2004 Nov;87(11):1349-54.

• Strongyloidiasis in patients at a comprehensive cancer center in the United States. Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KV. Cancer. 2004 Apr 1;100(7):1531-6.

• Sweet's syndrome: a reaction to non-tuberculous mycobacterial infections. Tuchinda C, Puavilai S, Sathapatayavongs B, Sungkanuparph S, Vibhagool A, Jirasutus S, Rajatanavin N, Timpatanapong P. J Med Assoc Thai. 2004 May;87(5):567-72. Review.

2003

• Chronic diarrhoea caused by Cryptococcus neoformans in a non-human immunodeficiency virus-infected patient. Sungkanuparph S, Tanphaichitra D, Pracharktam R. Scand J Infect Dis. 2003;35(3):211-2.

• Clinical presentation and medical complication in 59 cases of laboratory-confirmed leptospirosis in Bangkok. Ariyapruchya B, Sungkanuparph S, Dumrongkitchaiporn S. Southeast Asian J Trop Med Public Health. 2003 Mar;34(1):159-64.

• Concomitant tuberculous and cryptococcal thyroid abscess in a human immunodeficiency virus-infected patient. Kiertiburanakul S, Sungkanuparph S, Malathum K, Pracharktam R. Scand J Infect Dis. 2003;35(1):68-70.

• Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Vibhagool A, Sungkanuparph S, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C, Ingsathit A. Clin Infect Dis. 2003 May 15;36(10):1329-31.

• Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis. Sungkanuparph S, Vibhagool A, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C, Chantratita W. J Acquir Immune Defic Syndr. 2003 May 1;33(1):118-9.

• Infections with rapidly growing mycobacteria: report of 20 cases. Sungkanuparph S, Sathapatayavongs B, Pracharktam R. Int J Infect Dis. 2003 Sep;7(3):198-205.

• Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis. Sungkanuparph S, Vibhagool A, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C. AIDS. 2003 Sep 26;17(14):2129-31.

• Pneumocystis carinii pneumonia in patients without HIV infection. Saksasithon S, Sungkanuparph S, Thanakitcharu S. J Med Assoc Thai. 2003 Jul;86(7):612-6.

• Rapidly growing mycobacterial infections: spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes. Sungkanuparph S, Sathapatayavongs B, Pracharktam R. J Med Assoc Thai. 2003 Aug;86(8):772-80.

• Restriction of vancomycin use at a university hospital in Thailand. Ayuthya SK, Malathum K, Matangkasombut OP. Am J Health Syst Pharm. 2003 May 15;60(10):1053-4.

• Utilization of restricted antibiotics in a university hospital in Thailand. Ayuthya SK, Matangkasombut OP, Sirinavin S, Malathum K, Sathapatayavongs B. Southeast Asian J Trop Med Public Health. 2003 Mar;34(1):179-86.

2002

• Eubacterium bacteremia and colon cancer. Sungkanuparph S, Chansirikarnjana S, Vorachit M. Scand J Infect Dis. 2002;34(12):941-3.

• Detection of JC virus infection in progressive multifocal leukoencephalopathy: the first documented case in Thailand. Dujneungkunakorn T, Sungkanuparph S, Vibhagool A, Pairoj W, Chantratita W, Srichunrusami C, Laothamatas J, Pulkes T. J Med Assoc Thai. 2002 Oct;85(10):1139-44.

• Spontaneous cryptococcal peritonitis in cirrhotic patients. Sungkanuparph S, Vibhagool A, Pracharktam R. J Postgrad Med. 2002 Jul-Sep;48(3):201-2.

• Correlation between susceptibility of Mycobacterium tuberculosis by microtiter plate alamar blue assay and clinical outcomes. Sungkanuparph S, Pracharktam R, Thakkinstian A, Buabut B, Kiatatchasai W. J Med Assoc Thai. 2002 Jul;85(7):820-4.

• Burkholderia pseudomallei: abscess in an unusual site. Kiertiburanakul S, Sungkanuparph S, Kositchiwat S, Vorachit M. J Postgrad Med. 2002 Apr-Jun;48(2):124-6.

2001

• Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases. Sungkanuparph S, Sathapatayavongs B, Kunachak S, Luxameechanporn T, Cheewaruangroj W. J Med Assoc Thai. 2001 Apr;84(4):593-601.

• In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci. Singh KV, Malathum K, Murray BE. Antimicrob Agents Chemother. 2001 Dec;45(12):3640-3.

• In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification. Duh RW, Singh KV, Malathum K, Murray BE. Microb Drug Resist. 2001 Spring;7(1):39-46.

• Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Singh KV, Malathum K, Murray BE. Antimicrob Agents Chemother. 2001 Jan;45(1):263-6.

• Tuberculous meningitis associated with urinary tract tuberculosis. Chotmongkol V, Kiertiburanakul S. Southeast Asian J Trop Med Public Health. 2001 Jun;32(2):394-6.

2000

• Mycetoma and phaeohyphomycosis caused by Phialophora parasitica in Thailand. Pracharktam R, Chongtrakool P, Sriurairatana S, Sathapatayavongs B. J Med Assoc Thai. 2000 Mar;83 Suppl 1:S42-5.

• Preliminary report for the application of nucleic acid sequence-based amplification in detection of human cytomegalovirus (HCMV) late pp67 mRNA for diagnosis of HCMV infection. Pairoj W, Srichunrusami C, Chantratita W, Bodhiphala P, Sungkanuparph S, Vibhagool A. J Med Assoc Thai. 2000 Mar;83 Suppl 1:S28-34.